US6186145B1 - Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator - Google Patents
Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator Download PDFInfo
- Publication number
- US6186145B1 US6186145B1 US09/336,570 US33657099A US6186145B1 US 6186145 B1 US6186145 B1 US 6186145B1 US 33657099 A US33657099 A US 33657099A US 6186145 B1 US6186145 B1 US 6186145B1
- Authority
- US
- United States
- Prior art keywords
- patient
- virtual reality
- psychological
- microprocessor
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 79
- 238000011282 treatment Methods 0.000 title claims abstract description 65
- 238000003745 diagnosis Methods 0.000 title claims abstract description 32
- 230000002996 emotional effect Effects 0.000 title description 5
- 238000004088 simulation Methods 0.000 claims abstract description 174
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 24
- 230000007246 mechanism Effects 0.000 claims abstract description 23
- 238000012544 monitoring process Methods 0.000 claims abstract description 15
- 238000004590 computer program Methods 0.000 claims abstract description 7
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims description 73
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 68
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims description 68
- 208000020016 psychiatric disease Diseases 0.000 claims description 60
- 238000004891 communication Methods 0.000 claims description 57
- 238000012360 testing method Methods 0.000 claims description 51
- 230000000007 visual effect Effects 0.000 claims description 34
- 238000012545 processing Methods 0.000 claims description 25
- 238000007726 management method Methods 0.000 claims description 22
- 230000003111 delayed effect Effects 0.000 claims description 21
- 230000002452 interceptive effect Effects 0.000 claims description 21
- 230000036541 health Effects 0.000 claims description 16
- 230000004044 response Effects 0.000 claims description 15
- 208000019901 Anxiety disease Diseases 0.000 claims description 13
- 206010012335 Dependence Diseases 0.000 claims description 13
- 201000000980 schizophrenia Diseases 0.000 claims description 11
- 201000009032 substance abuse Diseases 0.000 claims description 11
- 208000013403 hyperactivity Diseases 0.000 claims description 10
- 230000035484 reaction time Effects 0.000 claims description 10
- 230000036506 anxiety Effects 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 9
- 208000019899 phobic disease Diseases 0.000 claims description 9
- 231100000736 substance abuse Toxicity 0.000 claims description 9
- 208000011117 substance-related disease Diseases 0.000 claims description 9
- 238000011269 treatment regimen Methods 0.000 claims description 9
- 206010020710 Hyperphagia Diseases 0.000 claims description 8
- 206010033664 Panic attack Diseases 0.000 claims description 8
- 235000020830 overeating Nutrition 0.000 claims description 8
- 208000019906 panic disease Diseases 0.000 claims description 8
- 231100000867 compulsive behavior Toxicity 0.000 claims description 7
- 230000002093 peripheral effect Effects 0.000 claims description 5
- 239000003368 psychostimulant agent Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- 238000013480 data collection Methods 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 3
- 229940127250 psychostimulant medication Drugs 0.000 claims description 3
- 230000003319 supportive effect Effects 0.000 claims description 3
- 238000013500 data storage Methods 0.000 claims description 2
- 208000035475 disorder Diseases 0.000 abstract description 19
- 239000003814 drug Substances 0.000 description 20
- 229940079593 drug Drugs 0.000 description 19
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 235000013399 edible fruits Nutrition 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- 238000005259 measurement Methods 0.000 description 15
- 238000011056 performance test Methods 0.000 description 12
- 238000013459 approach Methods 0.000 description 10
- 208000006673 asthma Diseases 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 10
- 238000013523 data management Methods 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 230000001276 controlling effect Effects 0.000 description 9
- 238000002405 diagnostic procedure Methods 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 230000006399 behavior Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 230000002354 daily effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 238000009223 counseling Methods 0.000 description 6
- 230000000391 smoking effect Effects 0.000 description 6
- 102000018997 Growth Hormone Human genes 0.000 description 5
- 108010051696 Growth Hormone Proteins 0.000 description 5
- 230000003542 behavioural effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000000122 growth hormone Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000002787 reinforcement Effects 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 241000086550 Dinosauria Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 208000037824 growth disorder Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000008450 motivation Effects 0.000 description 4
- 230000008054 signal transmission Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 description 3
- 208000030814 Eating disease Diseases 0.000 description 3
- 208000019454 Feeding and Eating disease Diseases 0.000 description 3
- 241000220225 Malus Species 0.000 description 3
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000014632 disordered eating Nutrition 0.000 description 3
- 235000005686 eating Nutrition 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000020925 Bipolar disease Diseases 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 208000027534 Emotional disease Diseases 0.000 description 2
- 208000030990 Impulse-control disease Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 240000002836 Ipomoea tricolor Species 0.000 description 2
- 241000406668 Loxodonta cyclotis Species 0.000 description 2
- 208000000810 Separation Anxiety Diseases 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 241000860832 Yoda Species 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 231100000871 behavioral problem Toxicity 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000024732 dysthymic disease Diseases 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- HRANPRDGABOKNQ-ORGXEYTDSA-N (1r,3r,3as,3br,7ar,8as,8bs,8cs,10as)-1-acetyl-5-chloro-3-hydroxy-8b,10a-dimethyl-7-oxo-1,2,3,3a,3b,7,7a,8,8a,8b,8c,9,10,10a-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-1-yl acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1[C@H](O)C[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 HRANPRDGABOKNQ-ORGXEYTDSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 206010010219 Compulsions Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010013486 Distractibility Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 208000001613 Gambling Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- 208000027120 Narcissistic personality disease Diseases 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000181025 Rosa gallica Species 0.000 description 1
- 235000000533 Rosa gallica Nutrition 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 244000107946 Spondias cytherea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- 208000026928 Turner syndrome Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 238000013542 behavioral therapy Methods 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 238000009225 cognitive behavioral therapy Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000010485 coping Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960000632 dexamfetamine Drugs 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000021149 fatty food Nutrition 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 238000009578 growth hormone therapy Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000005548 health behavior Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- JUMYIBMBTDDLNG-OJERSXHUSA-N hydron;methyl (2r)-2-phenyl-2-[(2r)-piperidin-2-yl]acetate;chloride Chemical compound Cl.C([C@@H]1[C@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 JUMYIBMBTDDLNG-OJERSXHUSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005032 impulse control Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000015046 intermittent explosive disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000012961 medicinal therapy Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 208000022821 personality disease Diseases 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 229940099204 ritalin Drugs 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/168—Evaluating attention deficit, hyperactivity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/744—Displaying an avatar, e.g. an animated cartoon character
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/20—Input arrangements for video game devices
- A63F13/23—Input arrangements for video game devices for interfacing with the game device, e.g. specific interfaces between game controller and console
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/45—Controlling the progress of the video game
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/50—Controlling the output signals based on the game progress
- A63F13/52—Controlling the output signals based on the game progress involving aspects of the displayed game scene
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/55—Controlling game characters or game objects based on the game progress
- A63F13/57—Simulating properties, behaviour or motion of objects in the game world, e.g. computing tyre load in a car race game
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/80—Special adaptations for executing a specific game genre or game mode
- A63F13/822—Strategy games; Role-playing games
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/20—Input arrangements for video game devices
- A63F13/21—Input arrangements for video game devices characterised by their sensors, purposes or types
- A63F13/212—Input arrangements for video game devices characterised by their sensors, purposes or types using sensors worn by the player, e.g. for measuring heart beat or leg activity
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/30—Interconnection arrangements between game servers and game devices; Interconnection arrangements between game devices; Interconnection arrangements between game servers
- A63F13/33—Interconnection arrangements between game servers and game devices; Interconnection arrangements between game devices; Interconnection arrangements between game servers using wide area network [WAN] connections
- A63F13/335—Interconnection arrangements between game servers and game devices; Interconnection arrangements between game devices; Interconnection arrangements between game servers using wide area network [WAN] connections using Internet
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/90—Constructional details or arrangements of video game devices not provided for in groups A63F13/20 or A63F13/25, e.g. housing, wiring, connections or cabinets
- A63F13/92—Video game devices specially adapted to be hand-held while playing
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/10—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterized by input arrangements for converting player-generated signals into game device control signals
- A63F2300/1012—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterized by input arrangements for converting player-generated signals into game device control signals involving biosensors worn by the player, e.g. for measuring heart beat, limb activity
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/20—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterised by details of the game platform
- A63F2300/204—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterised by details of the game platform the platform being a handheld device
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/40—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterised by details of platform network
- A63F2300/407—Data transfer via internet
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/50—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterized by details of game servers
- A63F2300/53—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterized by details of game servers details of basic data processing
- A63F2300/535—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game characterized by details of game servers details of basic data processing for monitoring, e.g. of user parameters, terminal parameters, application parameters, network parameters
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/60—Methods for processing data by generating or executing the game program
- A63F2300/63—Methods for processing data by generating or executing the game program for controlling the execution of the game in time
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/60—Methods for processing data by generating or executing the game program
- A63F2300/64—Methods for processing data by generating or executing the game program for computing dynamical parameters of game objects, e.g. motion determination or computation of frictional forces for a virtual car
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/60—Methods for processing data by generating or executing the game program
- A63F2300/66—Methods for processing data by generating or executing the game program for rendering three dimensional images
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/80—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game specially adapted for executing a specific type of game
- A63F2300/807—Role playing or strategy games
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/80—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game specially adapted for executing a specific type of game
- A63F2300/8082—Virtual reality
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/905—Feedback to patient of biological signal other than brain electric signal
Definitions
- the present invention relates to methods and apparatus for diagnosis and treatment of psychological and/or emotional conditions in human patients with the aid of a microprocessor-based virtual reality simulator.
- a patient's behavioral response to his/her medical condition is evaluated and treated in conjunction with other, conventional therapy and is conducted by the primary physician, psychologist, psychiatrist, or other health care specialist.
- a preliminary picture of the patient's emotional condition may be available to the specialist in the form of answers to questionnaires or results from a battery of tests.
- a patient may be experiencing any of a number of psychological conditions and/or disorders for which treatment is desired.
- disorders include schizophrenia, obsessive-compulsive disorder, dysthymic disorder, bipolar disorder, anxiety disorders, and impulse control disorders.
- the patient may be experiencing something that, while not considered to be a full-blown psychological disorder, is nevertheless a stressful, disturbing, and/or undesirable state of mind.
- a child may experience separation anxiety when he or she starts attending school.
- a married couple, confronted with monetary or sexual problems, may seek marriage counseling. During divorce proceedings, psychological evaluations could be conducted to assist in determining custody arrangements. Victims of child abuse may require evaluation to determine an appropriate course of treatment.
- DSM IV Diagnostic and Statistical Manual, Version IV
- This reference work is widely utilized by psychiatrists, psychologists, and other mental health professionals to classify psychological conditions and disorders.
- This reference work sometimes referred to as “DSM IV”
- DSM IV is edited by the American Psychiatric Association.
- the classification criteria tend to be classical categorizations, very academic in nature, and are often inapplicable or meaningless in the context of children and uneducated adults.
- the DSM-IV is geared more towards the general classification of disorders and is not intended to provide an optimized treatment regime for a particular patient suffering from a specific condition.
- ADHD Attention Deficit Hyperactivity Disorder
- indicia inattention, impulsivity, hyperactivity, and boredom.
- these indicia may manifest themselves as behavioral problems, social.maladjustment, aggression and/or academic difficulties. It is estimated that ADHD afflicts 3 to 5 percent of American children. Erickson, M., Behavior Disorders of Children and Adolescents, Prentice Hall, Englewood Cliffs, N.J. (1987); Barkley, R., Attention Deficit Hyperactivity Disorder, The Guilford Press, New York (1990). In many cases, ADHD significantly impairs performance at school. If left untreated, ADHD may continue into adulthood, creating problems at home and on the job.
- These sub-categories of ADHD include (1) the primarily inattentive type; (2) the primarily impulsive-hyperactive type, and (3) the combined type.
- Another object of the invention is to provide methods for monitoring, diagnosing and treating psychological disorders such as schizophrenia, and behavioral disorders and/or conditions such as depression, hyperactivity, phobias, panic attacks, anxiety, overeating, obsessive-compulsive behaviors, addictions and substance abuse, using a microprocessor-based system.
- a further object of the invention is to provide methods for diagnosing psychological disorders and conditions in children using a virtual reality simulation.
- Yet another object is to provide a method and associated apparatus for diagnosis of psychological and emotional disorders in children using a virtual reality simulation.
- Still another object is to provide methods and associated apparatus for the diagnosis of ADHD and sub-categories of ADHD, for those children who have ADHD but are not responsive to psychostimulants.
- Another object is to provide a means for linking the inventive system to a network with a peripheral server capable of receiving, storing, processing, analyzing and exchanging data within the network.
- One aspect of the invention is a microprocessor-controlled virtual reality simulator adapted to receive commands generated by a user suffering a psychological disorder.
- the system generates complex multidimensional virtual reality display outputs to the user characterized by indicia configured and presented in a manner directed to aid in the diagnosis of the psychological disorder.
- the system comprises a control mechanism which uses a stored protocol directed to a specific psychological disorder and/or condition.
- the protocol is comprised of display controlling functions which include programming commands for presenting the display outputs in the form of one or more graphical elements on a display device. These graphical elements are representative of a three-dimensional virtual reality volume.
- the diagnostic system also has an input mechanism for inputting user generated commands which are interactively entered in response to the virtual reality display outputs, and an output mechanism for relaying a series of diagnostic outputs to a health care professional such as a physician or nurse.
- the series of diagnostic outputs are configured so as to provide a presentation of the user's inputs to the health care professional to aid in the diagnosis of the psychological disorder and/or condition presented by the patient.
- the protocol of display controlling functions includes programming commands for manipulating at least one graphical character presented on the display.
- the stored protocol is specifically configured to provide a test battery of continuous performance tasks through displays to the user, and can further comprise a data collection subsystem for storing and analyzing the user's inputs responsive to the test battery, and for relaying the analytic results via the series of diagnostic outputs to the health care professional for diagnosing the psychological disorder.
- the system can further comprise an interfacing mechanism for linking the system to a network.
- the interfacing mechanism may comprise a device for interfacing the microprocessor to the network, and also to at least one peripheral server linked to the network. This server is adapted to receive the inputted user generated commands and the diagnostic outputs, and is also adapted to exchange data within the network.
- the server may include a receiver, a memory device, and a mechanism for processing the inputted user generated commands and the diagnostic outputs.
- the network server may include an optional second microprocessor-controlled data processing unit in communication with the system. This second microprocessor controlled data processing unit is adapted to process and exchange data with the system.
- the psychological disorders and/or conditions contemplated herein may include, by way of illustration but not limitation, obsessive-compulsive disorder, the impulse control disorders (anger control problems, intermittent-explosive disorder), dysthymic disorder, bipolar disorder, narcissistic personality disorder, ADHD, schizophrenia, depression, hyperactivity, phobias, panic attacks, anxiety, overeating, compulsive behaviors, addictions and substance abuse.
- obsessive-compulsive disorder may include, by way of illustration but not limitation, obsessive-compulsive disorder, the impulse control disorders (anger control problems, intermittent-explosive disorder), dysthymic disorder, bipolar disorder, narcissistic personality disorder, ADHD, schizophrenia, depression, hyperactivity, phobias, panic attacks, anxiety, overeating, compulsive behaviors, addictions and substance abuse.
- the invention is also applicable to psychological evaluations in the context of marital counseling, child custody arrangements, separation anxiety, pain management, child abuse investigations, and other potentially stressful situations.
- the invention may also provide for the administration of one or more disorder or condition-specific tests.
- these tests may include auditory and visual delayed reaction time tests for attention.
- the system may comprise an administrator program for configuring these tests.
- Another aspect of the invention is a method for diagnosing a psychological disorder in a human patient.
- electronic instructions are provided that represent an interactive virtual reality simulation configured for that psychological disorder and/or condition.
- the electronic instructions are executed on a microprocessor-based system adapted to receive input data from a patient, and also adapted to provide an interactive three-dimensional display to the patient.
- This system further includes memory device that stores a protocol directed to diagnosis criteria for one or more psychological disorders and/or conditions.
- the electronic instructions are loaded into the microprocessor-based system, and the human patient may optionally be instructed on how to use the microprocessor-based unit to play the virtual reality simulation.
- the inputted data from the patient are collected and analyzed, based on the protocol, to arrive at the diagnosis.
- the method can include analysis of the input data from the patient to categorize whether or not the patient is responsive to maintenance psychostimulants.
- the invention may also encompass a microprocessor-controlled virtual reality simulator directed to the treatment of a psychological disorder.
- the treatment system comprises a controlling mechanism for controlling the system using a stored protocol directed to the psychological disorder in question, comprised of display controlling functions wherein the functions include programming commands for controlling one or more three-dimensional graphical elements presented on a display.
- the treatment system also has an input mechanism for inputting user generated commands which are interactively entered by the user in response to display outputs presented on a multidimensional display mechanism.
- the system also includes an interpreting mechanism for interpreting the inputted user generated commands, then applying the stored protocols to the inputted commands, and based thereon, controlling the output to the display wherein the output is specifically configured to provide a presentation to the user that enhances the treatment of the psychological disorder.
- the stored protocol can also be configured to provide experiential education specific to the psychological disorder. For example, consider a therapeutic system based on treatment for ADHD. The stored protocol may then be configured to provide opportunities to practice activities such as “focus of attention” and “impulse control” while, at the same time, providing supportive and performance feedback, and general information about ADHD and its treatment.
- Also provided is a method for treatment of a psychological disorder in a human patient which initiates with providing the patient with a microprocessor controlled virtual reality simulator capable of interacting with the patient to obtain personal data related to the psychological disorder.
- the obtained personal data is transmitted to another microprocessor controlled system capable of collecting and analyzing the data.
- a compiled report based on the collected and analyzed data is automatically generated by the system and criteria specific to the patient are generated to implement a optimum treatment regimen for the psychological disorder.
- the treatment regimen includes management of psychostimulant medication.
- the invention also encompasses a method for monitoring a psychological disorder in a human patient comprising the steps of encoding electronic instructions for an interactive virtual reality simulation configured for the psychological disorder to be monitored.
- the simulation comprises a microprocessor controlled system capable of receiving input data from and providing a multidimensional interactive display to the patient.
- the system further comprises a stored protocol directed to criteria for monitoring the specific psychological disorder of the patient.
- the monitoring method further comprises the steps of loading the electronic instructions into the microprocessor-based system, instructing the patient on how to use the microprocessor-based unit to play the interactive virtual reality simulation, and monitoring input data from the patient.
- the stored protocol is specifically configured to provide a test battery of continuous performance tasks to the patient through the interactive display, and the input data from the patient in response to the test battery is monitored to facilitate diagnoses and treatment of the psychological disorder.
- FIG. 1 is a block diagram depicting the apparatus system employed in the method according to the invention.
- FIG. 2 is a block diagram of a system employing a handheld microprocessor unit for implementing the method and system of the present invention.
- FIG. 3 is a block diagram that illustrates microprocessor-based patient units connected in signal communication with a clinician's computer system and/or an independent web server through the internet, for collection and analysis of diagnostic data originating with a large number of patient units.
- FIG. 4 is a block diagram illustrating in greater detail the basic structure of a microprocessor-based patient unit and a digital signal processor of a type that can be used by the clinician's PC, an intranet at the clinician's site or by an independent web server.
- FIG. 5 is a flow chart illustrating how to select an appropriate virtual reality simulation treatment for some common medical conditions.
- FIGS. 6 and 7 are exemplary screens of a virtual reality simulation for treating growth disorders.
- FIGS. 8, 9 and 10 are exemplary screens of a virtual reality simulation for self-treatment of diabetes.
- FIG. 11 is a screen indicating the blood glucose measurement results compiled for the virtual reality simulation of FIGS. 8-10.
- FIG. 12A is a general flowchart of an Addiction Distraction virtual reality simulation according to the present invention.
- FIG. 12B is a detailed flowchart of the main game loop of the Addiction/Distraction virtual reality simulation shown in FIG. 12 A.
- FIG. 13 is a flowchart for the Growth virtual reality simulation.
- FIG. 14 illustrates a multidimensional graphic display suitable for use when a microprocessor-based patient unit administers a delayed reaction test in an embodiment of the invention that is configured for diagnostic measurements relating to Attention Deficit Hyperactivity Disorder (ADHD).
- ADHD Attention Deficit Hyperactivity Disorder
- FIG. 15 illustrates a graphic display suitable for use when a microprocessor-based patient unit administers continuous performance tests for diagnostic measurement relating to ADHD.
- FIG. 16 illustrates a graphic display suitable for use when a microprocessor-based patient unit administers continuous performance tests that also include visual distractions for diagnostic measurements for ADHD.
- FIG. 17 is a detailed flowchart for the ADHD virtual reality simulation according to the present invention.
- FIG. 1 shows a block diagram representing a typical embodiment of a computer or microprocessor-based unit 10 capable of supporting virtual reality simulations for patient treatment.
- a microprocessor 12 At the heart of unit 10 is a microprocessor 12 .
- microprocessor 12 can process multidimensional video data representative of a space having at least three dimensions. In more complicated systems, the tasks of microprocessor 12 can be performed by a number of microprocessors.
- a virtual reality display headset or screen 14 is connected to microprocessor 12 .
- the resolution and size of display screen 14 are sufficient to project multidimensional visual images generated by virtual reality simulations.
- Screen 14 can be a high-resolution video screen mounted within a headset or helmet that at least partially encircles the head of the wearer.
- a speaker 15 for producing virtual reality sounds is hooked up to microprocessor 12 as well.
- a patient input device 16 is also connected to microprocessor 12 .
- Input device 16 can be a keyboard, joystick, mouse, button, trigger, light-pen, simulated human hand, tracking ball, or the like, or combinations of these devices.
- a suitable choice of input device 16 is made based on the virtual reality simulation displayed on display screen 14 and the medical conditions of the human patient. The selected input device 16 will thus permit the patient to actively participate in the virtual reality simulation.
- microprocessor-based unit 10 has a memory 18 , which is in communication with microprocessor 12 .
- Memory 18 contains data used by microprocessor 12 to operate unit 10 . While in the exemplary embodiment illustrated in FIG. 1, memory 18 consists of a single unit, configurations with a plurality of memory units, and/or memory units of different types, are possible.
- Unit 10 is also coupled to a digital storage medium 20 and appropriate data reading devices (not shown).
- Digital storage medium 20 can represent, for example, a hard-disk, a floppy disk, a compact disk (CD), a cartridge, a network storage unit, a mechanism for sending signals over a network, a carrier wave, an electromagnetic wave, or any other entity capable of storing and/or conveying electronic instructions for running a virtual reality simulation on unit 10 .
- the ability to store and/or convey a large amount of data is desirable in the context of virtual reality simulations.
- FIG. 2 shows a particularly convenient embodiment for implementing the diagnosis and treatment method.
- a hand-held microprocessor unit 30 is equipped with a video display 34 capable of displaying three-dimensional simulations and a number of input switches or keys 36 a, 36 b, 36 c, 36 d and 36 e, which are mounted on a housing 32 .
- a set of components including a microprocessor, memory circuits and circuitry that interfaces keys 36 a, 36 b, 36 c 36 d and 36 e with the microprocessor is installed inside housing 30 but not shown in FIG. 2 .
- Stored in the memory of programmable hand-held microprocessor unit 30 is a set of electronically encoded program instructions.
- cartridge 38 of FIG. 2 includes read-only memory data encoding the instructions for activating a particular virtual reality simulation.
- Hand-held microprocessor unit 30 may be hooked up to a remote communication unit 42 via a connection cable 40 .
- unit 42 can be a modem capable of communicating over telephone lines, or a radio-frequency transceiver adapted for wireless communication of information.
- Other telecommunications devices known to the art can also be used.
- the embodiment shown in FIG. 2 utilizes a high-speed modem unit 42 .
- a communication line 44 in this event a telephone line, connects unit 42 to a data clearing house 46 and hospital computer 52 .
- This set-up establishes an efficient data pathway from hand-held microprocessor unit 30 to clearing house 46 and hospital computer 52 .
- Clearing house 46 is capable of classifying data and sending appropriate messages concerning the patient's medical condition to a health care professional or physician.
- clearing house 46 is connected by transmission line to a facsimile machine 50 standing in the office of a physician or health care professional.
- a physical parameter measuring device 54 such as a glucose blood meter or a respiratory flow meter, is also connected to hand-held unit 30 .
- Device 54 is designed for patient self-monitoring while engaged in a virtual reality simulation.
- device 54 is capable of downloading measurement data into hand-held microprocessor unit 30 .
- Appropriate choice of device 54 is made by the physician, possibly depending on other system hardware and/or the intended virtual reality simulation to be used for patient treatment.
- FIG. 3 illustrates one embodiment of a diagnostic measurement system configured in accordance with the invention.
- the depicted embodiment includes a programmable microprocessor-based unit 110 that includes a receptacle for receiving an external memory unit 112 , which can be easily inserted and removed from microprocessor-based unit 110 .
- Removable memory unit 112 includes a digital storage medium for storing program instructions that control the operation of microprocessor-based unit 110 and, in addition, allows storage of diagnostic test information that is generated during operation of microprocessor-based unit 110 for diagnostic assessment of a psychological condition.
- Various storage media known to those skilled in the art can be used as the digital storage medium of external memory unit 112 .
- conventional read-only memory (ROM) can be employed for storage of program instructions that are not changed or altered when external memory 112 is reconfigured for a different patient or reconfigured for measurements relating to a different type of psychological condition.
- Optically-scannable memory such as currently-available compact disc memory, can also be employed.
- various types of erasable read-only memory and random access memory (RAM) having a battery back-up can be used to provide a storage medium for program instructions that may be changed when external memory 112 is configured for use with a different patient or for the diagnostic assessment of a different psychological condition.
- Erasable read-only memory or battery backed-up RAM also can be used for storage of information gathered when microprocessor-based unit 110 is operated to gather diagnostic measurement information that relates to one or more psychological conditions.
- program instructions can be transmitted over interactive links to microprocessor-based unit 10 and stored in random access memory.
- microprocessor-based unit 110 is interconnected with an audio/visual display unit 114 equipped to display visual representatives in three or more dimensions.
- microprocessor-based unit 110 generates audio and video signals that are presented to the patient or system user by audio/visual display unit 114 .
- the audio/visual presentation is controlled by program instructions that are either stored in external memory 112 or are otherwise supplied to microprocessor-based unit 110 .
- the visual presentation is structured in the form of a virtual reality simulation to elicit responses from the user of microprocessor-based unit 110 , (e.g., a patient or research subject) so as to provide diagnostic measures relating to a particular psychological condition.
- one preferred embodiment disclosed herein is arranged for diagnostic assessment of Attention Deficit Hyperactivity Disorder (ADHD).
- ADHD Attention Deficit Hyperactivity Disorder
- the invention can be used in the diagnoses of various other psychological conditions and behavior patterns, including anxiety disorders, depression, schizophrenia, addiction, weight control disorders, the disorders and conditions mentioned in the Background of the Invention, and various other psychological disorders and/or conditions as well.
- a primary advantage of the invention is the ability to conduct diagnostic assessment procedures in environments other than a clinician's office or a health care facility.
- This particular aspect of the invention can be important with respect to diagnosing psychological conditions that are highly situation-dependent. Further, since it is not necessary for a clinician to be present when a diagnostic assessment procedure is executed, the costs of diagnosis and treatment are reduced.
- a clinician can instruct a patient or subject in the use of the invention for diagnostic assessment of a particular psychological condition.
- the patient or user uses microprocessor-based unit 110 , a suitably programmed external memory unit 112 , and a multidimensional audio/visual display unit 114 between clinical sessions to gather appropriate diagnostic measurements while the subject is in suitable environmental surroundings (e.g., at home, school, or the workplace). Information gathered during the diagnostic assessment is then made available to the clinician for consideration and analysis.
- the first technique for transferring test results, and/or for programming microprocessor-based unit 110 /external memory unit 112 involves data transmission between processor-based unit 110 and a remotely located clinician's office (or other health care facility).
- Another technique for transferring test results and/or programming utilizes a remotely-situated facility that stores test results for subsequent analysis and transmission to the clinician.
- microprocessor-based unit 110 or external memory unit 112 ) is physically transferred between the site at which the diagnostic assessment is made and the clinician's facility or other remote location.
- FIG. 3 schematically illustrates an arrangement of the invention for remote exchange of data and information between a microprocessor-based unit 110 and either a remotely located clinician 116 or, for example, a web server 118 through the internet which is independent of the clinician.
- independent web server 118 includes one or more digital signal processors sufficient for gathering diagnostic measurement information from a relatively large number of microprocessor-based diagnostic tools represented by microprocessor-based unit 110 and microprocessor-based unit # 2 of FIG. 3 .
- a communications link 120 is shown in FIG. 3 between independent web server 118 and the clinician's remote location 116 to indicate a transfer of information electronically and/or by other signal transmission means.
- Communications link 120 represents any of various ways of communicating information with and/or without the use of wires.
- communications link 120 may represent a signal path established by a telephone system.
- communications link 120 may be implemented using wireless technology, for example, in the form of an RF transceiver.
- RF transceivers, telephone lines, and/or modems can be utilized.
- Communications link 120 may also be established through the use of specialized digital networks, including those provided by interactive audio/video systems that operate using cable television, fiber optic cable, and/or RF communication links.
- Communications link 120 may be equpped to transfer data and information between web server 118 and a clinician by various conventional data transmission systems, including those implemented through the internet such as via HTTP, TCP/IP, and/or others.
- the signals sent by web server 118 to the clinician's facility 116 can be coupled to devices such as the clinician's computer 122 and/or the clincian's facsimile machine 124 . Signals transmitted to the clinician's computer 122 can be stored with or without additional processing.
- analytical signal processing of the diagnostic assessment data gathered by microprocessor-based unit can be performed at various stages of information transmission between patient and clinician.
- data processing can be performed in the microprocessor-based unit 110 , the clinician's computer 122 , web server 118 and/or a data management unit 128 to be described below.
- the diagnostic information when transmitted to the clinician's facility, it can be displayed on a display unit of the clinician's computer 122 , printed by a printer 126 that is connected to computer 122 , or processed by other devices that are peripheral to the clinician's computer 122 .
- the clinicians computer 122 at facility 116 can itself be programmed to be a web server with proper hardware configurations, as will likely be more practical with large numbers of patients and for multi-clinician-based hospitals.
- signals representative of information gathered during a diagnostic assessment procedure are coupled to (or from) independent web server 118 and the microprocessor-based unit 110 via a data management unit 128 and a communications link 130 .
- communications link 120 which provides for the transfer of information between web server 118 and the clinician's facility 116
- communications link 130 may represent any of various ways of communicating information with and/or without the use of wires.
- communications link 130 may represent a signal path established by a telephone system.
- communications link 130 may be implemented using wireless technology, for example, in the form of an RF transceiver.
- Communications link 130 may also be established through the use of specialized digital networks, including those provided by interactive audio/video systems that operate using cable television, fiber optic cable, and/or RF communication links. Communications link 130 may be equpped to transfer data and information between web server 118 and a clinician by various conventional data transmission systems, including those implemented through the internet such as via HTTP, TCP/IP, and/or others.
- data management unit 128 can be interconnected with its associated microprocessor-based unit 110 by a communications link which, for purposes of illustration, is shown as a cable 132 .
- a communications link which, for purposes of illustration, is shown as a cable 132 .
- cable 132 includes electrical conductors and/or fiber optic cable for carrying signals between the two units.
- this cable could be replaced by an IR (infrared) communications link, and/or a wireless communications link, and/or some other type of data communications link.
- Data management unit 128 provides the signal processing that is necessary for interfacing microprocessor-based unit 110 with communications link 130 and/or a communications link 134 .
- Communications link 134 provides for transmission of signals between microprocessor-based unit 110 -and the clinician's remote location 116 (e.g. coupling of signals to and from the clinician's computer 122 ).
- communications link 134 can be implemented in any of a variety of ways.
- data management unit 128 may take on any of various forms and configurations.
- communications link 130 and/or 134 represents a signal path established by a conventional telephone system
- data management unit 128 will include a modem and will operate to perform the signal processing necessary to transmit information to independent web server 118 and/or the clinician's remote location 116 .
- the signal processing required for modem data transmission will be implemented by a microprocessor unit that is incorporated in data management unit 128 .
- the microprocessor of processor-based unit 110 can be employed to perform the signal processing necessary for modem signal transmission.
- the hardware associated with modem transmission e.g. telephone line connection
- FIG. 3 also indicates one manner in which the invention can be employed for remote administration of diagnostic assessment of psychological conditions without the need for data management unit 128 and communications links 130 and 134 .
- an external memory unit 112 can be inserted in a receptacle 138 that electrically connects external memory unit 112 to the clinicians' computer 122 via a cable 136 .
- a clinician or other administrator of the diagnostic assessment to be performed can operate computer 122 to store program instructions appropriate for the diagnostic procedure in an external memory unit 112 .
- the programmed external memory unit 112 can be given to a patient or subject at the end of a clinical session or transmitted to the patient or subject by other appropriate means.
- the patient or subject can subsequently insert the programmed external memory unit 112 in a microprocessor-based unit 110 that is located at the patient's home or some other location at which the virtual reality simulation will be executed. Signals representative of the diagnostic information gathered during the virtual reality simulation are stored in external memory unit 112 when microprocessor unit 110 implements the diagnostic assessment procedure. External memory unit 112 is then returned to the clinician, inserted into receptacle 138 and the clinician's computer 122 is used to retrieve the diagnostic information stored in the external memory unit 112 . In situations in which program instructions and diagnostic results are stored internally in microprocessor-based unit 110 (i.e. without use of an external memory unit 112 ), the entire microprocessor-based unit can be taken to the clinician's office. Information relating to diagnostic assessment results can then be unloaded to the clinician's computer 122 and, if desired, program instructions can be downloaded to the microprocessor-based unit 110 for administering further diagnostic assessment.
- an additional microprocessor-based unit 110 and multidimensional audio/visual display unit 114 will be located at the clinician's office or other facility.
- the additional microprocessor-based unit 110 is directly connected to the clinician's computer 122 by an electrical cable 140 to allow signal transmission between the microprocessor-based unit and computer 122 .
- Providing a microprocessor-based unit 110 and multi-dimensional audio/visual display unit 114 at the clinician's location allows a patient or subject to be instructed in the use of the system and also allows the administration of diagnostic assessment procedures at the clinician's facility, if desired.
- FIG. 4 depicts a detailed block diagram of a microprocessor-based unit 110 that can be employed in the practice of the invention and an associated multidimensional audio/visual display unit 114 .
- a basic block diagram of a remotely located digital signal processing system 142 which typifies the arrangement of web server 118 and computer 122 of FIG. 3 .
- signals supplied by one or more control switches 144 are coupled to a microprocessor 146 of microprocessor-based unit 110 via an input/output circuit 148 .
- an external modem 150 which serves as data management unit 148 (FIG. 3) for the depicted arrangement.
- FIG. 4 it will be understood by those skilled in the art that interconnections such as the connection shown between microprocessor 146 and input/output unit 148 , generally include a data, address, and control bus.
- microprocessor 146 is interconnected with the receptacle that receives an external memory unit 112 so that microprocessor 146 can access virtual reality simulation program instructions stored in external memory unit 112 and store diagnostic assessment results in external memory 112 .
- virtual reality simulation program instructions can be provided to a microprocessor-based unit 110 via a digital signal communications system, instead of an external memory unit 112 .
- digital signals supplied by a system such as cable television or a digital communications can be coupled to microprocessor 146 via input/output unit 148 or other conventional signal processing arrangements.
- a random access memory 152 is interconnected with and is used by microprocessor 146 to implement a desired virtual reality simulation for purposes of diagnostic assessment and to perform any desired analysis of the gathered diagnostic data.
- random access memory 152 can be used for storing program instructions that are supplied to any embodiments of the invention that do not employ an external memory unit 112 (i.e. embodiments in which program instructions are supplied via a digital signal communications system).
- a clock circuit 154 is provided to allow microprocessor 146 to store date and time signals in situations in which date and time tags are to be included with the gathered diagnostic data.
- microprocessor-based unit 110 may include an internal read-only memory for storing various program instructions and data that are not necessarily unique to a particular virtual reality simulation or other application for the microprocessor-based unit 110 .
- the multidimensional audio/visual display unit 114 that is shown in FIG. 4 corresponds to a video display system that includes control circuitry 158 , a speaker 160 , and either or both of a holographic device and one or more display screens 156 .
- These display screens 156 and/or holographic projection devices may, but need not, be incorporated into a helmet which fits over or next to a patient's head.
- microprocessor 146 of microprocessor-based unit 110 controls the operation of a sound generator 162 and video circuits 164 in accordance with the program instructions stored in external memory 112 .
- a display random access memory 166 is used to store and format video signals which are coupled to display screens 156 and/or holographic projection devices of audio/visual display unit 114 .
- Control circuit 158 includes the circuitry necessary for adjusting volume and display quality as well as the circuitry for driving the display unit 114 .
- a television set may be used as part of the audio/visual display unit 114 and/or for speaker 160 , with microprocessor-based unit 110 supplying an appropriate modulated rf signal or being connected to the television set video and/or audio inputs.
- microprocessor-based unit 110 is a virtual reality, multidimensional video system, with external memory unit 112 being configured to correspond to the type of virtual reality simulation that is used with that particular video system.
- Virtual reality simulations are simple and intuitive to use. Therefore, little time is required for instructing a patient or other system user in how to operate the simulation for performance of a particular diagnostic assessment. Even further, a virtual reality simulation provides a convenient way for realizing diagnostic assessment procedures that are presented in game-like or fantasy-like format with animation or other graphics that provide motivation for all age groups while gathering needed diagnostic data. The cumulative effect is achievement of an unobtrusive test and diagnosis arrangement that is acceptable to patients and other subjects and can be used in many environments.
- the remotely located digital signal processing unit 142 may correspond to any of a wide range of computational arrangements, including the clinician's computer 122 and the previously discussed, more complex, web server 118 of FIG. 3 .
- a user interface 170 is connected in signal communication with a central processor unit 172 via a decoder circuit 174 .
- Random access memory 176 and read-only memory 178 can be accessed by central processor unit 172 of digital signal processing unit 142 during execution of the various programs and procedures used in carrying out the invention.
- An input/output unit 180 acts under the direction of central processor unit 172 to provide signals to a facsimile unit 124 and printer 126 . As also is indicated in FIG.
- signals can be provided to central processor unit 172 via input/output unit 180 by a modem 182 .
- a communication link 184 interconnects modem 182 with modem 150 , thus permitting the digital signal processing system to receive diagnostic test information from the microprocessor-based unit 110 .
- Input/output unit 180 can be connected to a receptacle 138 , which, as was described in the context of FIG. 3, allows the digital data processing system to access storage addresses within an external memory unit 112 that is connected to receptacle 138 .
- an administration program that is executable by digital signal processing unit 142 includes a program module that allows program instructions to be stored in an external memory unit 112 to establish a desired diagnostic assessment procedure. Execution of another module of the administration program by digital signal processing unit 142 allows the retrieval of diagnostic test data stored in external memory unit 112 when a diagnostic assessment procedure was conducted (i.e. when a patient or user executed a virtual reality simulation in accordance with a desired diagnostic procedure).
- One currently-preferred embodiment of the invention is directed to the diagnostic assessment of a psychological condition or disorder.
- the specific virtual reality simluation or simulations to be executed by the microprocessor-based unit 110 depend upon the particular disorder and/or condition to be diagnosed. Assume, for purposes of illustration, that attention deficit hyperactivity disorder (ADHD) is to be diagnosed, although it is to be clearly understood that other types of psychological conditions and/or disorders could be evaluated instead.
- ADHD attention deficit hyperactivity disorder
- a set of program instructions are provided to the microprocessor-based unit. These instructions provide virtual reality simulations that effectively perform one or more tests that assess various aspects of an ADHD patient's attention. These program instructions are stored in external memory unit 112 .
- programmable microprocessor-based unit 110 operates to generate an audible and/or multidimensional visual warning signal to alert the user—i.e., the patient—that the microprocessor-based unit soon will produce an audible and/or visual trigger stimulus.
- the trigger stimulus is generated, the patient and/or user activates a designated switch or control of microprocessor-based unit 110 (e.g., a switch, control, or transducer included in control switches 144 of FIG. 4 ).
- This designated switch or control may represent one or more predefined objects or entities of the virtual reality simulation.
- the clinician or other administrator of the virtual reality simulation can select one or more audio delayed reaction tests and/one or more video delayed reaction tests when establishing a battery of virtual reality simulation tests for a particular patient or user.
- the clinician establishes the battery of tests by executing a computer program, which also allows the clinician or administrator to establish the sequence in which various virtual reality simulation tests will be administered and, for each audio or visual delayed reaction test, select both the number of virtual reality trigger stimuli to be generated and a time delay range.
- the time delay range establishes the upper and lower bounds of the delay between virtual reality warning stimuli and virtual reality trigger stimuli.
- the specific delay between a particular warning stimulus and its associated trigger stimulus is selected randomly by microprocessor-based unit 110 when the delayed reaction test is conducted.
- a timer e.g. clock circuit 154 of FIG. 4
- a digital signal is stored indicating a failure to respond.
- a digital signal is stored indicating the user's reaction time (i.e. the time period between the occurrence of a virtual reality trigger stimulus and the patient's reaction).
- the stored data that are accumulated during the virtual reality simulation will allow later analysis to determine various measures that relate to the patient's degree of attention. For example, measures that can be important include the patient's fastest reaction time, his or her mean reaction time, and the standard deviation of reaction times.
- measures that can be important include the patient's fastest reaction time, his or her mean reaction time, and the standard deviation of reaction times.
- the difference between the results for audio and visual delayed reaction tasks may also be considered. For example, young children tend to respond more quickly to audio trigger stimuli than video trigger stimuli.
- the relationship between the results of audio and video delayed reaction tests for a patient may provide some insight as to that patient's relative deficit or development of both auditory and visual attention skills.
- FIG. 5 shows the psychological strategies which the physician can select for treating depression, attention deficit, addiction and/or diabetes.
- the psychological strategies used in the virtual reality simulation may include self-awareness training, self efficacy training, competition, communication and distraction. Other strategies such as positive reinforcement, negative reinforcement, role-playing and the like can be employed as well.
- the psychological treatment strategy can include counseling methods and self-care instructions.
- the treatment strategies can be combined as shown.
- FIG. 5 shows overcoming depression is best accomplished by a therapy which joins self-awareness training with learning self-efficacy to regain control over one's life.
- the medical condition to be treated is an addiction (such as smoking or alcoholism), and the appropriate psychological strategy for treating this condition is determined as distraction.
- the program is embodied within a computer-readable storage medium and/or transmitted using electromagnetic energy.
- the transmission of electromagnetic energy may be accomplished through the use of a carrier wave, and/or through the use of modulation techniques such as single-sideband (SSB) that suppress or eliminate the carrier wave from an electromagnetic signal.
- SSB single-sideband
- the program is embodied in data storage medium 20 (FIG. 1 ).
- the virtual reality simulation program can be loaded from this medium 20 into microprocessor 12 and memory 18 of unit 10 . This can be accomplished conveniently with a CD-ROM disk drive, since digital storage medium 20 is a CD disk.
- the patient receives unit 10 prepared as described above and is instructed by the physician as to how and when to engage the virtual reality simulation.
- the physician may also load several virtual reality simulations at once and instruct the patient as to the appropriate time in which to engage each one.
- the physician will also determine what patient input device 16 should be employed during the virtual reality simulation.
- the patient takes home unit 10 prepared in this manner, and follows the prescribed treatment by engaging the virtual reality simulation. Once in operation, unit 10 displays a multidimensional virtual reality video simulation on display device 14 and receives input through patient input device 16 .
- the beneficial effect of engaging the virtual reality simulation is available to the patient at any time in his/her own environment.
- FIG. 2 A particularly convenient method for delivering a virtual reality simulation to the patient is shown in FIG. 2 .
- Hand-held microprocessor unit 30 receives one or more virtual reality simulation programs from hospital computer 52 .
- the virtual reality simulation program(s) are transmitted over a communications link implemented using any of various techniques for sending information from one location to another.
- this communications link takes the form of a communication line 44 coupled to a remote communication unit 42 which receives information from the communication line 44 .
- Unit 42 downloads the simulation programs into hand-held unit 30 , for example, via connection cable 40 .
- Hand-held unit 30 in FIG. 2 also can communicate with clearing house 46 using a communications link such as, for example, communication line 44 .
- clearing house 46 can be a web server on the internet which is independent of the clinicians. The patient's progress throughout the virtual reality simulation can then be directly monitored by checking a set of simulation scores which are indicative of a patient's performance on the virtual reality simulation. This information is screened, classified, and sorted by clearing house 46 . An abstract or report is transmitted through transmission line 48 to facsimile machine 50 which can be conveniently located in the physician's office.
- Unit 30 shown in FIG. 2 can also be used by the patient to check her medical condition. To do this the patient follows instructions embedded in the virtual reality simulation which tells her to connect to unit 30 , the measuring device 54 (e.g. blood glucose meter in the case of a patient with diabetes). Unit 30 and device 54 may also be hooked up permanently by the physician. The virtual reality simulation instructions tell the patient that to continue the simulation, she needs to perform a regular self-measurement using device 54 .
- the measuring device 54 e.g. blood glucose meter in the case of a patient with diabetes.
- Unit 30 and device 54 may also be hooked up permanently by the physician.
- the virtual reality simulation instructions tell the patient that to continue the simulation, she needs to perform a regular self-measurement using device 54 .
- the measurement data are then downloaded into hand-held unit 30 to be used as input for the interactive video game session.
- An exemplary virtual reality simulation using this technique to collect data is described in Example 4, below.
- the blood glucose-data is also passed through cable 40 to remote communication unit 42 . From there the data follows the same path as described above for the simulation scores, and can be examined by the physician in the hospital.
- the patient has a severe case of nicotine addiction.
- the physician determines, according to the flowchart in FIG. 5, that distraction is the best psychological strategy to induce the patient to quit smoking. (A strategy of punishment is not likely to prove effective). Therefore, the physician prescribes playing the “Quit Gamer”, which is a virtual reality simulation containing a behavioral program based on distraction.
- This simulation contains graphical and/or three-dimensional characters engaging in various competitive activities upon proper input from the user. The smoker plays the game whenever he or she feels the urge to smoke.
- An exemplary virtual reality simulation to provide such an engaging distraction is shown in the flowchart of FIGS. 12A and 12B. In this example, the simulation is designed to distract the player with three-dimensional holographic projections of falling bricks which have to be stacked and arranged in rows.
- the graphical and/or three-dimensional characters communicate to the patient instructions and simple strategies to quit smoking immediately, and advise the user—the patient—to take this approach, all within the context of an entertaining virtual reality simulation.
- the simulation provides a timer and timeline for gradual reduction approaches to smoking cessation. Included among these programs are instructions for using nicotine patches. Built-in notification will serve to remind smokers to shift to a lower dose patch. Once the smoker has quit, the virtual reality simulation will provide a coping/relapse prevention model by using distraction methods during periods of smoking urges.
- An analogous virtual reality simulation strategy may be followed in dealing with other substance abuse conditions, alcoholism, and obsessive-compulsive disorders.
- the physician diagnoses the patient with a growth disorder, such as Turner's Syndrome or a similar condition, requiring growth hormone treatment and a psychological treatment strategy for helping the patient to cope with his or her condition.
- a growth disorder such as Turner's Syndrome or a similar condition
- the physician prescribes a virtual reality simulation combining self-awareness training, self-efficacy, role playing, counseling and competition.
- a 3-dimensional graphical character, Packy is a young elephant who, like the patient, is on growth hormone therapy.
- the simulation consists of three parts, each associated with a particular aspect of the treatment. In the first part, Packy encounters obstacles which he must surmount. In the second, Packy has to learn about growth hormone injections; and, in the third, he has to keep a personal growth diary.
- Packy learns about things that grow, from the smallest things in the world to the largest ones.
- Packy can pick up three-dimensional icons of “OM” (representing a growth hormone shot) for a boost of energy.
- OM representation a growth hormone shot
- Packy can pick up three-dimensional icons of “OM” (representing a growth hormone shot) for a boost of energy.
- OM representation a growth hormone shot
- Packy must push them away by activating a virtual reality transducer to lower his head and walk into them, or he must squirt them by activating another virtual reality transducer.
- Packy has a virtual reality, 3-dimensional dream in which he explores the world as a tiny creature. This scenario is illustrated in FIG. 7 . He finds that he is very small himself, while all the surrounding items are very large. As he works his way to the end of this level, he will encounter all types of three-dimensional animals and insects that are very small. This level will give Packy a feeling for what it is like to be really small. In the transition to the next level, Packy will wake up and see that he is still the same size, and ashamed that he is not so small.
- Packy is accompanied by a 3-D character in the form of a mosquito named Zippy.
- Zippy plays the role of a mentor and counsellor throughout the various levels of Packy's adventures.
- the patient will learn about preparing and administering doses of growth hormone.
- the user will see a virtual reality demonstration of how to mix a dose.
- the user will be provided with virtual reality instructions on how to prepare an injection device, such as a needle and/or a syringe, for injecting the hormone.
- an injection device such as a needle and/or a syringe
- the user will be provided with a virtual reality demonstration showing how an injection is performed. This demonstration may be developed in a manner so as to alleviate any of the use's fears regarding injections.
- the user will be challenged to mix and administer a dose seven times (Monday through Sunday) and provide accurate results.
- the third part of the virtual reality simulation is a growth diary where the patient records and sees various graphics displaying his or her personal progress. Playing this simulation is reassuring and helps children overcome growth disorders by emphasizing self awareness and self-efficacy training, role-playing, competition and counseling strategies embedded in the simulation. Analogous virtual reality simulation strategy is also used to treat anxiety and hyperactivity disorders, various types of phobias, as well as enuresis.
- the flowchart for the growth simulation is provided in FIG. 13 .
- the patient is diagnosed with insulin-dependent diabetes.
- the physician prescribes insulin shots and a virtual reality simulation based on positive-reinforcement and self-management.
- the 3-D game character is a pilot who has diabetes, just like the patients. The pilot needs to follow a proper diet and exercise regimen in order to avoid crashing a plane or balloon which he is flying. Illustrative displays for the simulation are shown in FIG. 8 and FIG. 9 . Eating wrong foods may cause blood glucose levels to increase, and the plane or balloon starts gaining altitude uncontrollably. Eventually, above a certain threshold, the balloon or plane spins out of control.
- the patient is requested to enter his own blood glucose level by using blood glucose meter 54 .
- An exemplary set-up for doing this is shown in FIG. 10 .
- the reading is used in the simulation and can also be transmitted to the hospital, as described in example 3. Also, the user can view his blood glucose readings in the form transmitted to the hospital and used in the simulation. An example of such reading for a number of measurement records is illustrated in FIG. 11 .
- a three-dimensional representative of a plane or balloon disappears behind a representation of clouds, thereby signifying uncertainty in blood glucose levels. This is indicated by the clouds in FIGS. 8 and 9.
- the clouds obscure the pilot's vision and lead to collisions with objects in the plane's or balloon's path.
- the plane or balloon crashes to the ground.
- This positive reinforcement-based strategy in which the blood glucose level is correlated to a virtual reality simulation parameter, e.g. plane altitude, teaches the patient how to cope with his condition on a day-to-day basis, while, at the same time making blood glucose monitoring fun. It also produces higher treatment compliance rates, especially in children who need to learn early on about proper diabetes self-management.
- a virtual reality simulation parameter e.g. plane altitude
- a virtual reality simulation treatment can be used for management of noninsulin dependent cases of diabetes (NIDDM).
- NIDDM noninsulin dependent cases of diabetes
- the simulation is an interactive information resource, as well as a role-playing game.
- the simulation helps the patient, especially an adult patient, explore the topic of Staged Diabetes Management.
- the information could be presented in hypertext format, allowing the patient to select a stage, read a brief overview of it, and select details to examine it in greater depth.
- the simulation encourages active involvement in learning and provides opportunities to rehearse various health behaviors and see the consequences that result by observing what happens to a 3-D game character who displays these behaviors.
- the contents of the simulation may be based on the Staged Diabetes management program, developed by the International Diabetes Center and Becton Dickinson & Company.
- the progressive set of stages ranges from least to most severe. For example, a patient in Stage I will learn to manage NIDDM through diet alone.
- the user can configure the 3-D simulation character in many ways.
- a checklist of choices allows the patient to combine a variety of physical features and clothes, as well as specifics about the character's health status including weight, age, and medications taken.
- the character, and thus the patient will make decisions in realistic settings such as restaurants and parties where rich foods are available.
- an exercise plan will fit in with the character's busy schedule of family, community, and work commitments. This format provides the patient with a playful atmosphere in which choices which the patient faces in his or her own life can be rehearsed.
- the patient is instructed by the 3-D game character to advance to the next treatment steps, eventually arriving at the stage where the patient will be instructed to inject insulin to control blood glucose levels.
- the goal of the NIDDM game is to remain at Stage I.
- a youngster diagnosed with asthma is given an asthma self-management virtual reality simulation for hand-held unit 30 .
- the graphical simulated character a young dinosaur from the pre-historic town of San Saurian, must cope with and manage his asthma.
- the simulated character confronts common asthma triggers, while learning to recognize early warning signs of an oncoming asthmatic episode.
- Asthma management techniques including avoidance, relaxation, and medicinal inhalers, are part of the daily routine for the young dinosaur who must return to his cave.
- the dinosaur runs, jumps and shoots a squirt gun at oncoming triggers while conquering each level and mastering his condition.
- the dinosaur requests the person engaged in the simulation to input his or her asthma condition by using physical parameter measuring device 54 , which in this case is a respiratory flow meter.
- This treatment based on role-playing and positive reinforcement makes the patient aware of the importance of prescribed drugs and teaches appropriate measures for dealing with the patients condition in real life situations.
- the physician determines that the patient suffers from an eating disorder causing the patient to gorge.
- the physician loads into the patient's microprocessor-based unit 10 or hand-held unit 30 a virtual reality simulation in which a graphical game character has to stay thin to survive.
- the challenges confronting the game character include avoiding fatty foods to stay trim, while, at the same time, eating a sufficient amount of healthy foods to combat dragons and surmount obstacles. Doing this involves making choices about what food presented on the screen to eat, keep for later, or reject. Wrong food choices have diet consequences in the graphical character's ability to survive.
- the simulation is scored according to the length of time the patient keep the game character alive, and the number of obstacles the character overcomes.
- the physician instructs the patient to play the simulation every time the patient feels an eating urge outside regular meal times.
- the doctor evaluates the patient's progress and checks the scores obtained in playing the simulation. Based on the analysis of the scores, the physician determines the severity of the problem and obtains an insight into the patient's motivation to comply with the therapy.
- the physician may instruct the patient to play another simulation designed for milder eating disorders, or a simulation utilizing a different psychological approach, e.g. negative reinforcement or distraction.
- a psychiatrist enrolls a patient in a series of home-based interactive virtual reality simulation sessions which the patient accesses from his microprocessor-based unit 10 through hospital network 26 .
- the simulation is then transmitted from the hospital network server 28 to the patient in unit 10 .
- the simulation involves interaction with a graphical game character resembling the Yoda character from the popular movie “Star Wars”.
- Yoda acts as a counselor and mentor to the patient, preparing him for various trial episodes in the simulation.
- the physician reviews how the patient responds to this type of treatment, and prepares another simulation to be transmitted to the patient.
- This treatment method is part of an on-going therapy for mild to medium-severe depression. This approach may also be used for schizophrenia and other psychological disorders.
- a home-based, highly motivating virtual reality simulation that includes continuous performance tasks can serve two important management functions for children with ADHD, both of which are currently unavailable. First, it gives these children opportunities to practice tasks requiring sustained attention and receive performance feedback within an educational simulation designed to improve their knowledge and attitudes about ADHD. Second, it provides a home- or school-based continuous performance task that would have great value as an additional, objective outcome measure in double-blind trials of medication for ADHD.
- an interactive multimedia intervention protocol for ADHD may be performed.
- Such intervention may include two components—(1) a virtual reality simulation that offers experiential education about focusing attention and controlling impulsiveness, and (2) a multimodal assessment for medication management.
- the experiential education simulation provides, in an action oriented simulation, opportunities to practice focus of attention and control of impulses, supportive and educational performance feedback and general information about ADHD and its treatment.
- the medication management system will allow patients to use a virtual reality simulation battery of continuous performance tasks and then send the results via a communications link (i.e., any of various ways of communicating information from one location to another, including wireless as well as wired technology) from home to a central computer that will enable communication of data directly from the child's home to the physician.
- Parents and teachers will respond to behavior rating scales via the communications link so that multimodal assessment can be accomplished conveniently and at low cost on a daily basis.
- the situation-dependent nature of ADHD indicates the need for a comprehensive test, as an attention deficiency is not always apparent in a clinical environment.
- the ADHD intervention allows for a multilateral approach. Data will be collected from parents and teachers through the use of questionnaires they can answer suing the virtual reality simulation.
- Data from the children will include their test results in the simulation, in the form of a battery of Continuous Performance Tasks (CPT battery).
- the simulation coordinating this approach will include a data collection system (electronic questionnaires and CPT battery results), a modem that will send the data from the virtual reality simulation to a central EBM computer via telephone lines, and a data analysis system with statistical tools that can generate clinical reports about individual patients and can aggregate data about many ADHD patients for use in epidemiological research.
- the medication management system which can comprise an intervention simulation, a communications link establishment device and an IBMTM and/or MacTM compatible reporting system will be available to health care providers and researchers.
- the child watches the screen as a car drives past mountain scenery and a line of trees.
- This simulation is designed to assess the test subject's visual continuous performance ability.
- Each tree bears one or more fruits, such as mangoes, grapes, apples, oranges, passion fruit, and/or lemons, one of which is the target fruit and is designated as the signal.
- the child is instructed to press a response button each time the car passes the target fruit. When the button is pressed, a net reaches up from the car to grab the fruit with appropriate sound effects. If the fruit is a correct target fruit, the car speeds up, as evidenced by a shorter interstimulus interval (ISI) between trees and an increase in the pitch of the car engine sound.
- ISI interstimulus interval
- Missing the target fruit, or impulsively pressing on a non-target fruit, will slow the ISI and lower the engine sound, thereby slowing the car. If the child presses the button after the fruit has passed the car, but while it is still on the screen, it is defined as a late hit and the ISI and engine speed are not adjusted. In this way, a miss due to reaction time alone will not be recorded as a miss and the speed will remain constant.
- butterflies, birds, flying saucers, and frogs are also moving on the screen to distract the child from the target stimuli.
- the car In an illustrative virtual reality simulation to test for auditory continuous performance, the car is driving past the trees at night with headlights that illuminate the tree trunks, but incompletely illuminate the fruit in the trees.
- the child must listen for either a high pitched beep (indicating a target) or a low pitched beep (indicating a non-target) and respond accordingly.
- the speed of the trees and the auditory clues from the net and the engine speed continue to reinforce the child on correct hits.
- a digitized voice of a child randomly says “Press it,” “Now,” and “Go” to distract the child from the correct beeps.
- the result of each simulation is sent to the administrator program, which calculates the minimum, mean, standard deviation and number of false starts.
- Each phase of the simulation (visual or auditory, undistracted or distracted) is calculated separately. Thirty-two evenly spaced samples of the ISI may be taken during each phase. These are then averaged for each test, or they can be displayed graphically.
- the administrator program also records the number of targets missed, the number of impulsive hits, and the number of late hits.
- the ADHD intervention has two components—(1) an educational virtual reality simulation and (2) a medication management system.
- the following is a description of the simulation and the medication management system.
- the ADHD virtual reality simulation delivers experiential education by providing opportunities for children to practice their attention skills. It is targeted in terms of themes, characters, reading level, and difficulty of game play-to children ages 6 to 12. Children who play the simulation will engage in continuous performance tasks (CPT's), rehearse attention skills during game play and learn about ADHD, all in the framework of a simulation game.
- CPT's continuous performance tasks
- the simulation When the simulation starts up, it gives the player two options—(1) Races or (2) Game.
- the races are the CPT's and DRT'S.
- the player goes through six in a row and receives a score on each one.
- the faces are used for fan or can be assigned under the supervision of a clinician for assessment, or during double-blind medication trials.
- the tasks are:
- each level of the simulation will require skills that were rehearsed in a previous CPT or DRT.
- Players will receive individualized feedback about their skill in the simulation on these tasks. Feedback will refer to their previous performance in the CPT or DRT.
- Players will receive bonus points for successfully accomplishing the CPT and DRT tasks within the simulation levels.
- buttons for example a red rose, which provides information about ADHD.
- the information deals with symptoms, medication, behavior management, environmental accommodations, social skills, and family and peer relationships.
- each controlling the actions of a rabbit they will soon realize that it is advantageous to cooperate.
- the rabbits will gain the most points if they wait their turn, stay close together (which requires at least one child to pay attention to the location of their partner's rabbit), and give each other what they need (supplies, food, jewels etc.), so both of them can have peak strength and power to meet oncoming challenges.
- the virtual reality simulation will improve the self-concepts and self-esteem of children with ADHD; improve attitudes about ADHD, and increase their motivation to learn more about it; enhance children's willingness to talk about ADHD with friends, family and clinicians; increase children's knowledge about ADHD; teach children some of the skills needed to focus attention and control impulses; and contribute to a decrease in behavioral problems at home and at school.
- the ADHD intervention provides the option to play the races virtual reality simulation only.
- the Races are CPT's and DRT's presented in an appealing and motivating format that children enjoy.
- Double-blind medication trials can occur daily, at home, with data transmitted via modem to a central computer. Patients send their daily data via a telephone link, and the central computer collects, analyzes and reports the data.
- Parents complete on-line rating scales, and teachers fill out paper versions of rating scales. These data are compiled, and a report sent to physicians as soon as the patient's double-blind trials are completed.
- the medication management system supports a multilateral approach to medication management.
- the system provides a convenient way for parents to respond to rating scales and for patients to take a computer-based assessment battery with results sent electronically to clinicians.
- the system reduces the time and clinical costs involved in double-blind trials, and provides a method for administering double-blind trials and a powerful tool for epidemiological researchers to analyze aggregate data collected from ADHD patients.
- Stimulant medication has been repeatedly demonstrated to have a beneficial short-term effect on the core symptoms of ADHD.
- choosing the proper dose and differentiating real therapeutic effects from expectation and placebo effects is not easily done with known methods.
- the virtual reality simulations, in conjunction with medicinal therapy, as presented by this invention enable a determination of the most appropriate dose, and monitor for side effects at different doses.
- the medication monitoring mode of the ADHD intervention is designed to assist in the daily home measurement of medication effects, including a behavioral rating scale, a side effects scale, and a continuous performance test, and to transmit this to the clinician on a daily basis for analysis.
- FIG. 14 shows an exemplary 2-dimensional projection of a 3-dimensional image field projected by the screen display.
- This projection represents an ADHD virtual reality simulation display.
- a car 290 is positioned at a starting line 292 on a roadway or racetrack 294 .
- a traffic signal 296 having a red light 298 , an amber light 200 , and a green light 202 , is prominently displayed.
- microprocessor-based unit 110 FIG. 3
- microprocessor-based unit 110 causes sequential illumination of red light 198 , amber light 200 , and green light 202 .
- Amber light 200 serves as the warning stimulus, with green light 202 providing a trigger stimulus after a randomly generated time delay that is within the time delay range that was established when the visual delayed reaction test being executed was established by the clinician or the administrator having control over the diagnostic testing.
- the words “ready . . . set . . . go” are used with the time interval between “set” and “go” being a random value within A range of values selected when a clinician established the diagnostic procedure.
- Two tones that are clearly distinct from one another also can be used for the warning and trigger stimuli.
- both visual and audible continuous performance tests can be administered. In each test, a sequence or series of events occurs for which the patient or user is to respond by activating a predetermined switch or control such as the control switches 144 in the arrangement of FIG. 4 .
- Performance-pacing refers to the notion that the inter-stimulus interval (i.e. the time that elapses between consecutive stimuli) is reduced by a predetermined amount each time a correct response is made. Likewise, the inter-stimulus interval is increased by the same or a different predetermined amount if an improper response occurs (i.e. the user responds to a non-target stimulus or fails to respond to a target stimulus).
- FIG. 15 A two-dimensional projection of a 3-dimensional image field for an illustrative virtual reality simulation is shown in FIG. 15 .
- This simulation implements continuous performance tests.
- the car 290 that is used in the above-discussed delayed reaction tests is shown traveling along a roadway 294 .
- the car 290 approaches a tree 204 , which is positioned along side roadway 294 .
- various types of fruit ovals, apples, lemons and grapes
- the object is for the patient or user to respond to a specified type of fruit only (e.g. apple 206 in FIG. 15) by depressing a selected switch such as one of the switches of control switches 144 in FIG.
- the display shows an image field including a car 290 traveling at night, with only a portion of roadway 294 being illuminated by the car's headlights.
- a low-frequency radar-like “beep” is heard if the tree does not bear is present, the desired fruit (apple 206 , FIG. 15 ).
- the desired fruit is emitted.
- Embodiments of the invention for diagnostic assessment for ADHD can also include programming for conduction of continuous performance tests that include distractions.
- a 3-D projection of a fluttering butterfly 210 or other moving object, such as a hopping frog or flying saucer can be generated in the peripheral region of the video display to provide a measure of the patient's degree of distractibility.
- synthesized voice signals such as “Now!” or “Go!” can be generated by the microprocessor-based unit 110 (FIG. 3 ). In situations in which synthesized voice is beyond the capability of the sound generator being used, the microprocessor-based unit 110 can supply various distractive sounds or noises.
- simulation instructions can be stored in external memory unit 112 (FIG. 3) or otherwise provided to a microprocessor-based unit, to determine the number of continuous performance tests to be performed and the type of each test (i.e. video without distractions; video with distractions; audio without distractions; and audio with distractions).
- the sequence of the tests is also determined by the clinician.
- the clinician can select the total number of target and non-target stimuli to be presented; the test duration; and the minimum stimulus duration (which is typically set at around 100 milliseconds).
- Diagnostic measures that are recorded in external memory unit 112 during conduction of continuous performance tests include: the number of target stimuli correctly identified (i.e. captured); the number of target stimuli for which the user failed to react (missed stimuli); the number of non-target stimuli for which there was a response; the number of times the button or switch was activated after a stimulus passed (late hits); and the final interstimulus interval (and/or the minimum interstimulus interval attained during the test).
- simulation instructions for establishing the diagnostic assessment procedure e.g. storing suitable program instructions in external memory 112
- retrieval of signals representative of the diagnostic measures gathered during diagnostic testing e.g. accessing information stored in external memory 112
- an administrator program with the clinician's computer ( 122 in FIG. 3; digital signal processing unit 142 in FIG. 4 ).
- a main menu screen is displayed, allowing the clinician to select menu items that include: the opening of a new file (i.e.
- establishing a diagnostic assessment procedure for a new patient or subject opening an existing file; saving a file (storing a diagnostic assessment configuration in memory of the clinician's computer); closing a file; and producing the diagnostic assessment procedure (i.e. storing the appropriate simulation instructions in an external memory 112 or, alternatively, initiating execution of a diagnostic assessment procedure with a microprocessor-based unit 110 that is directly connected to the clinician's computer (FIG. 4 ).
- a method for treating medical conditions in human patients using a microprocessor-based virtual reality simulation gives a better picture of the ailment through its standardized scoring procedure and makes the treatment much less costly by considerably reducing the number of therapy sessions with the physician or health care professional.
- virtual reality simulations provide the opportunity of treatment in the patient's own environment. This leads to self-help responses difficult to foster in therapy sessions.
- the patient recognizes the importance of medications and treatment regimens in an entertaining manner.
- the patient participates actively in the treatment by following instructions embedded in the virtual reality simulation or even generating positive physiological responses due to stimuli presented in the video game.
- the method of the invention also provides a treatment to which the patient can resort as the need arises.
- the intrinsic fun in playing virtual reality simulations ensures higher treatment compliance for all patients, and in particular children.
- the self-treatment instructions communicated by this method can be used to additionally induce patients to independently perform measurements of physical parameters associated with their medical condition.
- the scoring of the simulation provides an excellent standardized measure for evaluating treatment results and improving continued treatment.
- the microprocessor-based system can be expanded to use any number of communications devices, monitoring set-ups, and other state-of-the-art medical equipment. Therefore, the scope of the invention should be determined, not by examples given, but by the appended claims and their substantial equivalents.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Multimedia (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Developmental Disabilities (AREA)
- Human Computer Interaction (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Educational Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
Claims (28)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/336,570 US6186145B1 (en) | 1994-05-23 | 1999-06-21 | Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator |
US10/233,296 US7970620B2 (en) | 1992-11-17 | 2002-08-30 | Multi-user remote health monitoring system with biometrics support |
US10/435,619 US20040019259A1 (en) | 1992-11-17 | 2003-05-08 | Remote monitoring and data management platform |
US11/473,960 US9215979B2 (en) | 1992-11-17 | 2006-06-23 | Multi-user remote health monitoring system |
US11/509,337 US20060285660A1 (en) | 1992-11-17 | 2006-08-24 | Multi-user remote health monitoring system with biometrics support |
US11/509,425 US8407063B2 (en) | 1992-11-17 | 2006-08-25 | Multi-user remote health monitoring system with biometrics support |
US11/511,793 US20060285736A1 (en) | 1992-11-17 | 2006-08-29 | Multi-user remote health monitoring system with biometrics support |
US13/151,527 US8635085B2 (en) | 1992-11-17 | 2011-06-02 | Multi-user remote health monitoring system with biometrics support |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/247,716 US5678571A (en) | 1994-05-23 | 1994-05-23 | Method for treating medical conditions using a microprocessor-based video game |
US08/857,187 US5918603A (en) | 1994-05-23 | 1997-05-15 | Method for treating medical conditions using a microprocessor-based video game |
US08/958,786 US5913310A (en) | 1994-05-23 | 1997-10-29 | Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game |
US09/336,570 US6186145B1 (en) | 1994-05-23 | 1999-06-21 | Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/958,786 Continuation-In-Part US5913310A (en) | 1992-11-17 | 1997-10-29 | Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US49580900A Continuation-In-Part | 1992-11-17 | 2000-02-01 | |
US10/233,296 Continuation-In-Part US7970620B2 (en) | 1992-11-17 | 2002-08-30 | Multi-user remote health monitoring system with biometrics support |
Publications (1)
Publication Number | Publication Date |
---|---|
US6186145B1 true US6186145B1 (en) | 2001-02-13 |
Family
ID=26938859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/336,570 Expired - Lifetime US6186145B1 (en) | 1992-11-17 | 1999-06-21 | Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator |
Country Status (1)
Country | Link |
---|---|
US (1) | US6186145B1 (en) |
Cited By (386)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010011224A1 (en) * | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
US20010047252A1 (en) * | 1997-01-10 | 2001-11-29 | Brown Stephen J. | Disease simulation system and method |
US6335855B1 (en) * | 1998-04-20 | 2002-01-01 | George Alexanian | Battery powered programmable remote switch controller |
WO2001052014A3 (en) * | 2000-01-11 | 2002-01-17 | Health Performance Inc | Medical internet screening system |
US20020016719A1 (en) * | 2000-06-19 | 2002-02-07 | Nemeth Louis G. | Methods and systems for providing medical data to a third party in accordance with configurable distribution parameters |
US20020068857A1 (en) * | 2000-02-14 | 2002-06-06 | Iliff Edwin C. | Automated diagnostic system and method including reuse of diagnostic objects |
WO2002049732A1 (en) * | 2000-12-21 | 2002-06-27 | Telisar Corporation | System and method for portable interactive multi-player games and entertainment |
US20020084902A1 (en) * | 2000-12-29 | 2002-07-04 | Zadrozny Wlodek W. | Translator for infants and toddlers |
US20020086271A1 (en) * | 2000-12-28 | 2002-07-04 | Murgia Paula J. | Interactive system for personal life patterns |
WO2002065120A1 (en) * | 2001-02-13 | 2002-08-22 | Virginia Commonwealth University | Multi-drug titration and evaluation |
US20020120208A1 (en) * | 2001-02-23 | 2002-08-29 | Sun-Il Kim | System and method of providing service for enhancing attention on internet |
US6461297B1 (en) * | 2001-02-16 | 2002-10-08 | Guido Pagnacco | Apparatus and methods for measuring physical disorders |
WO2002062437A3 (en) * | 2001-02-06 | 2002-12-27 | Walton Lamar Moore | Monetary behavior detection in a networked environment method and apparatus |
US20030023387A1 (en) * | 2001-01-30 | 2003-01-30 | Gill-Garrison Rosalynn D. | Computer-assisted means for assessing lifestyle risk factors |
US20030037063A1 (en) * | 2001-08-10 | 2003-02-20 | Qlinx | Method and system for dynamic risk assessment, risk monitoring, and caseload management |
WO2003034912A1 (en) * | 2001-10-26 | 2003-05-01 | Disetronic Licensing Ag | Simulation device for playful evaluation and display of blood sugar levels |
US6595850B2 (en) * | 1998-06-29 | 2003-07-22 | Konami Co., Ltd. | Video game machine, video-game display control method, and computer-readable recording medium containing video game program |
US20030141981A1 (en) * | 2002-01-29 | 2003-07-31 | Tuan Bui | System and method for operating medical devices |
US20030148009A1 (en) * | 2002-02-01 | 2003-08-07 | Unilever Bestfoods North America, Division Of Conopco, Inc. | Process for preserving roasted vegetables |
US20030158755A1 (en) * | 2001-03-01 | 2003-08-21 | Neuman Sherry L. | System and method for conducting drug use evaluation |
US20030199789A1 (en) * | 2002-04-19 | 2003-10-23 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20030199791A1 (en) * | 2002-04-19 | 2003-10-23 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20030204419A1 (en) * | 2002-04-30 | 2003-10-30 | Wilkes Gordon J. | Automated messaging center system and method for use with a healthcare system |
US20030201697A1 (en) * | 2002-04-30 | 2003-10-30 | Richardson William R. | Storage device for health care facility |
US20030216628A1 (en) * | 2002-01-28 | 2003-11-20 | Bortz Jonathan David | Methods and systems for assessing glycemic control using predetermined pattern label analysis of blood glucose readings |
US20030225596A1 (en) * | 2002-05-31 | 2003-12-04 | Richardson Bill R. | Biometric security for access to a storage device for a healthcare facility |
US20040009100A1 (en) * | 1997-12-04 | 2004-01-15 | Agilent Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US20040019259A1 (en) * | 1992-11-17 | 2004-01-29 | Brown Stephen J. | Remote monitoring and data management platform |
US6692258B1 (en) * | 2000-06-26 | 2004-02-17 | Medical Learning Company, Inc. | Patient simulator |
US20040035434A1 (en) * | 2002-08-23 | 2004-02-26 | Easter Anna L. | Rib fracture score and protocol |
US20040049124A1 (en) * | 2002-09-06 | 2004-03-11 | Saul Kullok | Apparatus, method and computer program product to facilitate ordinary visual perception via an early perceptual-motor extraction of relational information from a light stimuli array to trigger an overall visual-sensory motor integration in a subject |
US20040092995A1 (en) * | 2002-04-19 | 2004-05-13 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling with improved sensing |
US6739877B2 (en) * | 2001-03-06 | 2004-05-25 | Medical Simulation Corporation | Distributive processing simulation method and system for training healthcare teams |
US20040121295A1 (en) * | 2002-12-20 | 2004-06-24 | Steven Stuart | Method, system, and program for using a virtual environment to provide information on using a product |
US20040132633A1 (en) * | 2002-02-13 | 2004-07-08 | Carter W Hans | Multi-drug titration and evaluation |
US20040152995A1 (en) * | 2001-05-04 | 2004-08-05 | Cox Daniel J. | Method, apparatus, and computer program product for assessment of attentional impairments |
US6781522B2 (en) | 2001-08-22 | 2004-08-24 | Kivalo, Inc. | Portable storage case for housing a medical monitoring device and an associated method for communicating therewith |
US20040172284A1 (en) * | 2003-02-13 | 2004-09-02 | Roche Diagnostics Corporation | Information management system |
ES2214954A1 (en) * | 2002-12-12 | 2004-09-16 | Universidad De Malaga | TRAINING SIMULATOR WITH EMOTIONAL FEEDBACK. |
US20040199409A1 (en) * | 1992-11-17 | 2004-10-07 | Brown Stephen J. | Remote health monitoring and maintenance system |
US20040220833A1 (en) * | 2003-04-15 | 2004-11-04 | Matthias Joseph A. | System and method for monitoring efficacy of web-based online behavioral clinical study |
US20040254434A1 (en) * | 2003-06-10 | 2004-12-16 | Goodnow Timothy T. | Glucose measuring module and insulin pump combination |
US20050003470A1 (en) * | 2003-06-10 | 2005-01-06 | Therasense, Inc. | Glucose measuring device for use in personal area network |
US20050010444A1 (en) * | 2003-06-06 | 2005-01-13 | Iliff Edwin C. | System and method for assisting medical diagnosis using an anatomic system and cause matrix |
US20050027562A1 (en) * | 1997-01-16 | 2005-02-03 | Brown Stephen J. | Personalized display of health information |
US20050038326A1 (en) * | 2003-05-30 | 2005-02-17 | Michael Mathur | System, device, and method for remote monitoring and servicing |
US20050053902A1 (en) * | 2001-09-28 | 2005-03-10 | Vladimirovich Utolin Konstantin | Method for working out the behavioural strategy of a player using a cognitive virtual reality, device for carrying out said method and an information-carrying medium for said device |
US20050060194A1 (en) * | 2003-04-04 | 2005-03-17 | Brown Stephen J. | Method and system for monitoring health of an individual |
US20050096518A1 (en) * | 2003-10-31 | 2005-05-05 | Yu-Hong Chang | Biological test system |
US20050101979A1 (en) * | 2001-06-12 | 2005-05-12 | Don Alden | Blood sampling apparatus and method |
US20050101980A1 (en) * | 2001-06-12 | 2005-05-12 | Don Alden | Method and apparatus for improving success rate of blood yield from a fingerstick |
US20050177335A1 (en) * | 2000-10-11 | 2005-08-11 | Riddell, Inc. | System and method for measuring the linear and rotational acceleration of a body part |
US20050193252A1 (en) * | 2001-05-08 | 2005-09-01 | Snap-On Technologies, Inc. | Integrated diagnostic system |
US20050216243A1 (en) * | 2004-03-02 | 2005-09-29 | Simon Graham | Computer-simulated virtual reality environments for evaluation of neurobehavioral performance |
US20050228883A1 (en) * | 1997-03-28 | 2005-10-13 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20050260549A1 (en) * | 2004-05-19 | 2005-11-24 | Feierstein Roslyn E | Method of analyzing question responses to select among defined possibilities and means of accomplishing same |
US20060004608A1 (en) * | 1996-10-30 | 2006-01-05 | American Board Of Family Practice, Inc. | Computer architecture and process of patient generation, evolution, and simulation for computer based testing system |
US6985870B2 (en) | 2002-01-11 | 2006-01-10 | Baxter International Inc. | Medication delivery system |
US20060089969A1 (en) * | 1997-03-10 | 2006-04-27 | Health Hero Network, Inc. | System and method for modifying documents sent over a communications network |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US20060135859A1 (en) * | 2004-10-22 | 2006-06-22 | Iliff Edwin C | Matrix interface for medical diagnostic and treatment advice system and method |
US20060155582A1 (en) * | 1992-11-17 | 2006-07-13 | Health Hero Network, Inc. | Modular microprocessor-based power tool system |
US20060150989A1 (en) * | 2005-01-12 | 2006-07-13 | Peter Migaly | Method of diagnosing, treating and educating individuals with and/or about depression |
US20060178687A1 (en) * | 2001-06-12 | 2006-08-10 | Dominique Freeman | Tissue penetration device |
US20060189853A1 (en) * | 1992-11-17 | 2006-08-24 | Health Hero Network, Inc. | Method and system for improving adherence with a diet program or other medical regimen |
US20060189852A1 (en) * | 2000-10-11 | 2006-08-24 | Greenwald Richard M | System and method for evaluating and providing treatment to sports participants |
US20060195128A1 (en) * | 2002-12-31 | 2006-08-31 | Don Alden | Method and apparatus for loading penetrating members |
US7122004B1 (en) * | 1999-08-13 | 2006-10-17 | Interactive Metronome, Inc. | Method and apparatus of enhancing learning capacity |
US20060234202A1 (en) * | 1994-05-23 | 2006-10-19 | Health Hero Network, Inc. | System and method for monitoring a physiological condition |
US20060241975A1 (en) * | 1992-11-17 | 2006-10-26 | Health Hero Network, Inc. | Multi-user remote health monitoring system with biometrics support |
US20060253303A1 (en) * | 1996-10-16 | 2006-11-09 | Brown Stephen J | Multiple patient monitoring system for proactive health management |
US20070008111A1 (en) * | 2005-06-13 | 2007-01-11 | Tice Lee D | System for monitoring activities and location |
US20070016447A1 (en) * | 1996-12-23 | 2007-01-18 | Brown Stephen J | Network media access control system for encouraging patient compliance with a treatment plan |
US20070021984A1 (en) * | 2001-03-14 | 2007-01-25 | Health Hero Network, Inc. | Interactive patient communication development system for reporting on patient healthcare management |
US20070038235A1 (en) * | 2002-04-19 | 2007-02-15 | Freeman Dominique M | Method and apparatus for penetrating tissue |
US20070043305A1 (en) * | 2002-04-19 | 2007-02-22 | Dirk Boecker | Method and apparatus for penetrating tissue |
US20070078818A1 (en) * | 2005-06-09 | 2007-04-05 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US20070083089A1 (en) * | 2005-09-14 | 2007-04-12 | Tice Lee D | In-residence monitoring system incorporating voice output |
US20070094049A1 (en) * | 1992-11-17 | 2007-04-26 | Brown Stephen J | Method and apparatus for remote health monitoring and providing health related information |
US20070142747A1 (en) * | 2002-04-19 | 2007-06-21 | Dirk Boecker | Method and apparatus for penetrating tissue |
US20070166690A1 (en) * | 2005-12-27 | 2007-07-19 | Bonnie Johnson | Virtual counseling practice |
US20070167875A1 (en) * | 2002-04-19 | 2007-07-19 | Dominique Freeman | Method and apparatus for penetrating tissue |
US20070179356A1 (en) * | 2005-12-29 | 2007-08-02 | Guidance Interactive Healthcare, Inc. | Programmable devices, systems and methods for encouraging the monitoring of medical parameters |
US7260480B1 (en) | 2003-04-07 | 2007-08-21 | Health Hero Network, Inc. | Method and system for integrating feedback loops in medical knowledge development and healthcare management |
US20070207449A1 (en) * | 2005-05-19 | 2007-09-06 | Feierstein Roslyn E | Method of analyzing question responses to select among defined possibilities and means of accomplishing same |
US20070213989A1 (en) * | 2006-03-08 | 2007-09-13 | Cooksy Douglas A | Task Minder System |
US20070213756A1 (en) * | 2002-04-19 | 2007-09-13 | Dominique Freeman | Method and apparatus for penetrating tissue |
US20070213998A1 (en) * | 2005-12-29 | 2007-09-13 | Butler Stephen F | National addictions vigilance, intervention and prevention program |
US20070226690A1 (en) * | 2006-02-08 | 2007-09-27 | Microsoft Corporation | In source code suppression of binary analysis |
US20070260271A1 (en) * | 2002-04-19 | 2007-11-08 | Freeman Dominique M | Device and method for variable speed lancet |
US7305348B1 (en) | 1996-02-20 | 2007-12-04 | Health Hero Network, Inc. | Aggregating and pooling health related information in a communication system with feedback |
US20070288266A1 (en) * | 2006-06-02 | 2007-12-13 | Suzanne Sysko | System and methods for chronic disease management and health assessment |
US20070299321A1 (en) * | 1992-11-17 | 2007-12-27 | Brown Stephen J | Method and apparatus for remote health monitoring and providing health related information |
US7316700B2 (en) | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US20080006700A1 (en) * | 2006-07-06 | 2008-01-10 | Zume Life | Method and apparatus for identifying and scheduling medicine intake |
US20080015422A1 (en) * | 2005-12-29 | 2008-01-17 | Guidance Interactive Healthcare, Inc. | Combined peripheral and health monitoring devices |
US20080033767A1 (en) * | 1998-09-25 | 2008-02-07 | Brown Stephen J | Dynamic modeling and scoring risk assessment |
US20080032267A1 (en) * | 2006-08-03 | 2008-02-07 | Suzansky James W | Multimedia system and process for medical, safety, and health improvements |
US20080045811A1 (en) * | 1997-03-13 | 2008-02-21 | Clinical Decision Support, Llc | Disease management system and method including significant symptom filtering |
US20080052119A1 (en) * | 1993-12-29 | 2008-02-28 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US20080052318A1 (en) * | 1993-12-29 | 2008-02-28 | Clinical Decision Support, Llc | Computerized medical diagnostic system utilizing list-based processing |
US20080059227A1 (en) * | 2006-08-31 | 2008-03-06 | Geoffrey Clapp | Health related location awareness |
US20080060955A1 (en) * | 2003-07-15 | 2008-03-13 | Therasense, Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US7344894B2 (en) | 2001-10-16 | 2008-03-18 | Agilent Technologies, Inc. | Thermal regulation of fluidic samples within a diagnostic cartridge |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US7374544B2 (en) | 2002-04-19 | 2008-05-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20080124689A1 (en) * | 2006-11-27 | 2008-05-29 | Pharos Innovations, Llc | Calculating a behavioral path based on a statistical profile |
US20080126276A1 (en) * | 2006-11-27 | 2008-05-29 | Pharos Innovations, Llc | Optimizing behavioral change based on a population statistical profile |
US20080126277A1 (en) * | 2006-11-27 | 2008-05-29 | Pharos Innovations, Llc | Optimizing behavioral change based on a patient statistical profile |
US7383358B1 (en) * | 1999-12-29 | 2008-06-03 | Ge Medical Technology Services, Inc. | System and method for remote servicing of in-field product |
US20080146892A1 (en) * | 2006-12-19 | 2008-06-19 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US20080146888A1 (en) * | 2006-12-15 | 2008-06-19 | General Electric Company | System and method for in-situ mental health monitoring and therapy administration |
US20080154177A1 (en) * | 2006-11-21 | 2008-06-26 | Baxter International Inc. | System and method for remote monitoring and/or management of infusion therapies |
US7399276B1 (en) | 2003-05-08 | 2008-07-15 | Health Hero Network, Inc. | Remote health monitoring system |
US7401111B1 (en) * | 1997-12-04 | 2008-07-15 | Roche Diagnostic Operations, Inc. | Instrument setup utility program |
US7410468B2 (en) | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20080219319A1 (en) * | 2007-01-05 | 2008-09-11 | Jay Buckalew | Biological parameter monitoring system and method therefor |
US20080220400A1 (en) * | 2004-03-18 | 2008-09-11 | Cox Daniel J | Method, Apparatus, And Computer Program Product For Stochastic Psycho-Physiological Assessment Of Attentional Impairments |
US20080228040A1 (en) * | 2007-03-16 | 2008-09-18 | Arthur Solomon Thompson | International medical expert diagnosis |
US20080242949A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080242951A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Effective low-profile health monitoring or the like |
US20080243005A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080242950A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080243543A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Effective response protocols for health monitoring or the like |
US20080242948A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Effective low-profile health monitoring or the like |
US20080242952A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liablity Corporation Of The State Of Delaware | Effective response protocols for health monitoring or the like |
US20080280276A1 (en) * | 2007-05-09 | 2008-11-13 | Oregon Health & Science University And Oregon Research Institute | Virtual reality tools and techniques for measuring cognitive ability and cognitive impairment |
US20080287821A1 (en) * | 2007-03-30 | 2008-11-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080294462A1 (en) * | 2007-05-23 | 2008-11-27 | Laura Nuhaan | System, Method, And Apparatus Of Facilitating Web-Based Interactions Between An Elderly And Caregivers |
US20080306770A1 (en) * | 2007-02-22 | 2008-12-11 | Sysko Ryan A | Systems and methods for disease control and management |
US20080319276A1 (en) * | 2007-03-30 | 2008-12-25 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20090005654A1 (en) * | 2007-03-30 | 2009-01-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20090005653A1 (en) * | 2007-03-30 | 2009-01-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20090018407A1 (en) * | 2007-03-30 | 2009-01-15 | Searete Llc, A Limited Corporation Of The State Of Delaware | Computational user-health testing |
US20090024050A1 (en) * | 2007-03-30 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20090097757A1 (en) * | 2007-10-15 | 2009-04-16 | Casey Wimsatt | System and method for teaching social skills, social thinking, and social awareness |
US7524293B2 (en) | 2002-04-19 | 2009-04-28 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20090112620A1 (en) * | 2007-10-30 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Polling for interest in computational user-health test output |
US20090112617A1 (en) * | 2007-10-31 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing responsive to a user interaction with advertiser-configured content |
US20090112616A1 (en) * | 2007-10-30 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Polling for interest in computational user-health test output |
US20090118593A1 (en) * | 2007-11-07 | 2009-05-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Determining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content |
US20090119154A1 (en) * | 2007-11-07 | 2009-05-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Determining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content |
US20090125333A1 (en) * | 2007-10-12 | 2009-05-14 | Patientslikeme, Inc. | Personalized management and comparison of medical condition and outcome based on profiles of community patients |
US20090132275A1 (en) * | 2007-11-19 | 2009-05-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Determining a demographic characteristic of a user based on computational user-health testing |
US7537571B2 (en) | 2001-06-12 | 2009-05-26 | Pelikan Technologies, Inc. | Integrated blood sampling analysis system with multi-use sampling module |
WO2009097344A1 (en) * | 2008-01-28 | 2009-08-06 | Chris Zois | Video game and method of play |
US7582063B2 (en) | 2000-11-21 | 2009-09-01 | Pelikan Technologies, Inc. | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US7582099B2 (en) | 2002-04-19 | 2009-09-01 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7587287B2 (en) | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US20090253973A1 (en) * | 2008-04-04 | 2009-10-08 | Eran Bashan | Apparatus for optimizing a patient's insulin dosage regimen |
US7604592B2 (en) | 2003-06-13 | 2009-10-20 | Pelikan Technologies, Inc. | Method and apparatus for a point of care device |
US20090267758A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and apparatus for measuring a bioactive agent effect |
US20090270688A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting a combination treatment |
US20090271375A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment selection methods and systems |
US20090271010A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment alteration methods and systems |
US20090271347A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US20090271122A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20090271009A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment modification methods and systems |
US20090269329A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination Therapeutic products and systems |
US20090271213A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Corporation Of The State Of Delaware | Combination treatment selection methods and systems |
US20090271219A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The Stste Of Delaware | Methods and systems for presenting a combination treatment |
US20090271011A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US20090270693A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for modifying bioactive agent use |
US20090270692A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment alteration methods and systems |
US20090271120A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US20090271121A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for detecting a bioactive agent effect |
US20090270786A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting a combination treatment |
US20090270694A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20090271217A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Side effect ameliorating combination therapeutic products and systems |
US20090271215A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for detecting a bioactive agent effect |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US20090292676A1 (en) * | 2008-04-24 | 2009-11-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment selection methods and systems |
US20090312668A1 (en) * | 2008-04-24 | 2009-12-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20090319301A1 (en) * | 2008-04-24 | 2009-12-24 | Searete Llc, A Limited Liability Corporation Of The State Of Delawar | Methods and systems for presenting a combination treatment |
US20100004762A1 (en) * | 2008-04-24 | 2010-01-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US20100017001A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100015583A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and method for memory modification |
US20100022820A1 (en) * | 2008-04-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100030089A1 (en) * | 2008-04-24 | 2010-02-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20100041964A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20100041958A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc | Computational system and method for memory modification |
US20100042578A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100076249A1 (en) * | 2008-04-24 | 2010-03-25 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100077458A1 (en) * | 2008-09-25 | 2010-03-25 | Card Access, Inc. | Apparatus, System, and Method for Responsibility-Based Data Management |
US7689438B1 (en) * | 1999-11-19 | 2010-03-30 | Microsoft Corporation | Method, apparatus and system for communicating healthcare information to and from a portable, hand-held device |
US20100081860A1 (en) * | 2008-04-24 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and Method for Memory Modification |
US20100100036A1 (en) * | 2008-04-24 | 2010-04-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and Method for Memory Modification |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
WO2010056718A2 (en) * | 2008-11-11 | 2010-05-20 | Hygieia, Inc. | Apparatus and system for diabetes management |
US20100125561A1 (en) * | 2008-04-24 | 2010-05-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100163036A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7780595B2 (en) | 2003-05-15 | 2010-08-24 | Clinical Decision Support, Llc | Panel diagnostic method and system |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US20100280332A1 (en) * | 2008-04-24 | 2010-11-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US7833171B2 (en) | 2002-04-19 | 2010-11-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20100301620A1 (en) * | 2009-05-27 | 2010-12-02 | Don Mei Tow | Multi-Function Chopsticks |
US20100311023A1 (en) * | 2009-05-07 | 2010-12-09 | Kan Kevin Gar Wah | Systems amd methods for evaluating neurobehavioural performance from reaction time tests |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7860544B2 (en) | 1998-04-30 | 2010-12-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US7874994B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7891125B1 (en) | 2001-09-07 | 2011-02-22 | Piccirillo Emily H | Therapeutic methods and apparatuses for processing an emotion triggering event |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US20110118555A1 (en) * | 2009-04-29 | 2011-05-19 | Abhijit Dhumne | System and methods for screening, treating, and monitoring psychological conditions |
US7959582B2 (en) | 2002-04-19 | 2011-06-14 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8027809B2 (en) | 1992-11-17 | 2011-09-27 | Health Hero Network, Inc. | Home power management system |
US8032399B2 (en) | 1994-04-26 | 2011-10-04 | Health Hero Network, Inc. | Treatment regimen compliance and efficacy with feedback |
US8078407B1 (en) | 1997-03-28 | 2011-12-13 | Health Hero Network, Inc. | System and method for identifying disease-influencing genes |
US8078431B2 (en) | 1992-11-17 | 2011-12-13 | Health Hero Network, Inc. | Home power management system |
US8095340B2 (en) | 1992-11-17 | 2012-01-10 | Health Hero Network, Inc. | Home power management system |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8149117B2 (en) | 2007-05-08 | 2012-04-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
USRE43433E1 (en) | 1993-12-29 | 2012-05-29 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8234128B2 (en) | 2002-04-30 | 2012-07-31 | Baxter International, Inc. | System and method for verifying medical device operational parameters |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20120265591A1 (en) * | 2011-04-14 | 2012-10-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US8333710B2 (en) | 2002-04-19 | 2012-12-18 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20130281798A1 (en) * | 2012-04-23 | 2013-10-24 | Sackett Solutions & Innovations, LLC | Cognitive biometric systems to monitor emotions and stress |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8626521B2 (en) | 1997-11-21 | 2014-01-07 | Robert Bosch Healthcare Systems, Inc. | Public health surveillance system |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US20140065585A1 (en) * | 2012-09-03 | 2014-03-06 | Sheri Kemp Osborn | System and method for assessing and improving a users life skills and self-efficacy for life stage readiness |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8775196B2 (en) | 2002-01-29 | 2014-07-08 | Baxter International Inc. | System and method for notification and escalation of medical data |
US8797165B2 (en) | 2000-10-11 | 2014-08-05 | Riddell, Inc. | System for monitoring a physiological parameter of players engaged in a sporting activity |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US8876688B2 (en) | 2008-04-24 | 2014-11-04 | The Invention Science Fund I, Llc | Combination treatment modification methods and systems |
US20140349261A1 (en) * | 2013-05-22 | 2014-11-27 | Personal Zen Ventures, Llc | Therapeutic video game device and method |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20150072322A1 (en) * | 2006-12-27 | 2015-03-12 | Case Western Reserve University | Situated simulation for training, education, and therapy |
US8989830B2 (en) | 2009-02-25 | 2015-03-24 | Valencell, Inc. | Wearable light-guiding devices for physiological monitoring |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US9005119B2 (en) | 1993-12-29 | 2015-04-14 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system including network access |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US9044180B2 (en) | 2007-10-25 | 2015-06-02 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9220456B2 (en) | 2008-04-04 | 2015-12-29 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9233204B2 (en) | 2014-01-31 | 2016-01-12 | Aseko, Inc. | Insulin management |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9289175B2 (en) | 2009-02-25 | 2016-03-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
WO2015181634A3 (en) * | 2014-05-15 | 2016-03-24 | Changebud Pty Limited | Methods, systems and user interfaces for behavioral learning |
EP2638534A4 (en) * | 2010-11-11 | 2016-04-06 | Univ California | ENHANCEMENT OF COGNITION IN THE PRESENCE OF DISTRACTION AND / OR INTERRUPTION |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
CN105559802A (en) * | 2015-07-29 | 2016-05-11 | 北京工业大学 | Tristimania diagnosis system and method based on attention and emotion information fusion |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9427191B2 (en) | 2011-07-25 | 2016-08-30 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
US9538921B2 (en) | 2014-07-30 | 2017-01-10 | Valencell, Inc. | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9585616B2 (en) | 2014-11-17 | 2017-03-07 | Elwha Llc | Determining treatment compliance using speech patterns passively captured from a patient environment |
US9589107B2 (en) | 2014-11-17 | 2017-03-07 | Elwha Llc | Monitoring treatment compliance using speech patterns passively captured from a patient environment |
WO2017066340A1 (en) | 2015-10-12 | 2017-04-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Virtual reality systems and methods for improving clinical outcomes |
US20170231560A1 (en) * | 2008-04-24 | 2017-08-17 | Searete Llc | Systems and apparatus for measuring a bioactive agent effect |
US9750462B2 (en) | 2009-02-25 | 2017-09-05 | Valencell, Inc. | Monitoring apparatus and methods for measuring physiological and/or environmental conditions |
US9794653B2 (en) | 2014-09-27 | 2017-10-17 | Valencell, Inc. | Methods and apparatus for improving signal quality in wearable biometric monitoring devices |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9801552B2 (en) | 2011-08-02 | 2017-10-31 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US9886556B2 (en) | 2015-08-20 | 2018-02-06 | Aseko, Inc. | Diabetes management therapy advisor |
US9892234B2 (en) | 2014-10-27 | 2018-02-13 | Aseko, Inc. | Subcutaneous outpatient management |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US9987489B2 (en) | 2015-03-27 | 2018-06-05 | Elwha Llc | Controlling ear stimulation in response to electrical contact sensing |
US10015582B2 (en) | 2014-08-06 | 2018-07-03 | Valencell, Inc. | Earbud monitoring devices |
US10016554B2 (en) | 2008-07-09 | 2018-07-10 | Baxter International Inc. | Dialysis system including wireless patient data |
US10039928B2 (en) | 2015-03-27 | 2018-08-07 | Equility Llc | Ear stimulation with neural feedback sensing |
US10061899B2 (en) | 2008-07-09 | 2018-08-28 | Baxter International Inc. | Home therapy machine |
US10076253B2 (en) | 2013-01-28 | 2018-09-18 | Valencell, Inc. | Physiological monitoring devices having sensing elements decoupled from body motion |
US10173008B2 (en) | 2002-01-29 | 2019-01-08 | Baxter International Inc. | System and method for communicating with a dialysis machine through a network |
US10188890B2 (en) | 2013-12-26 | 2019-01-29 | Icon Health & Fitness, Inc. | Magnetic resistance mechanism in a cable machine |
US20190033914A1 (en) * | 2014-09-11 | 2019-01-31 | Interaxon Inc. | System and method for enhanced training using a virtual reality environment and bio-signal data |
US10220259B2 (en) | 2012-01-05 | 2019-03-05 | Icon Health & Fitness, Inc. | System and method for controlling an exercise device |
US10226396B2 (en) | 2014-06-20 | 2019-03-12 | Icon Health & Fitness, Inc. | Post workout massage device |
US10272317B2 (en) | 2016-03-18 | 2019-04-30 | Icon Health & Fitness, Inc. | Lighted pace feature in a treadmill |
US10278633B1 (en) | 2014-06-23 | 2019-05-07 | Corman Attention Technologies, LLC | Systems and methods for assisting diagnosing and/or titrating medication for predetermined conditions and assessing the effectiveness of medication prescribed for a predetermined condition |
US10279212B2 (en) | 2013-03-14 | 2019-05-07 | Icon Health & Fitness, Inc. | Strength training apparatus with flywheel and related methods |
US10327984B2 (en) | 2015-03-27 | 2019-06-25 | Equility Llc | Controlling ear stimulation in response to image analysis |
US10347376B2 (en) | 2017-01-04 | 2019-07-09 | StoryUp, Inc. | System and method for modifying biometric activity using virtual reality therapy |
US10347374B2 (en) | 2008-10-13 | 2019-07-09 | Baxter Corporation Englewood | Medication preparation system |
US10391361B2 (en) | 2015-02-27 | 2019-08-27 | Icon Health & Fitness, Inc. | Simulating real-world terrain on an exercise device |
US10398902B2 (en) | 2015-03-27 | 2019-09-03 | Equility Llc | Neural stimulation method and system with audio output |
US10406376B2 (en) | 2015-03-27 | 2019-09-10 | Equility Llc | Multi-factor control of ear stimulation |
US10413197B2 (en) | 2006-12-19 | 2019-09-17 | Valencell, Inc. | Apparatus, systems and methods for obtaining cleaner physiological information signals |
US10430557B2 (en) | 2014-11-17 | 2019-10-01 | Elwha Llc | Monitoring treatment compliance using patient activity patterns |
US10426989B2 (en) | 2014-06-09 | 2019-10-01 | Icon Health & Fitness, Inc. | Cable system incorporated into a treadmill |
US10433612B2 (en) | 2014-03-10 | 2019-10-08 | Icon Health & Fitness, Inc. | Pressure sensor to quantify work |
US10445846B2 (en) | 2011-04-14 | 2019-10-15 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US10493349B2 (en) | 2016-03-18 | 2019-12-03 | Icon Health & Fitness, Inc. | Display on exercise device |
WO2019237204A1 (en) * | 2018-06-14 | 2019-12-19 | Robert Labron | Virtual reality software system and method |
US10512783B2 (en) | 2015-03-27 | 2019-12-24 | Equility Llc | User interface method and system for ear stimulation |
US10589105B2 (en) | 2015-03-27 | 2020-03-17 | The Invention Science Fund Ii, Llc | Method and system for controlling ear stimulation |
WO2020064022A1 (en) * | 2018-09-30 | 2020-04-02 | 浙江凡聚科技有限公司 | Detection and training method and system for attention deficit hyperactivity disorder of children based on virtual reality |
US10610158B2 (en) | 2015-10-23 | 2020-04-07 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
US10624577B2 (en) | 2008-04-04 | 2020-04-21 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
US10625137B2 (en) | 2016-03-18 | 2020-04-21 | Icon Health & Fitness, Inc. | Coordinated displays in an exercise device |
US10646405B2 (en) | 2012-10-26 | 2020-05-12 | Baxter Corporation Englewood | Work station for medical dose preparation system |
US10671705B2 (en) | 2016-09-28 | 2020-06-02 | Icon Health & Fitness, Inc. | Customizing recipe recommendations |
US10818387B2 (en) | 2014-12-05 | 2020-10-27 | Baxter Corporation Englewood | Dose preparation data analytics |
US10827979B2 (en) | 2011-01-27 | 2020-11-10 | Valencell, Inc. | Wearable monitoring device |
US10846607B2 (en) | 2007-02-22 | 2020-11-24 | WellDoc, Inc. | Adaptive analytical behavioral and health assistant system and related method of use |
US10872686B2 (en) | 2007-02-22 | 2020-12-22 | WellDoc, Inc. | Systems and methods for disease control and management |
US10874823B2 (en) | 2019-05-28 | 2020-12-29 | Bluetapp, Inc. | Remotely controlled bilateral alternating tactile stimulation therapeutic method and system |
CN112219242A (en) * | 2018-03-19 | 2021-01-12 | 科尼菲森股份有限公司 | Computer system and method for creating and modifying multi-sensory experience to improve health or performance |
US10898131B2 (en) | 2014-09-23 | 2021-01-26 | Icahn School Of Medicine At Mount Sinai | Systems and methods for treating a psychiatric disorder |
US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
US10948898B1 (en) | 2013-01-18 | 2021-03-16 | Bell Sports, Inc. | System and method for custom forming a protective helmet for a customer's head |
US10950355B2 (en) | 2018-03-20 | 2021-03-16 | International Business Machines Corporation | Simulation method and system |
US10952671B2 (en) | 2000-10-11 | 2021-03-23 | Riddell, Inc. | System for monitoring a physiological parameter of players engaged in a sporting activity |
US10963774B2 (en) | 2017-01-09 | 2021-03-30 | Microsoft Technology Licensing, Llc | Systems and methods for artificial intelligence interface generation, evolution, and/or adjustment |
US10963417B2 (en) | 2004-06-04 | 2021-03-30 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US10971257B2 (en) | 2012-10-26 | 2021-04-06 | Baxter Corporation Englewood | Image acquisition for medical dose preparation system |
US10966662B2 (en) | 2016-07-08 | 2021-04-06 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
US20210315508A1 (en) * | 2020-04-14 | 2021-10-14 | Neurotype Inc. | Assessing Motivated Attention with Cue Reactivity |
CN113610067A (en) * | 2021-10-11 | 2021-11-05 | 北京工业大学 | Emotional state display method, device and system |
US11176444B2 (en) * | 2019-03-22 | 2021-11-16 | Cognoa, Inc. | Model optimization and data analysis using machine learning techniques |
US11185255B2 (en) | 2011-09-01 | 2021-11-30 | Riddell, Inc. | Systems and methods for monitoring a physiological parameter of persons engaged in physical activity |
US11213736B2 (en) | 2016-07-20 | 2022-01-04 | Riddell, Inc. | System and methods for designing and manufacturing a bespoke protective sports helmet |
US20220016128A1 (en) * | 2016-04-29 | 2022-01-20 | Supernus Pharmaceuticals, Inc. | Methods, system, and kit for monitoring, diagnosing, and treating impulsive aggression |
US11277697B2 (en) | 2018-12-15 | 2022-03-15 | Starkey Laboratories, Inc. | Hearing assistance system with enhanced fall detection features |
US11294407B2 (en) | 2001-04-27 | 2022-04-05 | Roche Diabetes Care, Inc. | Device and method for insulin dosing |
KR20220072323A (en) * | 2020-11-25 | 2022-06-02 | 광운대학교 산학협력단 | Apparatus and method for providing online REBT game |
US11364380B2 (en) | 2015-03-27 | 2022-06-21 | Elwha Llc | Nerve stimulation system, subsystem, headset, and earpiece |
US11367533B2 (en) | 2014-06-30 | 2022-06-21 | Baxter Corporation Englewood | Managed medical information exchange |
US11399589B2 (en) | 2018-08-16 | 2022-08-02 | Riddell, Inc. | System and method for designing and manufacturing a protective helmet tailored to a selected group of helmet wearers |
US20220257118A1 (en) * | 2008-12-23 | 2022-08-18 | Roche Diabetes Care, Inc. | Status reporting of a structured collection procedure |
WO2022203628A1 (en) * | 2021-03-24 | 2022-09-29 | Dokuz Eylul Universitesi Rektorlugu | Smoking cessation treatment using virtual reality application |
US11495334B2 (en) | 2015-06-25 | 2022-11-08 | Gambro Lundia Ab | Medical device system and method having a distributed database |
US11516183B2 (en) | 2016-12-21 | 2022-11-29 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
US11534089B2 (en) | 2011-02-28 | 2022-12-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US11559355B2 (en) | 2018-07-30 | 2023-01-24 | Boston Scientific Neuromodulation Corporation | Augmented and virtual reality for use with neuromodulation therapy |
US11575673B2 (en) | 2014-09-30 | 2023-02-07 | Baxter Corporation Englewood | Central user management in a distributed healthcare information management system |
US11638563B2 (en) | 2018-12-27 | 2023-05-02 | Starkey Laboratories, Inc. | Predictive fall event management system and method of using same |
US11676221B2 (en) | 2009-04-30 | 2023-06-13 | Patientslikeme, Inc. | Systems and methods for encouragement of data submission in online communities |
US11682315B1 (en) * | 2016-09-08 | 2023-06-20 | Wayne State University | Augmented reality system and method for exposure therapy and motor skills training |
US11717639B2 (en) * | 2018-01-25 | 2023-08-08 | Cognifisense, Inc. | Combinatorial therapeutic systems and methods |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11894139B1 (en) | 2018-12-03 | 2024-02-06 | Patientslikeme Llc | Disease spectrum classification |
US11948112B2 (en) | 2015-03-03 | 2024-04-02 | Baxter Corporation Engelwood | Pharmacy workflow management with integrated alerts |
US11972336B2 (en) | 2015-12-18 | 2024-04-30 | Cognoa, Inc. | Machine learning platform and system for data analysis |
US12095940B2 (en) | 2019-07-19 | 2024-09-17 | Starkey Laboratories, Inc. | Hearing devices using proxy devices for emergency communication |
US20240315382A1 (en) * | 2023-03-10 | 2024-09-26 | Alan Carlson | Adjustable Head Engaging Apparatus with Display |
US12205725B2 (en) | 2016-11-14 | 2025-01-21 | Cognoa, Inc. | Methods and apparatus for evaluating developmental conditions and providing control over coverage and reliability |
US12254755B2 (en) | 2017-02-13 | 2025-03-18 | Starkey Laboratories, Inc. | Fall prediction system including a beacon and method of using same |
US12303766B2 (en) | 2021-11-08 | 2025-05-20 | Riddell, Inc. | Protective sports helmet with additively manufactured components |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5678571A (en) * | 1994-05-23 | 1997-10-21 | Raya Systems, Inc. | Method for treating medical conditions using a microprocessor-based video game |
US5918603A (en) * | 1994-05-23 | 1999-07-06 | Health Hero Network, Inc. | Method for treating medical conditions using a microprocessor-based video game |
-
1999
- 1999-06-21 US US09/336,570 patent/US6186145B1/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5678571A (en) * | 1994-05-23 | 1997-10-21 | Raya Systems, Inc. | Method for treating medical conditions using a microprocessor-based video game |
US5918603A (en) * | 1994-05-23 | 1999-07-06 | Health Hero Network, Inc. | Method for treating medical conditions using a microprocessor-based video game |
Cited By (973)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8015025B2 (en) | 1992-11-17 | 2011-09-06 | Health Hero Network, Inc. | Method and apparatus for remote health monitoring and providing health related information |
US20040106855A1 (en) * | 1992-11-17 | 2004-06-03 | Health Hero Network, Inc. | A system and method for monitoring air flow from a person |
US20070299321A1 (en) * | 1992-11-17 | 2007-12-27 | Brown Stephen J | Method and apparatus for remote health monitoring and providing health related information |
US20050256739A1 (en) * | 1992-11-17 | 2005-11-17 | Brown Stephen J | Radio frequency based remote health monitoring |
US8249894B2 (en) | 1992-11-17 | 2012-08-21 | Robert Bosch Healthcare, Inc. | Networked remote patient monitoring with handheld devices |
US20050086083A1 (en) * | 1992-11-17 | 2005-04-21 | Brown Stephen J. | User monitoring |
US7853455B2 (en) | 1992-11-17 | 2010-12-14 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US7223235B2 (en) | 1992-11-17 | 2007-05-29 | Health Hero Network, Inc. | System and method for monitoring blood pressure from a person |
US7223236B2 (en) | 1992-11-17 | 2007-05-29 | Health Hero Network, Inc. | System and method for monitoring user-related data from a person |
US20070118404A1 (en) * | 1992-11-17 | 2007-05-24 | Brown Stephen J | Method and apparatus for remote health monitoring and providing health related information |
US20070118403A1 (en) * | 1992-11-17 | 2007-05-24 | Brown Stephen J | Method and apparatus for remote health monitoring and providing health related information |
US20070094049A1 (en) * | 1992-11-17 | 2007-04-26 | Brown Stephen J | Method and apparatus for remote health monitoring and providing health related information |
US20060004611A1 (en) * | 1992-11-17 | 2006-01-05 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US20070016445A1 (en) * | 1992-11-17 | 2007-01-18 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20060285736A1 (en) * | 1992-11-17 | 2006-12-21 | Health Hero Network, Inc. | Multi-user remote health monitoring system with biometrics support |
US20060178914A1 (en) * | 1992-11-17 | 2006-08-10 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US20060247951A1 (en) * | 1992-11-17 | 2006-11-02 | Health Hero Network, Inc. | Universal serial bus (USB) based remote health monitoring |
US7941327B2 (en) | 1992-11-17 | 2011-05-10 | Health Hero Network, Inc. | User monitoring |
US20060241975A1 (en) * | 1992-11-17 | 2006-10-26 | Health Hero Network, Inc. | Multi-user remote health monitoring system with biometrics support |
US7877276B2 (en) | 1992-11-17 | 2011-01-25 | Health Hero Network, Inc. | Messaging to remote patients in a networked health-monitoring system |
US8617065B2 (en) | 1992-11-17 | 2013-12-31 | Robert Bosch Healthcare Systems, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7761312B2 (en) | 1992-11-17 | 2010-07-20 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US20060189853A1 (en) * | 1992-11-17 | 2006-08-24 | Health Hero Network, Inc. | Method and system for improving adherence with a diet program or other medical regimen |
US20100152552A1 (en) * | 1992-11-17 | 2010-06-17 | Brown Stephen J | User-based health monitoring |
US9477939B2 (en) | 1992-11-17 | 2016-10-25 | Robert Bosch Healthcare Systems, Inc. | Radio frequency based remote health monitoring |
US7979284B2 (en) | 1992-11-17 | 2011-07-12 | Health Hero Network, Inc. | Interactive video based remote health monitoring system |
US7613590B2 (en) | 1992-11-17 | 2009-11-03 | Health Hero Network, Inc. | Modular microprocessor-based power tool system |
US8489428B2 (en) | 1992-11-17 | 2013-07-16 | Robert Bosch Healthcare Systems, Inc. | Remote health monitoring and maintenance system |
US20040019259A1 (en) * | 1992-11-17 | 2004-01-29 | Brown Stephen J. | Remote monitoring and data management platform |
US7689440B2 (en) | 1992-11-17 | 2010-03-30 | Health Hero Network, Inc. | Method and apparatus for remote health monitoring and providing health related information |
US7264591B2 (en) | 1992-11-17 | 2007-09-04 | Health Hero Netowrk, Inc. | System and method for monitoring air flow from a person |
US20060010014A1 (en) * | 1992-11-17 | 2006-01-12 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US20060287889A1 (en) * | 1992-11-17 | 2006-12-21 | Health Hero Network, Inc. | Multi-user remote health monitoring system with biometrics support |
US8015030B2 (en) | 1992-11-17 | 2011-09-06 | Health Hero Network, Inc. | User-based health monitoring |
US8260630B2 (en) | 1992-11-17 | 2012-09-04 | Health Hero Network, Inc. | Modular microprocessor-based appliance system |
US20040107116A1 (en) * | 1992-11-17 | 2004-06-03 | Health Hero Network, Inc. | Networked health information system for monitoring food intake |
US20040117210A1 (en) * | 1992-11-17 | 2004-06-17 | Health Hero Network | Networked remote patient monitoring with handheld devices |
US20040117207A1 (en) * | 1992-11-17 | 2004-06-17 | Health Hero Network, Inc. | Report generation in a networked health-monitoring system |
US9215979B2 (en) | 1992-11-17 | 2015-12-22 | Robert Bosch Healthcare Systems, Inc. | Multi-user remote health monitoring system |
US8019618B2 (en) | 1992-11-17 | 2011-09-13 | Health Hero Network, Inc. | Report generation in a networked health-monitoring system |
US8024201B2 (en) | 1992-11-17 | 2011-09-20 | Health Hero Network, Inc. | Method and apparatus for remote health monitoring and providing health related information |
US8419636B2 (en) | 1992-11-17 | 2013-04-16 | Robert Bosch Healthcare Systems, Inc. | Method and system for improving adherence with a diet program or other medical regimen |
US8027809B2 (en) | 1992-11-17 | 2011-09-27 | Health Hero Network, Inc. | Home power management system |
US20060009705A1 (en) * | 1992-11-17 | 2006-01-12 | Health Hero Network, Inc. | System and method for monitoring air flow from a person |
US20060155582A1 (en) * | 1992-11-17 | 2006-07-13 | Health Hero Network, Inc. | Modular microprocessor-based power tool system |
US8407063B2 (en) | 1992-11-17 | 2013-03-26 | Robert Bosch Healthcare Systems, Inc. | Multi-user remote health monitoring system with biometrics support |
US20040199409A1 (en) * | 1992-11-17 | 2004-10-07 | Brown Stephen J. | Remote health monitoring and maintenance system |
US20060100910A1 (en) * | 1992-11-17 | 2006-05-11 | Health Hero Network, Inc. | Interactive video based remote health monitoring system |
US20060080152A1 (en) * | 1992-11-17 | 2006-04-13 | Health Hero Network, Inc. | Modular microprocessor-based appliance system |
US8078431B2 (en) | 1992-11-17 | 2011-12-13 | Health Hero Network, Inc. | Home power management system |
US8095340B2 (en) | 1992-11-17 | 2012-01-10 | Health Hero Network, Inc. | Home power management system |
US7624028B1 (en) | 1992-11-17 | 2009-11-24 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US8015138B2 (en) | 1993-12-29 | 2011-09-06 | Clinical Decision Support, Llc | Computerized medical self-diagnostic and treatment advice system |
US20080162393A1 (en) * | 1993-12-29 | 2008-07-03 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US20080059247A1 (en) * | 1993-12-29 | 2008-03-06 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
USRE43433E1 (en) | 1993-12-29 | 2012-05-29 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US8337409B2 (en) | 1993-12-29 | 2012-12-25 | Clinical Decision Support Llc | Computerized medical diagnostic system utilizing list-based processing |
US20080051640A1 (en) * | 1993-12-29 | 2008-02-28 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
USRE43548E1 (en) | 1993-12-29 | 2012-07-24 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US20080052318A1 (en) * | 1993-12-29 | 2008-02-28 | Clinical Decision Support, Llc | Computerized medical diagnostic system utilizing list-based processing |
US20080052119A1 (en) * | 1993-12-29 | 2008-02-28 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US9005119B2 (en) | 1993-12-29 | 2015-04-14 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system including network access |
US8032399B2 (en) | 1994-04-26 | 2011-10-04 | Health Hero Network, Inc. | Treatment regimen compliance and efficacy with feedback |
US20080103379A1 (en) * | 1994-05-23 | 2008-05-01 | Brown Stephen J | Diabetes management system |
US20080097181A1 (en) * | 1994-05-23 | 2008-04-24 | Brown Stephen J | Diabetes management system |
US20080109172A1 (en) * | 1994-05-23 | 2008-05-08 | Brown Stephen J | Diabetes management system |
US20060234202A1 (en) * | 1994-05-23 | 2006-10-19 | Health Hero Network, Inc. | System and method for monitoring a physiological condition |
US20070212671A1 (en) * | 1994-05-23 | 2007-09-13 | Brown Stephen J | System and method for monitoring a physiological condition |
US8616895B2 (en) | 1994-05-23 | 2013-12-31 | Robert Bosch Healthcare Systems, Inc. | System and method for monitoring a physiological condition |
US7972267B2 (en) | 1994-05-23 | 2011-07-05 | Health Hero Network, Inc. | Diabetes management system |
US20070048691A1 (en) * | 1994-05-23 | 2007-03-01 | Health Hero Network, Inc. | System and method for monitoring a physiological condition |
US7862506B2 (en) | 1994-05-23 | 2011-01-04 | Health Hero Network, Inc. | Diabetes management system |
US7867165B2 (en) | 1994-05-23 | 2011-01-11 | Health Hero Network, Inc. | System and method for monitoring a physiological condition |
US7869852B2 (en) | 1994-05-23 | 2011-01-11 | Health Hero Network, Inc. | Diabetes management system |
US8655259B2 (en) | 1994-05-23 | 2014-02-18 | Robert Bosch Healthcare Systems, Inc. | System and method for monitoring a physiological condition |
US7871376B2 (en) | 1994-05-23 | 2011-01-18 | Health Hero Network, Inc. | System and method for monitoring a physiological condition |
US7684999B2 (en) | 1995-06-07 | 2010-03-23 | Health Hero Network, Inc. | User-based health monitoring |
US20050080652A1 (en) * | 1995-06-07 | 2005-04-14 | Brown Stephen J. | User-based health monitoring |
US7258666B2 (en) | 1995-06-07 | 2007-08-21 | Health Hero Network, Inc. | System and methods for monitoring a patient's heart condition |
US20010011224A1 (en) * | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
US20050059895A1 (en) * | 1995-06-07 | 2005-03-17 | Brown Stephen J. | System and methods for monitoring a patient's heart condition |
US7305348B1 (en) | 1996-02-20 | 2007-12-04 | Health Hero Network, Inc. | Aggregating and pooling health related information in a communication system with feedback |
US20070299326A1 (en) * | 1996-10-16 | 2007-12-27 | Brown Stephen J | Multiple patient monitoring system for proactive health management |
US7840420B2 (en) | 1996-10-16 | 2010-11-23 | Health Hero Network, Inc. | Multiple patient monitoring system for proactive health management |
US20090112624A1 (en) * | 1996-10-16 | 2009-04-30 | Brown Stephen J | Multiple patient monitoring system for proactive health management |
US20100205003A1 (en) * | 1996-10-16 | 2010-08-12 | Health Hero Network, Inc. | Multiple patient monitoring system for proactive health management |
US7765112B2 (en) | 1996-10-16 | 2010-07-27 | Health Hero Network, Inc. | Multiple patient monitoring system for proactive health management |
US7769605B2 (en) | 1996-10-16 | 2010-08-03 | Health Hero Network, Inc. | Multiple patient monitoring system for proactive health management |
US7778845B2 (en) | 1996-10-16 | 2010-08-17 | Health Hero Network, Inc. | Multiple patient monitoring system for proactive health management |
US20060253303A1 (en) * | 1996-10-16 | 2006-11-09 | Brown Stephen J | Multiple patient monitoring system for proactive health management |
US7653556B2 (en) * | 1996-10-30 | 2010-01-26 | American Board Of Family Medicine, Inc. | Computer architecture and process of patient generation, evolution, and simulation for computer based testing system |
US20060004608A1 (en) * | 1996-10-30 | 2006-01-05 | American Board Of Family Practice, Inc. | Computer architecture and process of patient generation, evolution, and simulation for computer based testing system |
US20070016448A1 (en) * | 1996-12-23 | 2007-01-18 | Brown Stephen J | Network media access control system for encouraging patient compliance with a treatment plan |
US7636667B2 (en) | 1996-12-23 | 2009-12-22 | Health Hero Networks, Inc. | Network media access control system for encouraging patient compliance with a treatment plan |
US20070016447A1 (en) * | 1996-12-23 | 2007-01-18 | Brown Stephen J | Network media access control system for encouraging patient compliance with a treatment plan |
US7590549B2 (en) | 1996-12-23 | 2009-09-15 | Health Hero Network, Inc. | Network media access control system for encouraging patient compliance with a treatment plan |
US7584108B2 (en) | 1996-12-23 | 2009-09-01 | Health Hero Network, Inc. | Network media access control system for encouraging patient compliance with a treatment plan |
US7941308B2 (en) | 1997-01-10 | 2011-05-10 | Health Hero Network, Inc. | Disease simulation system and method |
US20070118348A1 (en) * | 1997-01-10 | 2007-05-24 | Brown Stephen J | Disease simulation system and method |
US20080109197A1 (en) * | 1997-01-10 | 2008-05-08 | Brown Stephen J | Diabetes care management system |
US20010047252A1 (en) * | 1997-01-10 | 2001-11-29 | Brown Stephen J. | Disease simulation system and method |
US20080103380A1 (en) * | 1997-01-10 | 2008-05-01 | Brown Stephen J | Diabetes care management system |
US7643971B2 (en) | 1997-01-10 | 2010-01-05 | Health Hero Network, Inc. | Disease simulation system and method |
US7937255B2 (en) | 1997-01-10 | 2011-05-03 | Health Hero Network, Inc. | Diabetes care management system |
US20080294028A1 (en) * | 1997-01-10 | 2008-11-27 | Health Hero Network | Disease simulation system and method |
US7912688B2 (en) | 1997-01-10 | 2011-03-22 | Health Hero Network, Inc. | Disease simulation system and method |
US7167818B2 (en) * | 1997-01-10 | 2007-01-23 | Health Hero Network, Inc. | Disease simulation system and method |
US7392167B2 (en) | 1997-01-10 | 2008-06-24 | Health Hero Network, Inc. | Disease simulation system and method |
US20070032997A1 (en) * | 1997-01-10 | 2007-02-08 | Health Hero Network, Inc. | Disease simulation system and method |
US20080097180A1 (en) * | 1997-01-10 | 2008-04-24 | Brown Stephen J | Diabetes care management system |
US7912684B2 (en) | 1997-01-10 | 2011-03-22 | Health Hero Network, Inc. | Diabetes care management system |
US7979259B2 (en) | 1997-01-10 | 2011-07-12 | Health Hero Network, Inc. | Diabetes care management system |
US20080108888A1 (en) * | 1997-01-10 | 2008-05-08 | Brown Stephen J | Diabetes care management system |
US20070078681A1 (en) * | 1997-01-10 | 2007-04-05 | Brown Stephen J | Disease simulation system and method |
US7920998B2 (en) | 1997-01-10 | 2011-04-05 | Health Hero Network, Inc. | Diabetes care management system |
US7925522B2 (en) | 1997-01-16 | 2011-04-12 | Health Hero Network, Inc. | Personalized body image |
US7555436B2 (en) | 1997-01-16 | 2009-06-30 | Health Hero Network, Inc. | Personalized display of health information |
US7613621B2 (en) | 1997-01-16 | 2009-11-03 | Health Hero Network, Inc. | Personalized body image |
US20050027562A1 (en) * | 1997-01-16 | 2005-02-03 | Brown Stephen J. | Personalized display of health information |
US20060089969A1 (en) * | 1997-03-10 | 2006-04-27 | Health Hero Network, Inc. | System and method for modifying documents sent over a communications network |
US7814143B2 (en) | 1997-03-10 | 2010-10-12 | Health Hero Network, Inc. | System and method for modifying documents sent over a communications network |
US20080052120A1 (en) * | 1997-03-13 | 2008-02-28 | Clinical Decision Support, Llc | Disease management system and health assessment method |
US8392217B2 (en) | 1997-03-13 | 2013-03-05 | Clinical Decision Support, Llc | Disease management system and method including preview mode |
US8740790B2 (en) | 1997-03-13 | 2014-06-03 | Clinical Decision Support, Llc | Disease management system and method |
US20080052118A1 (en) * | 1997-03-13 | 2008-02-28 | Clinical Decision Support, Llc | Disease management system and method including permission database |
US8628470B1 (en) | 1997-03-13 | 2014-01-14 | Clinical Decision Support, Llc | Disease management system and method including medication therapy self-management |
US8066636B2 (en) | 1997-03-13 | 2011-11-29 | Clinical Decision Support, Llc | Disease management system and method including pain code |
US20080052122A1 (en) * | 1997-03-13 | 2008-02-28 | Clinical Decision Support, Llc | Disease management system and method |
US20080045811A1 (en) * | 1997-03-13 | 2008-02-21 | Clinical Decision Support, Llc | Disease management system and method including significant symptom filtering |
US8682694B2 (en) | 1997-03-13 | 2014-03-25 | Clinical Decision Support, Llc | Disease management system and method including permission database |
US8060378B2 (en) | 1997-03-13 | 2011-11-15 | Clinical Decision Support, Llc | Disease management system and method including question version |
US7769600B2 (en) | 1997-03-13 | 2010-08-03 | Clinical Decision Support | Disease management system and method |
US8727979B2 (en) | 1997-03-13 | 2014-05-20 | Clinical Decision Support, Llc | Disease management system and method including significant symptom filtering |
US8663104B2 (en) | 1997-03-13 | 2014-03-04 | Clinical Decision Support, Llc | Disease management system and method including therapeutic alterations permission level |
US7993267B2 (en) | 1997-03-13 | 2011-08-09 | Clinical Decision Support, Llc | Disease management system including a no response method |
US8727976B2 (en) | 1997-03-13 | 2014-05-20 | Clinical Decision Support, Llc | Disease management system operating on a network |
US8630875B2 (en) | 1997-03-13 | 2014-01-14 | Clinical Decision Support, Llc | Disease management system and health assessment method |
US20080051641A1 (en) * | 1997-03-13 | 2008-02-28 | Clinical Decision Support , Llc | Disease management system including a no response method |
US20080052121A1 (en) * | 1997-03-13 | 2008-02-28 | Clinical Decision Support, Llc | Disease management system operating on a network |
US8870762B2 (en) | 1997-03-28 | 2014-10-28 | Robert Bosch Gmbh | Electronic data capture in clinical and pharmaceutical trials |
US20070156893A1 (en) * | 1997-03-28 | 2007-07-05 | Brown Stephen J | Drug marketing and development tool |
US20060287931A1 (en) * | 1997-03-28 | 2006-12-21 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7587469B2 (en) | 1997-03-28 | 2009-09-08 | Health Hero Network, Inc. | Audio instructions for appliances |
US20050228883A1 (en) * | 1997-03-28 | 2005-10-13 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US8990336B2 (en) | 1997-03-28 | 2015-03-24 | Robert Bosch Healthcare Systems, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US8140663B2 (en) | 1997-03-28 | 2012-03-20 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7252636B2 (en) | 1997-03-28 | 2007-08-07 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7533171B2 (en) | 1997-03-28 | 2009-05-12 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7310668B2 (en) | 1997-03-28 | 2007-12-18 | Health Hero Network, Inc. | Remotely monitoring an individual using scripted communications |
US8078407B1 (en) | 1997-03-28 | 2011-12-13 | Health Hero Network, Inc. | System and method for identifying disease-influencing genes |
US8353827B2 (en) | 1997-03-28 | 2013-01-15 | Robert Bosch Healthcare Systems, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7870249B2 (en) | 1997-03-28 | 2011-01-11 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7516192B2 (en) | 1997-03-28 | 2009-04-07 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7320030B2 (en) | 1997-03-28 | 2008-01-15 | Health Hero Network, Inc. | Remote health monitoring apparatus using scripted communications |
US20070168242A1 (en) * | 1997-03-28 | 2007-07-19 | Brown Stephen J | Networked system for interactive communication and remote monitoring of pharmaceutical manufacturer and clinical trials |
US20060252089A1 (en) * | 1997-03-28 | 2006-11-09 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20070011320A1 (en) * | 1997-03-28 | 2007-01-11 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20070156892A1 (en) * | 1997-03-28 | 2007-07-05 | Brown Stephen J | Smart appliance functionality |
US20060271404A1 (en) * | 1997-03-28 | 2006-11-30 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7822625B2 (en) | 1997-03-28 | 2010-10-26 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20070135688A1 (en) * | 1997-03-28 | 2007-06-14 | Brown Stephen J | Networked system for interactive communication and remote monitoring of individuals |
US7707270B2 (en) | 1997-03-28 | 2010-04-27 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20070124466A1 (en) * | 1997-03-28 | 2007-05-31 | Brown Stephen J | Audio instructions for appliances |
US8608653B2 (en) | 1997-03-28 | 2013-12-17 | Robert Bosch Gmbh | Networked system for interactive communication and remote monitoring of individuals |
US7987100B2 (en) | 1997-03-28 | 2011-07-26 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20060253574A1 (en) * | 1997-03-28 | 2006-11-09 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7730177B2 (en) | 1997-03-28 | 2010-06-01 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US7734718B2 (en) | 1997-03-28 | 2010-06-08 | Health Hero Network, Inc. | Smart appliance functionality |
US7921186B2 (en) | 1997-03-28 | 2011-04-05 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US20100274835A1 (en) * | 1997-03-28 | 2010-10-28 | Brown Stephen J | Remote monitoring for education, security, and inventory |
US8626521B2 (en) | 1997-11-21 | 2014-01-07 | Robert Bosch Healthcare Systems, Inc. | Public health surveillance system |
US7401111B1 (en) * | 1997-12-04 | 2008-07-15 | Roche Diagnostic Operations, Inc. | Instrument setup utility program |
US20040009100A1 (en) * | 1997-12-04 | 2004-01-15 | Agilent Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US7666149B2 (en) | 1997-12-04 | 2010-02-23 | Peliken Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6335855B1 (en) * | 1998-04-20 | 2002-01-01 | George Alexanian | Battery powered programmable remote switch controller |
US8649841B2 (en) | 1998-04-30 | 2014-02-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8366614B2 (en) | 1998-04-30 | 2013-02-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8235896B2 (en) | 1998-04-30 | 2012-08-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8641619B2 (en) | 1998-04-30 | 2014-02-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8622906B2 (en) | 1998-04-30 | 2014-01-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226558B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226557B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7860544B2 (en) | 1998-04-30 | 2010-12-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9014773B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8231532B2 (en) | 1998-04-30 | 2012-07-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8617071B2 (en) | 1998-04-30 | 2013-12-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8255031B2 (en) | 1998-04-30 | 2012-08-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8774887B2 (en) | 1998-04-30 | 2014-07-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7885699B2 (en) | 1998-04-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8597189B2 (en) | 1998-04-30 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8744545B2 (en) | 1998-04-30 | 2014-06-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8738109B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8260392B2 (en) | 1998-04-30 | 2012-09-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226555B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8224413B2 (en) | 1998-04-30 | 2012-07-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8473021B2 (en) | 1998-04-30 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8672844B2 (en) | 1998-04-30 | 2014-03-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011331B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8880137B2 (en) | 1998-04-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8409131B2 (en) | 1998-04-30 | 2013-04-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7869853B1 (en) | 1998-04-30 | 2011-01-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8265726B2 (en) | 1998-04-30 | 2012-09-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8391945B2 (en) | 1998-04-30 | 2013-03-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8177716B2 (en) | 1998-04-30 | 2012-05-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8380273B2 (en) | 1998-04-30 | 2013-02-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8372005B2 (en) | 1998-04-30 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326714B2 (en) | 1998-04-30 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9072477B2 (en) | 1998-04-30 | 2015-07-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8660627B2 (en) | 1998-04-30 | 2014-02-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8357091B2 (en) | 1998-04-30 | 2013-01-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8353829B2 (en) | 1998-04-30 | 2013-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734346B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346336B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066697B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734348B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066694B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8666469B2 (en) | 1998-04-30 | 2014-03-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8306598B2 (en) | 1998-04-30 | 2012-11-06 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9042953B2 (en) | 1998-04-30 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8175673B2 (en) | 1998-04-30 | 2012-05-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8273022B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8162829B2 (en) | 1998-04-30 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8670815B2 (en) | 1998-04-30 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8275439B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6595850B2 (en) * | 1998-06-29 | 2003-07-22 | Konami Co., Ltd. | Video game machine, video-game display control method, and computer-readable recording medium containing video game program |
US8521546B2 (en) | 1998-09-25 | 2013-08-27 | Health Hero Network | Dynamic modeling and scoring risk assessment |
US20080033767A1 (en) * | 1998-09-25 | 2008-02-07 | Brown Stephen J | Dynamic modeling and scoring risk assessment |
US8005690B2 (en) | 1998-09-25 | 2011-08-23 | Health Hero Network, Inc. | Dynamic modeling and scoring risk assessment |
US7122004B1 (en) * | 1999-08-13 | 2006-10-17 | Interactive Metronome, Inc. | Method and apparatus of enhancing learning capacity |
US20040138864A1 (en) * | 1999-11-01 | 2004-07-15 | Medical Learning Company, Inc., A Delaware Corporation | Patient simulator |
US7689438B1 (en) * | 1999-11-19 | 2010-03-30 | Microsoft Corporation | Method, apparatus and system for communicating healthcare information to and from a portable, hand-held device |
US8447629B2 (en) | 1999-11-19 | 2013-05-21 | Microsoft Corporation | Method, apparatus and system for communicating heatlhcare information to and from a portable, hand-held device |
US20100138236A1 (en) * | 1999-11-19 | 2010-06-03 | Microsoft Corporation | Method, apparatus and system for communicating heatlhcare information to and from a portable, hand-held device |
US7383358B1 (en) * | 1999-12-29 | 2008-06-03 | Ge Medical Technology Services, Inc. | System and method for remote servicing of in-field product |
WO2001052014A3 (en) * | 2000-01-11 | 2002-01-17 | Health Performance Inc | Medical internet screening system |
US20020068857A1 (en) * | 2000-02-14 | 2002-06-06 | Iliff Edwin C. | Automated diagnostic system and method including reuse of diagnostic objects |
US8019582B2 (en) | 2000-02-14 | 2011-09-13 | Clinical Decision Support, Llc | Automated diagnostic system and method |
US20020016719A1 (en) * | 2000-06-19 | 2002-02-07 | Nemeth Louis G. | Methods and systems for providing medical data to a third party in accordance with configurable distribution parameters |
US6692258B1 (en) * | 2000-06-26 | 2004-02-17 | Medical Learning Company, Inc. | Patient simulator |
US20060189852A1 (en) * | 2000-10-11 | 2006-08-24 | Greenwald Richard M | System and method for evaluating and providing treatment to sports participants |
US8554509B2 (en) | 2000-10-11 | 2013-10-08 | Riddell, Inc. | System and method for measuring the linear and rotational acceleration of a body part |
US10945601B2 (en) | 2000-10-11 | 2021-03-16 | Riddell, Inc. | System and method for evaluating and providing treatment to sports participants |
US9622661B2 (en) | 2000-10-11 | 2017-04-18 | Riddell, Inc. | Impact monitoring system for players engaged in a sporting activity |
US20050177335A1 (en) * | 2000-10-11 | 2005-08-11 | Riddell, Inc. | System and method for measuring the linear and rotational acceleration of a body part |
US8797165B2 (en) | 2000-10-11 | 2014-08-05 | Riddell, Inc. | System for monitoring a physiological parameter of players engaged in a sporting activity |
US10702152B2 (en) | 2000-10-11 | 2020-07-07 | Riddell, Inc. | Impact monitoring system for players engaged in a sporting activity |
US10292650B2 (en) | 2000-10-11 | 2019-05-21 | Riddell, Inc. | System for monitoring a physiological parameter of players engaged in a sporting activity |
US10952671B2 (en) | 2000-10-11 | 2021-03-23 | Riddell, Inc. | System for monitoring a physiological parameter of players engaged in a sporting activity |
US8548768B2 (en) * | 2000-10-11 | 2013-10-01 | Riddell, Inc. | System and method for evaluating and providing treatment to sports participants |
US7582063B2 (en) | 2000-11-21 | 2009-09-01 | Pelikan Technologies, Inc. | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
WO2002049732A1 (en) * | 2000-12-21 | 2002-06-27 | Telisar Corporation | System and method for portable interactive multi-player games and entertainment |
US20020086271A1 (en) * | 2000-12-28 | 2002-07-04 | Murgia Paula J. | Interactive system for personal life patterns |
US6769915B2 (en) | 2000-12-28 | 2004-08-03 | Personal Beasties Group, Inc. | Interactive system for personal life patterns |
US20030108850A1 (en) * | 2000-12-28 | 2003-06-12 | Personal Beasties Group, Inc. | Interactive system for personal life patterns |
US20020084902A1 (en) * | 2000-12-29 | 2002-07-04 | Zadrozny Wlodek W. | Translator for infants and toddlers |
US7143044B2 (en) * | 2000-12-29 | 2006-11-28 | International Business Machines Corporation | Translator for infants and toddlers |
US9498159B2 (en) | 2001-01-02 | 2016-11-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9610034B2 (en) | 2001-01-02 | 2017-04-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011332B2 (en) | 2001-01-02 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8668645B2 (en) | 2001-01-02 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7054758B2 (en) | 2001-01-30 | 2006-05-30 | Sciona Limited | Computer-assisted means for assessing lifestyle risk factors |
US20030023387A1 (en) * | 2001-01-30 | 2003-01-30 | Gill-Garrison Rosalynn D. | Computer-assisted means for assessing lifestyle risk factors |
US20100286923A1 (en) * | 2001-01-30 | 2010-11-11 | Gill-Garrison Rosalynn D | Computer-assisted means for assessing lifestyle risk factors |
US20060178837A1 (en) * | 2001-01-30 | 2006-08-10 | Gill-Garrison Rosalynn D | Computer-assisted means for assessing lifestyle risk factors |
WO2002062437A3 (en) * | 2001-02-06 | 2002-12-27 | Walton Lamar Moore | Monetary behavior detection in a networked environment method and apparatus |
WO2002065120A1 (en) * | 2001-02-13 | 2002-08-22 | Virginia Commonwealth University | Multi-drug titration and evaluation |
US6461297B1 (en) * | 2001-02-16 | 2002-10-08 | Guido Pagnacco | Apparatus and methods for measuring physical disorders |
US20020120208A1 (en) * | 2001-02-23 | 2002-08-29 | Sun-Il Kim | System and method of providing service for enhancing attention on internet |
US20030158755A1 (en) * | 2001-03-01 | 2003-08-21 | Neuman Sherry L. | System and method for conducting drug use evaluation |
US6739877B2 (en) * | 2001-03-06 | 2004-05-25 | Medical Simulation Corporation | Distributive processing simulation method and system for training healthcare teams |
US20070021984A1 (en) * | 2001-03-14 | 2007-01-25 | Health Hero Network, Inc. | Interactive patient communication development system for reporting on patient healthcare management |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US9477811B2 (en) | 2001-04-02 | 2016-10-25 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US8236242B2 (en) | 2001-04-02 | 2012-08-07 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US7976778B2 (en) | 2001-04-02 | 2011-07-12 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US8268243B2 (en) | 2001-04-02 | 2012-09-18 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US8765059B2 (en) | 2001-04-02 | 2014-07-01 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US11294407B2 (en) | 2001-04-27 | 2022-04-05 | Roche Diabetes Care, Inc. | Device and method for insulin dosing |
US20040152995A1 (en) * | 2001-05-04 | 2004-08-05 | Cox Daniel J. | Method, apparatus, and computer program product for assessment of attentional impairments |
US8340752B2 (en) * | 2001-05-04 | 2012-12-25 | University Of Virginia Patent Foundation | Method, apparatus and computer program product for assessment of attentional impairments |
US20090156954A1 (en) * | 2001-05-04 | 2009-06-18 | University Of Virginia Patent Foundation | Method, Apparatus and Computer Program Product For Assessment of Attentional Impairments |
US7403814B2 (en) | 2001-05-04 | 2008-07-22 | University Of Virginia Patent Foundation | Method, apparatus, and computer program product for assessment of attentional impairments |
US20050193252A1 (en) * | 2001-05-08 | 2005-09-01 | Snap-On Technologies, Inc. | Integrated diagnostic system |
US8343075B2 (en) | 2001-06-12 | 2013-01-01 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8206317B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US20060178687A1 (en) * | 2001-06-12 | 2006-08-10 | Dominique Freeman | Tissue penetration device |
US8679033B2 (en) | 2001-06-12 | 2014-03-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7981055B2 (en) | 2001-06-12 | 2011-07-19 | Pelikan Technologies, Inc. | Tissue penetration device |
US20050101979A1 (en) * | 2001-06-12 | 2005-05-12 | Don Alden | Blood sampling apparatus and method |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7316700B2 (en) | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US20060195131A1 (en) * | 2001-06-12 | 2006-08-31 | Dominique Freeman | Tissue penetration device |
US20050101980A1 (en) * | 2001-06-12 | 2005-05-12 | Don Alden | Method and apparatus for improving success rate of blood yield from a fingerstick |
US8016774B2 (en) | 2001-06-12 | 2011-09-13 | Pelikan Technologies, Inc. | Tissue penetration device |
US8622930B2 (en) | 2001-06-12 | 2014-01-07 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8382683B2 (en) | 2001-06-12 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8216154B2 (en) | 2001-06-12 | 2012-07-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8211037B2 (en) | 2001-06-12 | 2012-07-03 | Pelikan Technologies, Inc. | Tissue penetration device |
US7850622B2 (en) | 2001-06-12 | 2010-12-14 | Pelikan Technologies, Inc. | Tissue penetration device |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8360991B2 (en) | 2001-06-12 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US8206319B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7841992B2 (en) | 2001-06-12 | 2010-11-30 | Pelikan Technologies, Inc. | Tissue penetration device |
US8162853B2 (en) | 2001-06-12 | 2012-04-24 | Pelikan Technologies, Inc. | Tissue penetration device |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US8123700B2 (en) | 2001-06-12 | 2012-02-28 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7537571B2 (en) | 2001-06-12 | 2009-05-26 | Pelikan Technologies, Inc. | Integrated blood sampling analysis system with multi-use sampling module |
US8282577B2 (en) | 2001-06-12 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8641643B2 (en) | 2001-06-12 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US20030037063A1 (en) * | 2001-08-10 | 2003-02-20 | Qlinx | Method and system for dynamic risk assessment, risk monitoring, and caseload management |
US6781522B2 (en) | 2001-08-22 | 2004-08-24 | Kivalo, Inc. | Portable storage case for housing a medical monitoring device and an associated method for communicating therewith |
US7891125B1 (en) | 2001-09-07 | 2011-02-22 | Piccirillo Emily H | Therapeutic methods and apparatuses for processing an emotion triggering event |
US20050053902A1 (en) * | 2001-09-28 | 2005-03-10 | Vladimirovich Utolin Konstantin | Method for working out the behavioural strategy of a player using a cognitive virtual reality, device for carrying out said method and an information-carrying medium for said device |
US7344894B2 (en) | 2001-10-16 | 2008-03-18 | Agilent Technologies, Inc. | Thermal regulation of fluidic samples within a diagnostic cartridge |
US20050004437A1 (en) * | 2001-10-26 | 2005-01-06 | Heiner Kaufmann | Simulation device for playful evaluation and display of blood sugar levels |
WO2003034912A1 (en) * | 2001-10-26 | 2003-05-01 | Disetronic Licensing Ag | Simulation device for playful evaluation and display of blood sugar levels |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US7668731B2 (en) | 2002-01-11 | 2010-02-23 | Baxter International Inc. | Medication delivery system |
US6985870B2 (en) | 2002-01-11 | 2006-01-10 | Baxter International Inc. | Medication delivery system |
US20030216628A1 (en) * | 2002-01-28 | 2003-11-20 | Bortz Jonathan David | Methods and systems for assessing glycemic control using predetermined pattern label analysis of blood glucose readings |
US10556062B2 (en) | 2002-01-29 | 2020-02-11 | Baxter International Inc. | Electronic medication order transfer and processing methods and apparatus |
US8775196B2 (en) | 2002-01-29 | 2014-07-08 | Baxter International Inc. | System and method for notification and escalation of medical data |
US20030141981A1 (en) * | 2002-01-29 | 2003-07-31 | Tuan Bui | System and method for operating medical devices |
US10173008B2 (en) | 2002-01-29 | 2019-01-08 | Baxter International Inc. | System and method for communicating with a dialysis machine through a network |
US20030148009A1 (en) * | 2002-02-01 | 2003-08-07 | Unilever Bestfoods North America, Division Of Conopco, Inc. | Process for preserving roasted vegetables |
US20040132633A1 (en) * | 2002-02-13 | 2004-07-08 | Carter W Hans | Multi-drug titration and evaluation |
US7610153B2 (en) | 2002-02-13 | 2009-10-27 | Virginia Commonwealth University | Multi-drug titration and evaluation |
US8414503B2 (en) | 2002-04-19 | 2013-04-09 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US8382682B2 (en) | 2002-04-19 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8403864B2 (en) | 2002-04-19 | 2013-03-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US20030199789A1 (en) * | 2002-04-19 | 2003-10-23 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909774B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20030199791A1 (en) * | 2002-04-19 | 2003-10-23 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7833171B2 (en) | 2002-04-19 | 2010-11-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8202231B2 (en) | 2002-04-19 | 2012-06-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8197423B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8430828B2 (en) | 2002-04-19 | 2013-04-30 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7481776B2 (en) | 2002-04-19 | 2009-01-27 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7938787B2 (en) | 2002-04-19 | 2011-05-10 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20070043305A1 (en) * | 2002-04-19 | 2007-02-22 | Dirk Boecker | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7959582B2 (en) | 2002-04-19 | 2011-06-14 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7731729B2 (en) | 2002-04-19 | 2010-06-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US20040092995A1 (en) * | 2002-04-19 | 2004-05-13 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling with improved sensing |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7524293B2 (en) | 2002-04-19 | 2009-04-28 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7988644B2 (en) | 2002-04-19 | 2011-08-02 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7874994B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8337420B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7410468B2 (en) | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8333710B2 (en) | 2002-04-19 | 2012-12-18 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7374544B2 (en) | 2002-04-19 | 2008-05-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8062231B2 (en) | 2002-04-19 | 2011-11-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7563232B2 (en) | 2002-04-19 | 2009-07-21 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7582099B2 (en) | 2002-04-19 | 2009-09-01 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US20070038235A1 (en) * | 2002-04-19 | 2007-02-15 | Freeman Dominique M | Method and apparatus for penetrating tissue |
US7297151B2 (en) | 2002-04-19 | 2007-11-20 | Elikan Technologies, Inc. | Method and apparatus for body fluid sampling with improved sensing |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US20070260271A1 (en) * | 2002-04-19 | 2007-11-08 | Freeman Dominique M | Device and method for variable speed lancet |
US20070142747A1 (en) * | 2002-04-19 | 2007-06-21 | Dirk Boecker | Method and apparatus for penetrating tissue |
US20070213756A1 (en) * | 2002-04-19 | 2007-09-13 | Dominique Freeman | Method and apparatus for penetrating tissue |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8388551B2 (en) | 2002-04-19 | 2013-03-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for multi-use body fluid sampling device with sterility barrier release |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US20070167875A1 (en) * | 2002-04-19 | 2007-07-19 | Dominique Freeman | Method and apparatus for penetrating tissue |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US8234128B2 (en) | 2002-04-30 | 2012-07-31 | Baxter International, Inc. | System and method for verifying medical device operational parameters |
US20030201697A1 (en) * | 2002-04-30 | 2003-10-30 | Richardson William R. | Storage device for health care facility |
US20030204419A1 (en) * | 2002-04-30 | 2003-10-30 | Wilkes Gordon J. | Automated messaging center system and method for use with a healthcare system |
US20030225596A1 (en) * | 2002-05-31 | 2003-12-04 | Richardson Bill R. | Biometric security for access to a storage device for a healthcare facility |
US20040035434A1 (en) * | 2002-08-23 | 2004-02-26 | Easter Anna L. | Rib fracture score and protocol |
US7225813B2 (en) * | 2002-08-23 | 2007-06-05 | Board Of Trustees Of The University Of Arkansas | Rib fracture score and protocol |
US7309315B2 (en) | 2002-09-06 | 2007-12-18 | Epoch Innovations, Ltd. | Apparatus, method and computer program product to facilitate ordinary visual perception via an early perceptual-motor extraction of relational information from a light stimuli array to trigger an overall visual-sensory motor integration in a subject |
US20040049124A1 (en) * | 2002-09-06 | 2004-03-11 | Saul Kullok | Apparatus, method and computer program product to facilitate ordinary visual perception via an early perceptual-motor extraction of relational information from a light stimuli array to trigger an overall visual-sensory motor integration in a subject |
ES2214954B1 (en) * | 2002-12-12 | 2005-12-16 | Universidad De Malaga | TRAINING SIMULATOR WITH EMOTIONAL FEEDBACK. |
ES2214954A1 (en) * | 2002-12-12 | 2004-09-16 | Universidad De Malaga | TRAINING SIMULATOR WITH EMOTIONAL FEEDBACK. |
US20040121295A1 (en) * | 2002-12-20 | 2004-06-24 | Steven Stuart | Method, system, and program for using a virtual environment to provide information on using a product |
US7229288B2 (en) | 2002-12-20 | 2007-06-12 | Medtronic Minimed, Inc. | Method, system, and program for using a virtual environment to provide information on using a product |
US20070087315A1 (en) * | 2002-12-20 | 2007-04-19 | Medtronic Minimed, Inc. | Method, system, and program for using a virtual environment to provide information on using a product |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US20060195128A1 (en) * | 2002-12-31 | 2006-08-31 | Don Alden | Method and apparatus for loading penetrating members |
US8622903B2 (en) | 2002-12-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US10039881B2 (en) | 2002-12-31 | 2018-08-07 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8187183B2 (en) | 2002-12-31 | 2012-05-29 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US9962091B2 (en) | 2002-12-31 | 2018-05-08 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US10750952B2 (en) | 2002-12-31 | 2020-08-25 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US20040172284A1 (en) * | 2003-02-13 | 2004-09-02 | Roche Diagnostics Corporation | Information management system |
US7587287B2 (en) | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US20100076288A1 (en) * | 2003-04-04 | 2010-03-25 | Brian Edmond Connolly | Method and System for Transferring Analyte Test Data |
US20050060194A1 (en) * | 2003-04-04 | 2005-03-17 | Brown Stephen J. | Method and system for monitoring health of an individual |
US8437966B2 (en) | 2003-04-04 | 2013-05-07 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US20100121168A1 (en) * | 2003-04-04 | 2010-05-13 | Abbott Diabetes Care Inc. | Method and System for Transferring Analyte Test Data |
US8483974B2 (en) | 2003-04-04 | 2013-07-09 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US8560250B2 (en) | 2003-04-04 | 2013-10-15 | Abbott Laboratories | Method and system for transferring analyte test data |
US8682598B2 (en) | 2003-04-04 | 2014-03-25 | Abbott Laboratories | Method and system for transferring analyte test data |
US7260480B1 (en) | 2003-04-07 | 2007-08-21 | Health Hero Network, Inc. | Method and system for integrating feedback loops in medical knowledge development and healthcare management |
US20040220833A1 (en) * | 2003-04-15 | 2004-11-04 | Matthias Joseph A. | System and method for monitoring efficacy of web-based online behavioral clinical study |
US8945009B2 (en) | 2003-05-08 | 2015-02-03 | Robert Bosch Heathcare Systems, Inc. | Remote health monitoring system |
US7399276B1 (en) | 2003-05-08 | 2008-07-15 | Health Hero Network, Inc. | Remote health monitoring system |
US7780595B2 (en) | 2003-05-15 | 2010-08-24 | Clinical Decision Support, Llc | Panel diagnostic method and system |
US8731968B1 (en) | 2003-05-15 | 2014-05-20 | Clinical Decision Support, Llc | Panel diagnostic method and system including automated diagnostic analysis |
US20100318381A1 (en) * | 2003-05-15 | 2010-12-16 | Clinical Decision Support, Llc | Panel diagnostic method and system |
US8055516B2 (en) | 2003-05-15 | 2011-11-08 | Clinical Decision Support, Llc | Panel diagnostic method and system |
US8301467B2 (en) | 2003-05-15 | 2012-10-30 | Clinical Decision Support, Llc | Panel diagnostic method and system including active and passive strategies |
US20050038326A1 (en) * | 2003-05-30 | 2005-02-17 | Michael Mathur | System, device, and method for remote monitoring and servicing |
US8251921B2 (en) | 2003-06-06 | 2012-08-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US20050010444A1 (en) * | 2003-06-06 | 2005-01-13 | Iliff Edwin C. | System and method for assisting medical diagnosis using an anatomic system and cause matrix |
US8512239B2 (en) | 2003-06-10 | 2013-08-20 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US9730584B2 (en) | 2003-06-10 | 2017-08-15 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US20050003470A1 (en) * | 2003-06-10 | 2005-01-06 | Therasense, Inc. | Glucose measuring device for use in personal area network |
US8647269B2 (en) | 2003-06-10 | 2014-02-11 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US20040254434A1 (en) * | 2003-06-10 | 2004-12-16 | Goodnow Timothy T. | Glucose measuring module and insulin pump combination |
US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US7604592B2 (en) | 2003-06-13 | 2009-10-20 | Pelikan Technologies, Inc. | Method and apparatus for a point of care device |
US8029443B2 (en) | 2003-07-15 | 2011-10-04 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US20080060955A1 (en) * | 2003-07-15 | 2008-03-13 | Therasense, Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US20050096518A1 (en) * | 2003-10-31 | 2005-05-05 | Yu-Hong Chang | Biological test system |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8296918B2 (en) | 2003-12-31 | 2012-10-30 | Sanofi-Aventis Deutschland Gmbh | Method of manufacturing a fluid sampling device with improved analyte detecting member configuration |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US20050216243A1 (en) * | 2004-03-02 | 2005-09-29 | Simon Graham | Computer-simulated virtual reality environments for evaluation of neurobehavioral performance |
US20080220400A1 (en) * | 2004-03-18 | 2008-09-11 | Cox Daniel J | Method, Apparatus, And Computer Program Product For Stochastic Psycho-Physiological Assessment Of Attentional Impairments |
US7761144B2 (en) | 2004-03-18 | 2010-07-20 | University Of Virginia Patent Foundation | Method, apparatus, and computer program product for stochastic psycho-physiological assessment of attentional impairments |
US20050260549A1 (en) * | 2004-05-19 | 2005-11-24 | Feierstein Roslyn E | Method of analyzing question responses to select among defined possibilities and means of accomplishing same |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US12056079B2 (en) | 2004-06-04 | 2024-08-06 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US11507530B2 (en) | 2004-06-04 | 2022-11-22 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US11182332B2 (en) | 2004-06-04 | 2021-11-23 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US10963417B2 (en) | 2004-06-04 | 2021-03-30 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US9081879B2 (en) | 2004-10-22 | 2015-07-14 | Clinical Decision Support, Llc | Matrix interface for medical diagnostic and treatment advice system and method |
US20060135859A1 (en) * | 2004-10-22 | 2006-06-22 | Iliff Edwin C | Matrix interface for medical diagnostic and treatment advice system and method |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US20060150989A1 (en) * | 2005-01-12 | 2006-07-13 | Peter Migaly | Method of diagnosing, treating and educating individuals with and/or about depression |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US20070207449A1 (en) * | 2005-05-19 | 2007-09-06 | Feierstein Roslyn E | Method of analyzing question responses to select among defined possibilities and means of accomplishing same |
US8251904B2 (en) | 2005-06-09 | 2012-08-28 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US10311209B2 (en) | 2005-06-09 | 2019-06-04 | Roche Diabetes Care, Inc. | Device and method for insulin dosing |
US20070078818A1 (en) * | 2005-06-09 | 2007-04-05 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US7405653B2 (en) | 2005-06-13 | 2008-07-29 | Honeywell International Inc. | System for monitoring activities and location |
US20070008111A1 (en) * | 2005-06-13 | 2007-01-11 | Tice Lee D | System for monitoring activities and location |
US20070083089A1 (en) * | 2005-09-14 | 2007-04-12 | Tice Lee D | In-residence monitoring system incorporating voice output |
US7511623B2 (en) | 2005-09-14 | 2009-03-31 | Honeywell International Inc. | In-residence monitoring system incorporating voice output |
US11272867B2 (en) | 2005-11-01 | 2022-03-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11363975B2 (en) | 2005-11-01 | 2022-06-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8915850B2 (en) | 2005-11-01 | 2014-12-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11911151B1 (en) | 2005-11-01 | 2024-02-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11103165B2 (en) | 2005-11-01 | 2021-08-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10952652B2 (en) | 2005-11-01 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10201301B2 (en) | 2005-11-01 | 2019-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10231654B2 (en) | 2005-11-01 | 2019-03-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11399748B2 (en) | 2005-11-01 | 2022-08-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8920319B2 (en) | 2005-11-01 | 2014-12-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326716B2 (en) | 2005-11-01 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11538580B2 (en) | 2005-11-04 | 2022-12-27 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US8585591B2 (en) | 2005-11-04 | 2013-11-19 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9669162B2 (en) | 2005-11-04 | 2017-06-06 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9323898B2 (en) | 2005-11-04 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US20070166690A1 (en) * | 2005-12-27 | 2007-07-19 | Bonnie Johnson | Virtual counseling practice |
US20070179356A1 (en) * | 2005-12-29 | 2007-08-02 | Guidance Interactive Healthcare, Inc. | Programmable devices, systems and methods for encouraging the monitoring of medical parameters |
US20080015422A1 (en) * | 2005-12-29 | 2008-01-17 | Guidance Interactive Healthcare, Inc. | Combined peripheral and health monitoring devices |
US20070213998A1 (en) * | 2005-12-29 | 2007-09-13 | Butler Stephen F | National addictions vigilance, intervention and prevention program |
US8214228B2 (en) * | 2005-12-29 | 2012-07-03 | Inflexxion, Inc. | National addictions vigilance, intervention and prevention program |
US20070226690A1 (en) * | 2006-02-08 | 2007-09-27 | Microsoft Corporation | In source code suppression of binary analysis |
US20070213989A1 (en) * | 2006-03-08 | 2007-09-13 | Cooksy Douglas A | Task Minder System |
US8933664B2 (en) | 2006-03-31 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9625413B2 (en) | 2006-03-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9039975B2 (en) | 2006-03-31 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9743863B2 (en) | 2006-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8597575B2 (en) | 2006-03-31 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8593109B2 (en) | 2006-03-31 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9380971B2 (en) | 2006-03-31 | 2016-07-05 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US20070288266A1 (en) * | 2006-06-02 | 2007-12-13 | Suzanne Sysko | System and methods for chronic disease management and health assessment |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US20080006700A1 (en) * | 2006-07-06 | 2008-01-10 | Zume Life | Method and apparatus for identifying and scheduling medicine intake |
US8758019B2 (en) | 2006-08-03 | 2014-06-24 | James W. Suzansky | Multimedia game based system and process for medical, safety and health improvements |
US20080032267A1 (en) * | 2006-08-03 | 2008-02-07 | Suzansky James W | Multimedia system and process for medical, safety, and health improvements |
US8758238B2 (en) | 2006-08-31 | 2014-06-24 | Health Hero Network, Inc. | Health related location awareness |
US20080059227A1 (en) * | 2006-08-31 | 2008-03-06 | Geoffrey Clapp | Health related location awareness |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US20080154177A1 (en) * | 2006-11-21 | 2008-06-26 | Baxter International Inc. | System and method for remote monitoring and/or management of infusion therapies |
US8540515B2 (en) | 2006-11-27 | 2013-09-24 | Pharos Innovations, Llc | Optimizing behavioral change based on a population statistical profile |
US20080126277A1 (en) * | 2006-11-27 | 2008-05-29 | Pharos Innovations, Llc | Optimizing behavioral change based on a patient statistical profile |
US20080126276A1 (en) * | 2006-11-27 | 2008-05-29 | Pharos Innovations, Llc | Optimizing behavioral change based on a population statistical profile |
US8540516B2 (en) | 2006-11-27 | 2013-09-24 | Pharos Innovations, Llc | Optimizing behavioral change based on a patient statistical profile |
US20080124689A1 (en) * | 2006-11-27 | 2008-05-29 | Pharos Innovations, Llc | Calculating a behavioral path based on a statistical profile |
US8540517B2 (en) | 2006-11-27 | 2013-09-24 | Pharos Innovations, Llc | Calculating a behavioral path based on a statistical profile |
US20080146888A1 (en) * | 2006-12-15 | 2008-06-19 | General Electric Company | System and method for in-situ mental health monitoring and therapy administration |
US7540841B2 (en) * | 2006-12-15 | 2009-06-02 | General Electric Company | System and method for in-situ mental health monitoring and therapy administration |
US11324407B2 (en) | 2006-12-19 | 2022-05-10 | Valencell, Inc. | Methods and apparatus for physiological and environmental monitoring with optical and footstep sensors |
US20110106627A1 (en) * | 2006-12-19 | 2011-05-05 | Leboeuf Steven Francis | Physiological and Environmental Monitoring Systems and Methods |
US8702607B2 (en) | 2006-12-19 | 2014-04-22 | Valencell, Inc. | Targeted advertising systems and methods |
US11109767B2 (en) | 2006-12-19 | 2021-09-07 | Valencell, Inc. | Apparatus, systems and methods for obtaining cleaner physiological information signals |
US11083378B2 (en) | 2006-12-19 | 2021-08-10 | Valencell, Inc. | Wearable apparatus having integrated physiological and/or environmental sensors |
US11412938B2 (en) | 2006-12-19 | 2022-08-16 | Valencell, Inc. | Physiological monitoring apparatus and networks |
US10413197B2 (en) | 2006-12-19 | 2019-09-17 | Valencell, Inc. | Apparatus, systems and methods for obtaining cleaner physiological information signals |
US11399724B2 (en) | 2006-12-19 | 2022-08-02 | Valencell, Inc. | Earpiece monitor |
US10595730B2 (en) | 2006-12-19 | 2020-03-24 | Valencell, Inc. | Physiological monitoring methods |
US11000190B2 (en) | 2006-12-19 | 2021-05-11 | Valencell, Inc. | Apparatus, systems and methods for obtaining cleaner physiological information signals |
US20080146892A1 (en) * | 2006-12-19 | 2008-06-19 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US11395595B2 (en) | 2006-12-19 | 2022-07-26 | Valencell, Inc. | Apparatus, systems and methods for monitoring and evaluating cardiopulmonary functioning |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US10258243B2 (en) | 2006-12-19 | 2019-04-16 | Valencell, Inc. | Apparatus, systems, and methods for measuring environmental exposure and physiological response thereto |
US11272848B2 (en) | 2006-12-19 | 2022-03-15 | Valencell, Inc. | Wearable apparatus for multiple types of physiological and/or environmental monitoring |
US20110098112A1 (en) * | 2006-12-19 | 2011-04-28 | Leboeuf Steven Francis | Physiological and Environmental Monitoring Systems and Methods |
US11350831B2 (en) | 2006-12-19 | 2022-06-07 | Valencell, Inc. | Physiological monitoring apparatus |
US10987005B2 (en) | 2006-12-19 | 2021-04-27 | Valencell, Inc. | Systems and methods for presenting personal health information |
US8204786B2 (en) | 2006-12-19 | 2012-06-19 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US10716481B2 (en) | 2006-12-19 | 2020-07-21 | Valencell, Inc. | Apparatus, systems and methods for monitoring and evaluating cardiopulmonary functioning |
US11272849B2 (en) | 2006-12-19 | 2022-03-15 | Valencell, Inc. | Wearable apparatus |
US11295856B2 (en) | 2006-12-19 | 2022-04-05 | Valencell, Inc. | Apparatus, systems, and methods for measuring environmental exposure and physiological response thereto |
US20150072322A1 (en) * | 2006-12-27 | 2015-03-12 | Case Western Reserve University | Situated simulation for training, education, and therapy |
US10089895B2 (en) * | 2006-12-27 | 2018-10-02 | Case Western Reserve University | Situated simulation for training, education, and therapy |
US20080219319A1 (en) * | 2007-01-05 | 2008-09-11 | Jay Buckalew | Biological parameter monitoring system and method therefor |
US12040067B2 (en) | 2007-02-18 | 2024-07-16 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US10860943B2 (en) | 2007-02-22 | 2020-12-08 | WellDoc, Inc. | Systems and methods for disease control and management |
US10872686B2 (en) | 2007-02-22 | 2020-12-22 | WellDoc, Inc. | Systems and methods for disease control and management |
US10818389B2 (en) | 2007-02-22 | 2020-10-27 | WellDoc, Inc. | Systems and methods for disease control and management |
US12009086B2 (en) | 2007-02-22 | 2024-06-11 | WellDoc, Inc. | Systems and methods for disease control and management |
US20080306770A1 (en) * | 2007-02-22 | 2008-12-11 | Sysko Ryan A | Systems and methods for disease control and management |
US9754077B2 (en) | 2007-02-22 | 2017-09-05 | WellDoc, Inc. | Systems and methods for disease control and management |
US11699511B2 (en) | 2007-02-22 | 2023-07-11 | WellDoc, Inc. | Systems and methods for disease control and management |
US10846607B2 (en) | 2007-02-22 | 2020-11-24 | WellDoc, Inc. | Adaptive analytical behavioral and health assistant system and related method of use |
US11004558B2 (en) | 2007-02-22 | 2021-05-11 | WellDoc, Inc. | Systems and methods for disease control and management |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9095290B2 (en) | 2007-03-01 | 2015-08-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9801545B2 (en) | 2007-03-01 | 2017-10-31 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US20080228040A1 (en) * | 2007-03-16 | 2008-09-18 | Arthur Solomon Thompson | International medical expert diagnosis |
US20090005653A1 (en) * | 2007-03-30 | 2009-01-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080242949A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20090024050A1 (en) * | 2007-03-30 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080287821A1 (en) * | 2007-03-30 | 2008-11-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20090018407A1 (en) * | 2007-03-30 | 2009-01-15 | Searete Llc, A Limited Corporation Of The State Of Delaware | Computational user-health testing |
US20080242951A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Effective low-profile health monitoring or the like |
US20080242950A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080242948A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Effective low-profile health monitoring or the like |
US20080242952A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liablity Corporation Of The State Of Delaware | Effective response protocols for health monitoring or the like |
US20080243005A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20090005654A1 (en) * | 2007-03-30 | 2009-01-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US20080243543A1 (en) * | 2007-03-30 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Effective response protocols for health monitoring or the like |
US20080319276A1 (en) * | 2007-03-30 | 2008-12-25 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing |
US9035767B2 (en) | 2007-05-08 | 2015-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8593287B2 (en) | 2007-05-08 | 2013-11-26 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9000929B2 (en) | 2007-05-08 | 2015-04-07 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10178954B2 (en) | 2007-05-08 | 2019-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8149117B2 (en) | 2007-05-08 | 2012-04-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9949678B2 (en) | 2007-05-08 | 2018-04-24 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US11696684B2 (en) | 2007-05-08 | 2023-07-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10653317B2 (en) | 2007-05-08 | 2020-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10952611B2 (en) | 2007-05-08 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8362904B2 (en) | 2007-05-08 | 2013-01-29 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9649057B2 (en) | 2007-05-08 | 2017-05-16 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9314198B2 (en) | 2007-05-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9177456B2 (en) | 2007-05-08 | 2015-11-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9574914B2 (en) | 2007-05-08 | 2017-02-21 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US20080280276A1 (en) * | 2007-05-09 | 2008-11-13 | Oregon Health & Science University And Oregon Research Institute | Virtual reality tools and techniques for measuring cognitive ability and cognitive impairment |
US8475171B2 (en) | 2007-05-09 | 2013-07-02 | Oregon Health & Science University | Object recognition testing tools and techniques for measuring cognitive ability and cognitive impairment |
US20090298025A1 (en) * | 2007-05-09 | 2009-12-03 | Oregon Health & Science University | Object recognition testing tools and techniques for measuring cognitive ability and cognitive impairment |
US20080294462A1 (en) * | 2007-05-23 | 2008-11-27 | Laura Nuhaan | System, Method, And Apparatus Of Facilitating Web-Based Interactions Between An Elderly And Caregivers |
US20090144089A1 (en) * | 2007-10-12 | 2009-06-04 | Patientslikeme, Inc. | Personalized management and monitoring of medical conditions |
US9589104B2 (en) | 2007-10-12 | 2017-03-07 | Patientslikeme, Inc. | Self-improving method of using online communities to predict health-related outcomes |
US10832816B2 (en) | 2007-10-12 | 2020-11-10 | Patientslikeme, Inc. | Personalized management and monitoring of medical conditions |
US20090125333A1 (en) * | 2007-10-12 | 2009-05-14 | Patientslikeme, Inc. | Personalized management and comparison of medical condition and outcome based on profiles of community patients |
US10665344B2 (en) | 2007-10-12 | 2020-05-26 | Patientslikeme, Inc. | Personalized management and comparison of medical condition and outcome based on profiles of community patients |
US8160901B2 (en) | 2007-10-12 | 2012-04-17 | Patientslikeme, Inc. | Personalized management and comparison of medical condition and outcome based on profiles of community patients |
US20090097757A1 (en) * | 2007-10-15 | 2009-04-16 | Casey Wimsatt | System and method for teaching social skills, social thinking, and social awareness |
US8714982B2 (en) | 2007-10-15 | 2014-05-06 | Casey Wimsatt | System and method for teaching social skills, social thinking, and social awareness |
US9044180B2 (en) | 2007-10-25 | 2015-06-02 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
US9808204B2 (en) | 2007-10-25 | 2017-11-07 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
US20090112620A1 (en) * | 2007-10-30 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Polling for interest in computational user-health test output |
US20090112616A1 (en) * | 2007-10-30 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Polling for interest in computational user-health test output |
US20090112617A1 (en) * | 2007-10-31 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational user-health testing responsive to a user interaction with advertiser-configured content |
US8065240B2 (en) | 2007-10-31 | 2011-11-22 | The Invention Science Fund I | Computational user-health testing responsive to a user interaction with advertiser-configured content |
US20090118593A1 (en) * | 2007-11-07 | 2009-05-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Determining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content |
US20090119154A1 (en) * | 2007-11-07 | 2009-05-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Determining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content |
US20090132275A1 (en) * | 2007-11-19 | 2009-05-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Determining a demographic characteristic of a user based on computational user-health testing |
WO2009097344A1 (en) * | 2008-01-28 | 2009-08-06 | Chris Zois | Video game and method of play |
US20090253973A1 (en) * | 2008-04-04 | 2009-10-08 | Eran Bashan | Apparatus for optimizing a patient's insulin dosage regimen |
US8457901B2 (en) | 2008-04-04 | 2013-06-04 | Hygieia, Inc. | System for optimizing a patient's insulin dosage regimen |
US10272198B2 (en) | 2008-04-04 | 2019-04-30 | Hygieia, Inc. | System for optimizing a patient's insulin dosage regimen |
US8370077B2 (en) | 2008-04-04 | 2013-02-05 | Hygieia, Inc. | System for optimizing a patient's insulin dosage regimen |
US12183445B2 (en) | 2008-04-04 | 2024-12-31 | Hygieia, Inc. | Apparatus for optimizing a patient's insulin dosage regimen |
US9220456B2 (en) | 2008-04-04 | 2015-12-29 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
US20090253970A1 (en) * | 2008-04-04 | 2009-10-08 | Eran Bashan | System for optimizing a patient's insulin dosage regimen |
US11723592B2 (en) | 2008-04-04 | 2023-08-15 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
US10335546B2 (en) | 2008-04-04 | 2019-07-02 | Hygieia, Inc. | Apparatus for optimizing a patient's insulin dosage regimen |
US10624577B2 (en) | 2008-04-04 | 2020-04-21 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
US8600682B2 (en) | 2008-04-04 | 2013-12-03 | Hygieia, Inc. | Apparatus for optimizing a patient's insulin dosage regimen |
US10736562B2 (en) | 2008-04-04 | 2020-08-11 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
US11869648B2 (en) | 2008-04-04 | 2024-01-09 | Hygieia, Inc. | System for optimizing a patient's insulin dosage regimen |
US11826163B2 (en) | 2008-04-04 | 2023-11-28 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
US11756661B2 (en) | 2008-04-04 | 2023-09-12 | Hygieia, Inc. | Apparatus for optimizing a patient's insulin dosage regimen |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US20090312668A1 (en) * | 2008-04-24 | 2009-12-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100015583A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and method for memory modification |
US9560967B2 (en) | 2008-04-24 | 2017-02-07 | The Invention Science Fund I Llc | Systems and apparatus for measuring a bioactive agent effect |
US20090271347A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US20090271122A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US9282927B2 (en) * | 2008-04-24 | 2016-03-15 | Invention Science Fund I, Llc | Methods and systems for modifying bioactive agent use |
US20090271009A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment modification methods and systems |
US9239906B2 (en) | 2008-04-24 | 2016-01-19 | The Invention Science Fund I, Llc | Combination treatment selection methods and systems |
US9358361B2 (en) * | 2008-04-24 | 2016-06-07 | The Invention Science Fund I, Llc | Methods and systems for presenting a combination treatment |
US20170068800A1 (en) * | 2008-04-24 | 2017-03-09 | Searete Llc | Combination treatment selection methods and systems |
US20090269329A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination Therapeutic products and systems |
US20090271213A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Corporation Of The State Of Delaware | Combination treatment selection methods and systems |
US20170100540A1 (en) * | 2008-04-24 | 2017-04-13 | Searete Llc | Methods and systems for modifying bioactive agent use |
US20090271219A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The Stste Of Delaware | Methods and systems for presenting a combination treatment |
US9504788B2 (en) * | 2008-04-24 | 2016-11-29 | Searete Llc | Methods and systems for modifying bioactive agent use |
US20090271011A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US9649469B2 (en) * | 2008-04-24 | 2017-05-16 | The Invention Science Fund I Llc | Methods and systems for presenting a combination treatment |
US20090270693A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for modifying bioactive agent use |
US9662391B2 (en) * | 2008-04-24 | 2017-05-30 | The Invention Science Fund I Llc | Side effect ameliorating combination therapeutic products and systems |
US20090267758A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and apparatus for measuring a bioactive agent effect |
US9064036B2 (en) | 2008-04-24 | 2015-06-23 | The Invention Science Fund I, Llc | Methods and systems for monitoring bioactive agent use |
US20090270692A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment alteration methods and systems |
US9026369B2 (en) | 2008-04-24 | 2015-05-05 | The Invention Science Fund I, Llc | Methods and systems for presenting a combination treatment |
US20090271120A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US9449150B2 (en) | 2008-04-24 | 2016-09-20 | The Invention Science Fund I, Llc | Combination treatment selection methods and systems |
US20170231560A1 (en) * | 2008-04-24 | 2017-08-17 | Searete Llc | Systems and apparatus for measuring a bioactive agent effect |
US7974787B2 (en) | 2008-04-24 | 2011-07-05 | The Invention Science Fund I, Llc | Combination treatment alteration methods and systems |
US20090271121A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for detecting a bioactive agent effect |
US20090270786A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting a combination treatment |
US20090270694A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20090271217A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Side effect ameliorating combination therapeutic products and systems |
US20090271215A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for detecting a bioactive agent effect |
US20090292676A1 (en) * | 2008-04-24 | 2009-11-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment selection methods and systems |
US10572629B2 (en) * | 2008-04-24 | 2020-02-25 | The Invention Science Fund I, Llc | Combination treatment selection methods and systems |
US20090270688A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting a combination treatment |
US20090319301A1 (en) * | 2008-04-24 | 2009-12-24 | Searete Llc, A Limited Liability Corporation Of The State Of Delawar | Methods and systems for presenting a combination treatment |
US8930208B2 (en) | 2008-04-24 | 2015-01-06 | The Invention Science Fund I, Llc | Methods and systems for detecting a bioactive agent effect |
US20100004762A1 (en) * | 2008-04-24 | 2010-01-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US8876688B2 (en) | 2008-04-24 | 2014-11-04 | The Invention Science Fund I, Llc | Combination treatment modification methods and systems |
US20140275739A1 (en) * | 2008-04-24 | 2014-09-18 | Searete Llc | Methods and systems for presenting a combination treatment |
US20100017001A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20090271010A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment alteration methods and systems |
US20100022820A1 (en) * | 2008-04-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100030089A1 (en) * | 2008-04-24 | 2010-02-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20100041964A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20130289360A1 (en) * | 2008-04-24 | 2013-10-31 | Searete Llc | Methods and systems for modifying bioactive agent use |
US8682687B2 (en) | 2008-04-24 | 2014-03-25 | The Invention Science Fund I, Llc | Methods and systems for presenting a combination treatment |
US20100041958A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc | Computational system and method for memory modification |
US20100042578A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20100280332A1 (en) * | 2008-04-24 | 2010-11-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US20100076249A1 (en) * | 2008-04-24 | 2010-03-25 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US7801686B2 (en) | 2008-04-24 | 2010-09-21 | The Invention Science Fund I, Llc | Combination treatment alteration methods and systems |
US20200384198A1 (en) * | 2008-04-24 | 2020-12-10 | The Invention Science Fund I, Llc | Methods and Systems for Modifying Bioactive Agent Use |
US20100081860A1 (en) * | 2008-04-24 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and Method for Memory Modification |
US20100100036A1 (en) * | 2008-04-24 | 2010-04-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and Method for Memory Modification |
US8606592B2 (en) | 2008-04-24 | 2013-12-10 | The Invention Science Fund I, Llc | Methods and systems for monitoring bioactive agent use |
US20090271375A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment selection methods and systems |
US8615407B2 (en) | 2008-04-24 | 2013-12-24 | The Invention Science Fund I, Llc | Methods and systems for detecting a bioactive agent effect |
US20100125561A1 (en) * | 2008-04-24 | 2010-05-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US10786626B2 (en) * | 2008-04-24 | 2020-09-29 | The Invention Science Fund I, Llc | Methods and systems for modifying bioactive agent use |
US11918721B2 (en) | 2008-07-09 | 2024-03-05 | Baxter International Inc. | Dialysis system having adaptive prescription management |
US10646634B2 (en) | 2008-07-09 | 2020-05-12 | Baxter International Inc. | Dialysis system and disposable set |
US10224117B2 (en) | 2008-07-09 | 2019-03-05 | Baxter International Inc. | Home therapy machine allowing patient device program selection |
US10068061B2 (en) | 2008-07-09 | 2018-09-04 | Baxter International Inc. | Home therapy entry, modification, and reporting system |
US10016554B2 (en) | 2008-07-09 | 2018-07-10 | Baxter International Inc. | Dialysis system including wireless patient data |
US10095840B2 (en) | 2008-07-09 | 2018-10-09 | Baxter International Inc. | System and method for performing renal therapy at a home or dwelling of a patient |
US10061899B2 (en) | 2008-07-09 | 2018-08-28 | Baxter International Inc. | Home therapy machine |
US10272190B2 (en) | 2008-07-09 | 2019-04-30 | Baxter International Inc. | Renal therapy system including a blood pressure monitor |
US11311658B2 (en) | 2008-07-09 | 2022-04-26 | Baxter International Inc. | Dialysis system having adaptive prescription generation |
US20100077458A1 (en) * | 2008-09-25 | 2010-03-25 | Card Access, Inc. | Apparatus, System, and Method for Responsibility-Based Data Management |
US10347374B2 (en) | 2008-10-13 | 2019-07-09 | Baxter Corporation Englewood | Medication preparation system |
US9907508B2 (en) | 2008-11-11 | 2018-03-06 | Hygieia, Inc. | Apparatus and system for diabetes management |
WO2010056718A3 (en) * | 2008-11-11 | 2010-07-29 | Hygieia, Inc. | Apparatus and system for diabetes management |
WO2010056718A2 (en) * | 2008-11-11 | 2010-05-20 | Hygieia, Inc. | Apparatus and system for diabetes management |
US11172878B2 (en) | 2008-11-11 | 2021-11-16 | Hygieia, Inc. | Apparatus and system for diabetes management |
US8992464B2 (en) | 2008-11-11 | 2015-03-31 | Hygieia, Inc. | Apparatus and system for diabetes management |
US20220257118A1 (en) * | 2008-12-23 | 2022-08-18 | Roche Diabetes Care, Inc. | Status reporting of a structured collection procedure |
US20100163036A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US8676513B2 (en) | 2009-01-29 | 2014-03-18 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8473220B2 (en) | 2009-01-29 | 2013-06-25 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9066709B2 (en) | 2009-01-29 | 2015-06-30 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US10092245B2 (en) | 2009-02-25 | 2018-10-09 | Valencell, Inc. | Methods and apparatus for detecting motion noise and for removing motion noise from physiological signals |
US10716480B2 (en) | 2009-02-25 | 2020-07-21 | Valencell, Inc. | Hearing aid earpiece covers |
US9750462B2 (en) | 2009-02-25 | 2017-09-05 | Valencell, Inc. | Monitoring apparatus and methods for measuring physiological and/or environmental conditions |
US10842389B2 (en) | 2009-02-25 | 2020-11-24 | Valencell, Inc. | Wearable audio devices |
US11660006B2 (en) | 2009-02-25 | 2023-05-30 | Valencell, Inc. | Wearable monitoring devices with passive and active filtering |
US9301696B2 (en) | 2009-02-25 | 2016-04-05 | Valencell, Inc. | Earbud covers |
US8989830B2 (en) | 2009-02-25 | 2015-03-24 | Valencell, Inc. | Wearable light-guiding devices for physiological monitoring |
US10842387B2 (en) | 2009-02-25 | 2020-11-24 | Valencell, Inc. | Apparatus for assessing physiological conditions |
US10076282B2 (en) | 2009-02-25 | 2018-09-18 | Valencell, Inc. | Wearable monitoring devices having sensors and light guides |
US9289175B2 (en) | 2009-02-25 | 2016-03-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US10750954B2 (en) | 2009-02-25 | 2020-08-25 | Valencell, Inc. | Wearable devices with flexible optical emitters and/or optical detectors |
US10973415B2 (en) | 2009-02-25 | 2021-04-13 | Valencell, Inc. | Form-fitted monitoring apparatus for health and environmental monitoring |
US9131312B2 (en) | 2009-02-25 | 2015-09-08 | Valencell, Inc. | Physiological monitoring methods |
US11589812B2 (en) | 2009-02-25 | 2023-02-28 | Valencell, Inc. | Wearable devices for physiological monitoring |
US10898083B2 (en) | 2009-02-25 | 2021-01-26 | Valencell, Inc. | Wearable monitoring devices with passive and active filtering |
US11026588B2 (en) | 2009-02-25 | 2021-06-08 | Valencell, Inc. | Methods and apparatus for detecting motion noise and for removing motion noise from physiological signals |
US9289135B2 (en) | 2009-02-25 | 2016-03-22 | Valencell, Inc. | Physiological monitoring methods and apparatus |
US9314167B2 (en) | 2009-02-25 | 2016-04-19 | Valencell, Inc. | Methods for generating data output containing physiological and motion-related information |
US10448840B2 (en) | 2009-02-25 | 2019-10-22 | Valencell, Inc. | Apparatus for generating data output containing physiological and motion-related information |
US9955919B2 (en) | 2009-02-25 | 2018-05-01 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US11160460B2 (en) | 2009-02-25 | 2021-11-02 | Valencell, Inc. | Physiological monitoring methods |
US11471103B2 (en) | 2009-02-25 | 2022-10-18 | Valencell, Inc. | Ear-worn devices for physiological monitoring |
US10542893B2 (en) | 2009-02-25 | 2020-01-28 | Valencell, Inc. | Form-fitted monitoring apparatus for health and environmental monitoring |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US20110118555A1 (en) * | 2009-04-29 | 2011-05-19 | Abhijit Dhumne | System and methods for screening, treating, and monitoring psychological conditions |
US11676221B2 (en) | 2009-04-30 | 2023-06-13 | Patientslikeme, Inc. | Systems and methods for encouragement of data submission in online communities |
US20100311023A1 (en) * | 2009-05-07 | 2010-12-09 | Kan Kevin Gar Wah | Systems amd methods for evaluating neurobehavioural performance from reaction time tests |
US8794976B2 (en) * | 2009-05-07 | 2014-08-05 | Trustees Of The Univ. Of Pennsylvania | Systems and methods for evaluating neurobehavioural performance from reaction time tests |
US20100301620A1 (en) * | 2009-05-27 | 2010-12-02 | Don Mei Tow | Multi-Function Chopsticks |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11045147B2 (en) | 2009-08-31 | 2021-06-29 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9968302B2 (en) | 2009-08-31 | 2018-05-15 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US11635332B2 (en) | 2009-08-31 | 2023-04-25 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US10429250B2 (en) | 2009-08-31 | 2019-10-01 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods for managing power and noise |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US11150145B2 (en) | 2009-08-31 | 2021-10-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US12279894B2 (en) | 2009-08-31 | 2025-04-22 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9750439B2 (en) | 2009-09-29 | 2017-09-05 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US10349874B2 (en) | 2009-09-29 | 2019-07-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US11049408B2 (en) | 2010-11-11 | 2021-06-29 | The Regents Of The University Of California | Enhancing cognition in the presence of distraction and/or interruption |
EP3863000A1 (en) * | 2010-11-11 | 2021-08-11 | The Regents Of The University Of California | Enhancing cognition in the presence of distraction and/or interruption |
EP2638534A4 (en) * | 2010-11-11 | 2016-04-06 | Univ California | ENHANCEMENT OF COGNITION IN THE PRESENCE OF DISTRACTION AND / OR INTERRUPTION |
US11830379B2 (en) | 2010-11-11 | 2023-11-28 | The Regents Of The University Of California | Enhancing cognition in the presence of distraction and/or interruption |
US11324445B2 (en) | 2011-01-27 | 2022-05-10 | Valencell, Inc. | Headsets with angled sensor modules |
US10827979B2 (en) | 2011-01-27 | 2020-11-10 | Valencell, Inc. | Wearable monitoring device |
US11534089B2 (en) | 2011-02-28 | 2022-12-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US10853819B2 (en) * | 2011-04-14 | 2020-12-01 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US20120265591A1 (en) * | 2011-04-14 | 2012-10-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US10445846B2 (en) | 2011-04-14 | 2019-10-15 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US9427191B2 (en) | 2011-07-25 | 2016-08-30 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
US9521962B2 (en) | 2011-07-25 | 2016-12-20 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
US9788785B2 (en) | 2011-07-25 | 2017-10-17 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
US11375902B2 (en) | 2011-08-02 | 2022-07-05 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
US9801552B2 (en) | 2011-08-02 | 2017-10-31 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
US10512403B2 (en) | 2011-08-02 | 2019-12-24 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
US11185255B2 (en) | 2011-09-01 | 2021-11-30 | Riddell, Inc. | Systems and methods for monitoring a physiological parameter of persons engaged in physical activity |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US10220259B2 (en) | 2012-01-05 | 2019-03-05 | Icon Health & Fitness, Inc. | System and method for controlling an exercise device |
US10617351B2 (en) * | 2012-04-23 | 2020-04-14 | Sackett Solutions & Innovations Llc | Cognitive biometric systems to monitor emotions and stress |
US20130281798A1 (en) * | 2012-04-23 | 2013-10-24 | Sackett Solutions & Innovations, LLC | Cognitive biometric systems to monitor emotions and stress |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
US20140065585A1 (en) * | 2012-09-03 | 2014-03-06 | Sheri Kemp Osborn | System and method for assessing and improving a users life skills and self-efficacy for life stage readiness |
US9728101B2 (en) * | 2012-09-03 | 2017-08-08 | Sheri Kemp Osborn | System and method for assessing and improving a user's life skills and self-efficacy for life stage readiness |
US11950936B2 (en) | 2012-09-17 | 2024-04-09 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US11612363B2 (en) | 2012-09-17 | 2023-03-28 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US10971257B2 (en) | 2012-10-26 | 2021-04-06 | Baxter Corporation Englewood | Image acquisition for medical dose preparation system |
US10646405B2 (en) | 2012-10-26 | 2020-05-12 | Baxter Corporation Englewood | Work station for medical dose preparation system |
US10948898B1 (en) | 2013-01-18 | 2021-03-16 | Bell Sports, Inc. | System and method for custom forming a protective helmet for a customer's head |
US11419383B2 (en) | 2013-01-18 | 2022-08-23 | Riddell, Inc. | System and method for custom forming a protective helmet for a customer's head |
US11889883B2 (en) | 2013-01-18 | 2024-02-06 | Bell Sports, Inc. | System and method for forming a protective helmet for a customer's head |
US10076253B2 (en) | 2013-01-28 | 2018-09-18 | Valencell, Inc. | Physiological monitoring devices having sensing elements decoupled from body motion |
US12076126B2 (en) | 2013-01-28 | 2024-09-03 | Yukka Magic Llc | Physiological monitoring devices having sensing elements decoupled from body motion |
US10856749B2 (en) | 2013-01-28 | 2020-12-08 | Valencell, Inc. | Physiological monitoring devices having sensing elements decoupled from body motion |
US11684278B2 (en) | 2013-01-28 | 2023-06-27 | Yukka Magic Llc | Physiological monitoring devices having sensing elements decoupled from body motion |
US11266319B2 (en) | 2013-01-28 | 2022-03-08 | Valencell, Inc. | Physiological monitoring devices having sensing elements decoupled from body motion |
US10279212B2 (en) | 2013-03-14 | 2019-05-07 | Icon Health & Fitness, Inc. | Strength training apparatus with flywheel and related methods |
US20140349261A1 (en) * | 2013-05-22 | 2014-11-27 | Personal Zen Ventures, Llc | Therapeutic video game device and method |
US10188890B2 (en) | 2013-12-26 | 2019-01-29 | Icon Health & Fitness, Inc. | Magnetic resistance mechanism in a cable machine |
US11081233B2 (en) | 2014-01-31 | 2021-08-03 | Aseko, Inc. | Insulin management |
US9710611B2 (en) | 2014-01-31 | 2017-07-18 | Aseko, Inc. | Insulin management |
US11783945B2 (en) | 2014-01-31 | 2023-10-10 | Aseko, Inc. | Method and system for insulin infusion rate management |
US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
US11490837B2 (en) | 2014-01-31 | 2022-11-08 | Aseko, Inc. | Insulin management |
US10811133B2 (en) | 2014-01-31 | 2020-10-20 | Aseko, Inc. | System for administering insulin boluses to a patient |
US11783946B2 (en) | 2014-01-31 | 2023-10-10 | Aseko, Inc. | Method and system for insulin bolus management |
US11468987B2 (en) | 2014-01-31 | 2022-10-11 | Aseko, Inc. | Insulin management |
US11804300B2 (en) | 2014-01-31 | 2023-10-31 | Aseko, Inc. | Insulin management |
US9892235B2 (en) | 2014-01-31 | 2018-02-13 | Aseko, Inc. | Insulin management |
US9504789B2 (en) | 2014-01-31 | 2016-11-29 | Aseko, Inc. | Insulin management |
US12288620B2 (en) | 2014-01-31 | 2025-04-29 | Glytec, Llc | Method and system for insulin management |
US11857314B2 (en) | 2014-01-31 | 2024-01-02 | Aseko, Inc. | Insulin management |
US11311213B2 (en) | 2014-01-31 | 2022-04-26 | Aseko, Inc. | Insulin management |
US10535426B2 (en) | 2014-01-31 | 2020-01-14 | Aseko, Inc. | Insulin management |
US10255992B2 (en) | 2014-01-31 | 2019-04-09 | Aseko, Inc. | Insulin management |
US9965595B2 (en) | 2014-01-31 | 2018-05-08 | Aseko, Inc. | Insulin management |
US12127831B2 (en) | 2014-01-31 | 2024-10-29 | Aseko, Inc. | Insulin management |
US12027266B2 (en) | 2014-01-31 | 2024-07-02 | Aseko, Inc. | Insulin management |
US9604002B2 (en) | 2014-01-31 | 2017-03-28 | Aseko, Inc. | Insulin management |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
US9233204B2 (en) | 2014-01-31 | 2016-01-12 | Aseko, Inc. | Insulin management |
US10453568B2 (en) | 2014-01-31 | 2019-10-22 | Aseko, Inc. | Method for managing administration of insulin |
US11621074B2 (en) | 2014-01-31 | 2023-04-04 | Aseko, Inc. | Insulin management |
US11158424B2 (en) | 2014-01-31 | 2021-10-26 | Aseko, Inc. | Insulin management |
US10433612B2 (en) | 2014-03-10 | 2019-10-08 | Icon Health & Fitness, Inc. | Pressure sensor to quantify work |
WO2015181634A3 (en) * | 2014-05-15 | 2016-03-24 | Changebud Pty Limited | Methods, systems and user interfaces for behavioral learning |
US20170263144A1 (en) * | 2014-05-15 | 2017-09-14 | Changebud Pty Limited | Methods, systems and user interfaces for behavioral learning |
US10426989B2 (en) | 2014-06-09 | 2019-10-01 | Icon Health & Fitness, Inc. | Cable system incorporated into a treadmill |
US10226396B2 (en) | 2014-06-20 | 2019-03-12 | Icon Health & Fitness, Inc. | Post workout massage device |
US10278633B1 (en) | 2014-06-23 | 2019-05-07 | Corman Attention Technologies, LLC | Systems and methods for assisting diagnosing and/or titrating medication for predetermined conditions and assessing the effectiveness of medication prescribed for a predetermined condition |
US11367533B2 (en) | 2014-06-30 | 2022-06-21 | Baxter Corporation Englewood | Managed medical information exchange |
US11337655B2 (en) | 2014-07-30 | 2022-05-24 | Valencell, Inc. | Physiological monitoring devices and methods using optical sensors |
US9538921B2 (en) | 2014-07-30 | 2017-01-10 | Valencell, Inc. | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
US11638561B2 (en) | 2014-07-30 | 2023-05-02 | Yukka Magic Llc | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
US11179108B2 (en) | 2014-07-30 | 2021-11-23 | Valencell, Inc. | Physiological monitoring devices and methods using optical sensors |
US11412988B2 (en) | 2014-07-30 | 2022-08-16 | Valencell, Inc. | Physiological monitoring devices and methods using optical sensors |
US11638560B2 (en) | 2014-07-30 | 2023-05-02 | Yukka Magic Llc | Physiological monitoring devices and methods using optical sensors |
US10893835B2 (en) | 2014-07-30 | 2021-01-19 | Valencell, Inc. | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
US12274567B2 (en) | 2014-07-30 | 2025-04-15 | Yukka Magic Llc | Physiological monitoring devices and methods using optical sensors |
US11185290B2 (en) | 2014-07-30 | 2021-11-30 | Valencell, Inc. | Physiological monitoring devices and methods using optical sensors |
US12193845B2 (en) | 2014-07-30 | 2025-01-14 | Yukka Magic Llc | Physiological monitoring devices and methods using optical sensors |
US10015582B2 (en) | 2014-08-06 | 2018-07-03 | Valencell, Inc. | Earbud monitoring devices |
US11252498B2 (en) | 2014-08-06 | 2022-02-15 | Valencell, Inc. | Optical physiological monitoring devices |
US11330361B2 (en) | 2014-08-06 | 2022-05-10 | Valencell, Inc. | Hearing aid optical monitoring apparatus |
US10536768B2 (en) | 2014-08-06 | 2020-01-14 | Valencell, Inc. | Optical physiological sensor modules with reduced signal noise |
US11252499B2 (en) | 2014-08-06 | 2022-02-15 | Valencell, Inc. | Optical physiological monitoring devices |
US10623849B2 (en) | 2014-08-06 | 2020-04-14 | Valencell, Inc. | Optical monitoring apparatus and methods |
US10768665B2 (en) * | 2014-09-11 | 2020-09-08 | Interaxon Inc. | System and method for enhanced training using a virtual reality environment and bio-signal data |
US12253882B2 (en) | 2014-09-11 | 2025-03-18 | Interaxon Inc. | System and method for enhanced training using a virtual reality environment and bio-signal data |
US11815951B2 (en) | 2014-09-11 | 2023-11-14 | Interaxon Inc. | System and method for enhanced training using a virtual reality environment and bio-signal data |
US11287848B2 (en) | 2014-09-11 | 2022-03-29 | Interaxon Inc. | System and method for enhanced training using a virtual reality environment and bio-signal data |
US20190033914A1 (en) * | 2014-09-11 | 2019-01-31 | Interaxon Inc. | System and method for enhanced training using a virtual reality environment and bio-signal data |
US11903725B2 (en) | 2014-09-23 | 2024-02-20 | Icahn School of Medicine of Mount Sinai | Systems and methods for treating a psychiatric disorder |
US10898131B2 (en) | 2014-09-23 | 2021-01-26 | Icahn School Of Medicine At Mount Sinai | Systems and methods for treating a psychiatric disorder |
US10779062B2 (en) | 2014-09-27 | 2020-09-15 | Valencell, Inc. | Wearable biometric monitoring devices and methods for determining if wearable biometric monitoring devices are being worn |
US9794653B2 (en) | 2014-09-27 | 2017-10-17 | Valencell, Inc. | Methods and apparatus for improving signal quality in wearable biometric monitoring devices |
US10798471B2 (en) | 2014-09-27 | 2020-10-06 | Valencell, Inc. | Methods for improving signal quality in wearable biometric monitoring devices |
US10834483B2 (en) | 2014-09-27 | 2020-11-10 | Valencell, Inc. | Wearable biometric monitoring devices and methods for determining if wearable biometric monitoring devices are being worn |
US10382839B2 (en) | 2014-09-27 | 2019-08-13 | Valencell, Inc. | Methods for improving signal quality in wearable biometric monitoring devices |
US10506310B2 (en) | 2014-09-27 | 2019-12-10 | Valencell, Inc. | Wearable biometric monitoring devices and methods for determining signal quality in wearable biometric monitoring devices |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
US11575673B2 (en) | 2014-09-30 | 2023-02-07 | Baxter Corporation Englewood | Central user management in a distributed healthcare information management system |
US9892234B2 (en) | 2014-10-27 | 2018-02-13 | Aseko, Inc. | Subcutaneous outpatient management |
US10128002B2 (en) | 2014-10-27 | 2018-11-13 | Aseko, Inc. | Subcutaneous outpatient management |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
US11678800B2 (en) | 2014-10-27 | 2023-06-20 | Aseko, Inc. | Subcutaneous outpatient management |
US12023127B2 (en) | 2014-10-27 | 2024-07-02 | Aseko, Inc. | Subcutaneous outpatient management |
US10403397B2 (en) | 2014-10-27 | 2019-09-03 | Aseko, Inc. | Subcutaneous outpatient management |
US11694785B2 (en) | 2014-10-27 | 2023-07-04 | Aseko, Inc. | Method and dosing controller for subcutaneous outpatient management |
US9589107B2 (en) | 2014-11-17 | 2017-03-07 | Elwha Llc | Monitoring treatment compliance using speech patterns passively captured from a patient environment |
US10430557B2 (en) | 2014-11-17 | 2019-10-01 | Elwha Llc | Monitoring treatment compliance using patient activity patterns |
US9585616B2 (en) | 2014-11-17 | 2017-03-07 | Elwha Llc | Determining treatment compliance using speech patterns passively captured from a patient environment |
US10818387B2 (en) | 2014-12-05 | 2020-10-27 | Baxter Corporation Englewood | Dose preparation data analytics |
US10391361B2 (en) | 2015-02-27 | 2019-08-27 | Icon Health & Fitness, Inc. | Simulating real-world terrain on an exercise device |
US11948112B2 (en) | 2015-03-03 | 2024-04-02 | Baxter Corporation Engelwood | Pharmacy workflow management with integrated alerts |
US10327984B2 (en) | 2015-03-27 | 2019-06-25 | Equility Llc | Controlling ear stimulation in response to image analysis |
US10406376B2 (en) | 2015-03-27 | 2019-09-10 | Equility Llc | Multi-factor control of ear stimulation |
US10589105B2 (en) | 2015-03-27 | 2020-03-17 | The Invention Science Fund Ii, Llc | Method and system for controlling ear stimulation |
US11364380B2 (en) | 2015-03-27 | 2022-06-21 | Elwha Llc | Nerve stimulation system, subsystem, headset, and earpiece |
US10293158B2 (en) | 2015-03-27 | 2019-05-21 | Equility Llc | Controlling ear stimulation in response to a status of a subject |
US10512783B2 (en) | 2015-03-27 | 2019-12-24 | Equility Llc | User interface method and system for ear stimulation |
US10039928B2 (en) | 2015-03-27 | 2018-08-07 | Equility Llc | Ear stimulation with neural feedback sensing |
US10398902B2 (en) | 2015-03-27 | 2019-09-03 | Equility Llc | Neural stimulation method and system with audio output |
US9987489B2 (en) | 2015-03-27 | 2018-06-05 | Elwha Llc | Controlling ear stimulation in response to electrical contact sensing |
US11495334B2 (en) | 2015-06-25 | 2022-11-08 | Gambro Lundia Ab | Medical device system and method having a distributed database |
CN105559802A (en) * | 2015-07-29 | 2016-05-11 | 北京工业大学 | Tristimania diagnosis system and method based on attention and emotion information fusion |
CN105559802B (en) * | 2015-07-29 | 2018-11-02 | 北京工业大学 | Based on the depressed diagnostic system and data processing method paid attention to and emotion information merges |
US12040096B2 (en) | 2015-08-20 | 2024-07-16 | Aseko, Inc. | Diabetes management therapy advisor |
US9886556B2 (en) | 2015-08-20 | 2018-02-06 | Aseko, Inc. | Diabetes management therapy advisor |
US11200988B2 (en) | 2015-08-20 | 2021-12-14 | Aseko, Inc. | Diabetes management therapy advisor |
US10380328B2 (en) | 2015-08-20 | 2019-08-13 | Aseko, Inc. | Diabetes management therapy advisor |
US11574742B2 (en) | 2015-08-20 | 2023-02-07 | Aseko, Inc. | Diabetes management therapy advisor |
US20180292888A1 (en) * | 2015-10-12 | 2018-10-11 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Virtual reality systems and methods for improving clinical outcomes |
US10551910B2 (en) | 2015-10-12 | 2020-02-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Virtual reality systems and methods for improving clinical outcomes |
WO2017066340A1 (en) | 2015-10-12 | 2017-04-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Virtual reality systems and methods for improving clinical outcomes |
EP3362878A4 (en) * | 2015-10-12 | 2019-06-12 | The Arizona Board of Regents On Behalf of the University of Arizona | SYSTEMS AND METHODS FOR VIRTUAL REALITY TO IMPROVE CLINICAL OUTCOMES |
US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
US12285244B2 (en) | 2015-10-23 | 2025-04-29 | Yukka Magic Llc | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
US10610158B2 (en) | 2015-10-23 | 2020-04-07 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
US11972336B2 (en) | 2015-12-18 | 2024-04-30 | Cognoa, Inc. | Machine learning platform and system for data analysis |
US10493349B2 (en) | 2016-03-18 | 2019-12-03 | Icon Health & Fitness, Inc. | Display on exercise device |
US10272317B2 (en) | 2016-03-18 | 2019-04-30 | Icon Health & Fitness, Inc. | Lighted pace feature in a treadmill |
US10625137B2 (en) | 2016-03-18 | 2020-04-21 | Icon Health & Fitness, Inc. | Coordinated displays in an exercise device |
US20220016128A1 (en) * | 2016-04-29 | 2022-01-20 | Supernus Pharmaceuticals, Inc. | Methods, system, and kit for monitoring, diagnosing, and treating impulsive aggression |
US10966662B2 (en) | 2016-07-08 | 2021-04-06 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
US11712615B2 (en) | 2016-07-20 | 2023-08-01 | Riddell, Inc. | System and method of assembling a protective sports helmet |
US11213736B2 (en) | 2016-07-20 | 2022-01-04 | Riddell, Inc. | System and methods for designing and manufacturing a bespoke protective sports helmet |
US11682315B1 (en) * | 2016-09-08 | 2023-06-20 | Wayne State University | Augmented reality system and method for exposure therapy and motor skills training |
US10671705B2 (en) | 2016-09-28 | 2020-06-02 | Icon Health & Fitness, Inc. | Customizing recipe recommendations |
US12205725B2 (en) | 2016-11-14 | 2025-01-21 | Cognoa, Inc. | Methods and apparatus for evaluating developmental conditions and providing control over coverage and reliability |
US11516183B2 (en) | 2016-12-21 | 2022-11-29 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
US11101031B2 (en) | 2017-01-04 | 2021-08-24 | StoryUp, Inc. | System and method for modifying biometric activity using virtual reality therapy |
US10347376B2 (en) | 2017-01-04 | 2019-07-09 | StoryUp, Inc. | System and method for modifying biometric activity using virtual reality therapy |
US10963774B2 (en) | 2017-01-09 | 2021-03-30 | Microsoft Technology Licensing, Llc | Systems and methods for artificial intelligence interface generation, evolution, and/or adjustment |
US12254755B2 (en) | 2017-02-13 | 2025-03-18 | Starkey Laboratories, Inc. | Fall prediction system including a beacon and method of using same |
US11717639B2 (en) * | 2018-01-25 | 2023-08-08 | Cognifisense, Inc. | Combinatorial therapeutic systems and methods |
CN112219242A (en) * | 2018-03-19 | 2021-01-12 | 科尼菲森股份有限公司 | Computer system and method for creating and modifying multi-sensory experience to improve health or performance |
US10950355B2 (en) | 2018-03-20 | 2021-03-16 | International Business Machines Corporation | Simulation method and system |
US10885709B2 (en) | 2018-06-14 | 2021-01-05 | Robert Labron | Virtual reality software system and method for treating medical condition in user |
WO2019237204A1 (en) * | 2018-06-14 | 2019-12-19 | Robert Labron | Virtual reality software system and method |
US11559355B2 (en) | 2018-07-30 | 2023-01-24 | Boston Scientific Neuromodulation Corporation | Augmented and virtual reality for use with neuromodulation therapy |
US12089899B2 (en) | 2018-07-30 | 2024-09-17 | Boston Scientific Neuromodulation Corporation | Augmented and virtual reality for use with neuromodulation therapy |
US12161183B2 (en) | 2018-08-16 | 2024-12-10 | Riddell, Inc. | System for monitoring a physiological parameter of a person wearing protective sports equipment while engaged in physical activity |
US12059051B2 (en) | 2018-08-16 | 2024-08-13 | Riddell, Inc. | System and method for designing and manufacturing a protective sports helmet |
US12268270B2 (en) | 2018-08-16 | 2025-04-08 | Riddell, Inc. | Position specific protective sports helmet |
US11399589B2 (en) | 2018-08-16 | 2022-08-02 | Riddell, Inc. | System and method for designing and manufacturing a protective helmet tailored to a selected group of helmet wearers |
WO2020064022A1 (en) * | 2018-09-30 | 2020-04-02 | 浙江凡聚科技有限公司 | Detection and training method and system for attention deficit hyperactivity disorder of children based on virtual reality |
US11894139B1 (en) | 2018-12-03 | 2024-02-06 | Patientslikeme Llc | Disease spectrum classification |
US12149893B2 (en) | 2018-12-15 | 2024-11-19 | Starkey Laboratories, Inc. | Hearing assistance system with enhanced fall detection features |
US11277697B2 (en) | 2018-12-15 | 2022-03-15 | Starkey Laboratories, Inc. | Hearing assistance system with enhanced fall detection features |
US11638563B2 (en) | 2018-12-27 | 2023-05-02 | Starkey Laboratories, Inc. | Predictive fall event management system and method of using same |
US11176444B2 (en) * | 2019-03-22 | 2021-11-16 | Cognoa, Inc. | Model optimization and data analysis using machine learning techniques |
US11862339B2 (en) | 2019-03-22 | 2024-01-02 | Cognoa, Inc. | Model optimization and data analysis using machine learning techniques |
US10874823B2 (en) | 2019-05-28 | 2020-12-29 | Bluetapp, Inc. | Remotely controlled bilateral alternating tactile stimulation therapeutic method and system |
US12095940B2 (en) | 2019-07-19 | 2024-09-17 | Starkey Laboratories, Inc. | Hearing devices using proxy devices for emergency communication |
US20210315508A1 (en) * | 2020-04-14 | 2021-10-14 | Neurotype Inc. | Assessing Motivated Attention with Cue Reactivity |
KR20220072323A (en) * | 2020-11-25 | 2022-06-02 | 광운대학교 산학협력단 | Apparatus and method for providing online REBT game |
KR102545696B1 (en) | 2020-11-25 | 2023-06-20 | 광운대학교 산학협력단 | Apparatus and method for providing online REBT game |
WO2022203628A1 (en) * | 2021-03-24 | 2022-09-29 | Dokuz Eylul Universitesi Rektorlugu | Smoking cessation treatment using virtual reality application |
CN113610067B (en) * | 2021-10-11 | 2021-12-28 | 北京工业大学 | Emotional state display method, device and system |
CN113610067A (en) * | 2021-10-11 | 2021-11-05 | 北京工业大学 | Emotional state display method, device and system |
US12303766B2 (en) | 2021-11-08 | 2025-05-20 | Riddell, Inc. | Protective sports helmet with additively manufactured components |
US20240315382A1 (en) * | 2023-03-10 | 2024-09-26 | Alan Carlson | Adjustable Head Engaging Apparatus with Display |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6186145B1 (en) | Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator | |
US5913310A (en) | Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game | |
US5918603A (en) | Method for treating medical conditions using a microprocessor-based video game | |
US5678571A (en) | Method for treating medical conditions using a microprocessor-based video game | |
US5828943A (en) | Modular microprocessor-based diagnostic measurement apparatus and method for psychological conditions | |
US7862506B2 (en) | Diabetes management system | |
US5940801A (en) | Modular microprocessor-based diagnostic measurement apparatus and method for psychological conditions | |
US10322338B2 (en) | Adapting operation of a computing device based on intrinsic motivators | |
US6334778B1 (en) | Remote psychological diagnosis and monitoring system | |
US20130138450A1 (en) | Digital health care environment for implementing and monitoring patient health care for chronic diseases through configurable and interactive tasks | |
US9468852B2 (en) | System and methods for identifying intrinsic motivators, play profiles and play personalities through captured actions in an online environment | |
US11654350B2 (en) | Generating doppelgangers that reflect play personality or intrinsic motivators of a user/subject | |
Kayali et al. | Design considerations for a serious game for children after hematopoietic stem cell transplantation | |
US20080045780A1 (en) | Method for treating medical conditions using a microprocessor-based video game | |
AU731435B2 (en) | Method for treating medical conditions using a microprocessor-based video game | |
Vieira | Study and Development of Custom “Serious Games” for Patients and Users | |
Ching et al. | Gaming health: A goals-means-agency framework for evaluating and designing physical activity games | |
NZ338043A (en) | Method for treating medical conditions using a microprocessor-based video game | |
Faiola et al. | Diabetes education and serious gaming: Teaching adolescents to cope with diabetes | |
Klangpremjit | Rocket ninja: New approaches to the design of diabetic health games for Thai children | |
Tian | Towards a Framework for Estimation of User Susceptibility to Cybersickness | |
Lobo | A Dynamic Difficulty Adjustment Framework for Serious Games Applications in Neurorehabilitation | |
Marçal | Serious Games for an Active Ageing | |
Veltkamp et al. | Adaptive Futuro Cube: Using Dynamic Difficulty Adjustment In Minigames To Train Fine Motor Skills. | |
Vink | Adaptive games for training children’s fine motor skills |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HEALTH HERO NETWORK, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BROWN, STEPHEN J.;REEL/FRAME:011486/0929 Effective date: 20000929 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |